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The Centers for Disease Control and Prevention (CDC) receives, analyzes and disseminates data on CDC-funded HIV testing 
events. Test-level data are reported by CDC grantees through the National HIV Prevention Program Monitoring and Evaluation 
(NHM&E) system. These data can be used to describe the demographics of persons tested, as well as additional programmatic 
activities that are funded by CDC, including important indicators of linkage to HIV medical care and referral to partner services 
and HIV prevention services. The HIV Testing at CDC-Funded Sites Annual Report (hereafter: Annual HIV Testing Report) 
summarizes the test-level NHM&E data for testing events in the United States and dependent areas. 
This report includes HIV testing data from 59 CDC-funded jurisdictions, and would not be possible without the collaboration, 
dedication and hard work of grantees from all state, territorial and local health departments and community-based organizations 
(CBOs). Test-level data were available from 55 of 59 health department jurisdictions, which represents the highest number of 
jurisdictions reporting test-level data in an Annual HIV Testing Report. Aggregate data were reported for 4 health department 
jurisdictions unable to submit test-level data. The Testing Monitoring and Evaluation Team (TMET) in the Division of HIV/AIDS 
Prevention’s (DHAP) Program Evaluation Branch (PEB) reviewed the completeness and quality of the HIV testing data from CDC-
funded jurisdictions in determining data for inclusion in this report. CDC staff worked with all Health Department grantees to 
ensure that their jurisdiction’s HIV testing data were complete. 
NHM&E HIV testing data are intended to be used in conjunction with other relevant information (e.g., progress reports, 
surveillance data, and census data) by HIV program managers and policy makers, HIV testing service providers, CDC project 
officers, evaluators, researchers, and others interested in the public health implications of HIV prevention program activities. 
These data can be utilized as a tool to learn systematically from our work, inform program practice, and more rigorously and 
credibly document program progress toward local, state and national HIV prevention goals. DHAP’s NHM&E HIV testing data 
have been used at the national and local levels for HIV prevention policy, program decision-making, program monitoring, 
evaluation activities, research, presentations, and reports. 
This report includes data submitted to CDC for testing events funded by the following five program announcements: PS10-1001 
funded comprehensive HIV prevention services for 59 health departments; PS07-768 and PS10-10138 funded  expanded HIV 
testing services for disproportionately affected populations for 30 health departments; PS08-0803 funded HIV testing services 
for CBOs in Puerto Rico and U.S. Virgin Islands; PS10-1003 funded HIV prevention interventions for CBOs; and PS06-618 funded 
HIV prevention interventions serving young men of color who have sex with men and young transgendered persons of color 
for CBOs. 
report revision 
The 2011 HIV testing report has been revised from previous years to address the changing needs of programs to access, interpret, 
and utilize their data. These changes include: 
•	 Emphasis on the continuum of HIV testing-related activities, including: 
•	 Tracking newly-identified HIV-positive testing events; 
•	 Informing tested individuals of results; 
•	 Timely linkage to HIV medical care; and 
•	 Referrals to HIV prevention and partner services. 
•	 Provision and description of information about missing/invalid data for continuum of HIV testing-related activities 
indicators; 
•	 Focused reporting of continuum of HIV testing-related activities among newly identified confirmed HIV-positive 
individuals; and 
•	 Inclusion of tables for testing events by gender, test setting (health care including correctional facilities or non-health 
care facilities), and among risk groups of men who have sex with men (MSM), high-risk heterosexual males and high-
risk heterosexual females. 
report Content and organization 
The content of this report provides data related to the goals of the National HIV/AIDS Strategy (NHAS) and the DHAP Strategic 
Plan, specifically 
•	 Reduce the number of persons who become HIV infected; 
•	 Increase access to care and improve health outcomes for persons living with HIV; and 
•	 Reduce HIV related health disparities.  
The report also contributes information to other CDC reporting requirements (e.g., Government Reporting and Results Act or 
Annual HIV Testing Report | 2011|  Introduction | Page 1 
GPRA) and  answers national HIV testing monitoring and evaluation questions for CDC-funded HIV testing programs, including: 
total numbers of HIV testing events and newly identified confirmed HIV-positive testing events both nationally, by jurisdiction 
and by client characteristics; receipt of HIV-positive test results by client characteristics; persons tested by risk category; and 
newly identified confirmed HIV-positive testing events linked to HIV medical care and referred to partner services and HIV 
prevention services. 
This report contains four sections of tables and seven complimentary figures: 
•	 CDC-funded HIV testing events by jurisdiction; 
•	 HIV positivity and receipt of test results; 
•	 Continuum of HIV testing related activities among newly identified confirmed HIV-positive individuals; and 
•	 Risk groups among newly identified confirmed HIV-positive individuals. 
The data presented include all CDC-funded HIV testing events reported to CDC as of April 5, 2013. Table 1 presents both test-
level (55 health department jurisdictions) and aggregate (4 health department jurisdictions) data to provide the most complete 
estimate of CDC-funded testing events in 2011.  All other tables display only test-level data and exclude the four jurisdictions 
treated in aggregate format due to incomplete 2011 data submission (Chicago, Illinois (excluding Chicago), Nevada and the U.S. 
Virgin Islands). Results are summarized in text and figures and technical notes are provided to assist with interpretation. Readers 
are encouraged to review all figure and table titles and footnotes carefully to ensure a complete understanding of the displayed 
data. 
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HIgHlIgHtS oF tHE 2011 rEPort 
1. HIV Testing events 
•	 3.4 million CDC-funded HIV testing events were conducted in the 59 health department jurisdictions in the United 
States, Puerto Rico and the U.S. Virgin Islands. 
•	 3.3 million HIV testing events were submitted to CDC with complete test-level NHM&E data from 55 health department 
jurisdictions. 
•	 Four jurisdictions together accounted for about 30% of all CDC-funded HIV testing events, specifically, Florida (12%), 
North Carolina (6.8%), Texas (excluding Houston) (5.7%), and New York (excluding New York City) (5.1%) (Table 1). 
2. Newly identified confirmed HIV positivity 
•	 There were 18,446 newly identified confirmed HIV-positive individuals for a positivity percentage of 0.6% among 55 
health department jurisdictions submitting test-level data (Table 1). 
•	 The jurisdictions with the highest newly identified confirmed HIV positivity percentages were Arizona (1.3%), Arkansas 
(1.2%), Louisiana (1.1%), Mississippi (1.1%), and Puerto Rico (1.0%) (Table 1). 
•	 The client characteristic or risk groups with highest newly identified confirmed HIV positivity percentages were MSM 
(2.8%) and transgender persons (2.7%) (Tables 21 and 18, Figure 1).  
3. Testing continuum among newly identified confirmed HIV-positive individuals 
•	 93% of newly identified confirmed HIV-positive individuals received their test results (Table 15, Figure 2). 
•	 75% of newly identified confirmed HIV-positive individuals were linked to HIV medical care (Table 15, Figure 2). 
•	 77% of newly identified confirmed HIV-positive individuals were referred to partner services (Table 24, Figure 2). 
•	 64% of newly identified confirmed HIV-positive individuals were referred to HIV prevention services (Table 24, Figure 2). 
4. Missing or invalid data among newly identified confirmed HIV-positive individuals for testing 
continuum indicators 
•	 14% for receipt of test results (Table 15, Figure 2). 
•	 46% for linkage to HIV medical care (Table 15, Figure 2). 
•	 27% for referral to partner services (Table 24, Figure 2). 
•	 46% for referral to HIV prevention services (Table 24, Figure 2). 
5. Programmatic impact 
•	 Compared to previous Annual HIV Testing reports, the data included in this report is more complete and representative 
of all CDC-funded HIV testing programs because data for 55 jurisdictions are reported at the test-level, which is the 
most number of jurisdictions ever reported. 
•	 Compared to data published in the 2010 Annual HIV Testing Report:  
•	 In 2011, increased proportions of newly identified confirmed HIV positive individuals were linked to HIV
medical care (69.8% in 2010), referred to partner services (71.9% in 2010), and referred to HIV prevention
services (61.8% in 2010); and 
•	 In 2011, increased proportions of data were missing/invalid for the indicators of referral to partner services
(25% in 2010) and referral to HIV prevention services (41% in 2010) among newly identified confirmed
HIV-positive individuals. 
•	 The proportions linked to HIV medical care and referred to partner or HIV prevention services are below the NHAS 
objectives and/or GPRA performance goals. There continues to be room for improvement on these indicators. 
•	 The high percentage of missing/invalid linkage to HIV medical care and referral to HIV prevention services data is 
problematic and limits our ability to monitor CDC-funded HIV testing programs for these important indicators. 
Test-level testing events 3,301,519 
Newly identified confirmed HIV-positive individuals 18,446 (0.6%) 
Indicator percentage Missing/invalid
 percentage 
Results received 93.2% 14.0% 
Linked to HIV medical care 74.9% 46.3% 
Referred to partner services 77.4% 28.6% 
Referred to HIV prevention services 64.0% 46.7% 
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In 2011, approximately 3.4 million CDC-funded HIV testing 
events were conducted in the 59 jurisdictions in the United 
States, Puerto Rico and U.S. Virgin Islands. Of those testing 
events, complete test-level NHM&E data were submitted 
to CDC for 3.3 million testing events from 55 jurisdictions. 
Jurisdictions submitting aggregate level data include 
Chicago, Illinois (excluding Chicago), Nevada and the U.S. 
Virgin Islands. Four jurisdictions accounted for about 30% 
of all total testing events, specifically, Florida (12%), North 
Carolina (6.8%), Texas (excluding Houston) (5.8%), and New 
York (excluding New York City) (5.1%) (Table 1). 
By gender, almost equal numbers of testing events were 
conducted among males (1.6 million, 48%) and females (1.7 
million, 51%). A smaller number of tests were conducted 
among transgender persons (6,192, 0.2%) (Table 2). By 
testing site type, a majority of testing events were conducted 
in health care and correctional facilities (2.4 million, 74%) 
compared to non-health care settings (0.7 million, 21%) 
(Table 3). Fewer than one-quarter of all testing events were 
conducted among self-identified high-risk individuals, 
specifically 16% among high-risk heterosexual males, 8% 
among MSM, and 0.4% in high-risk heterosexual females 
(Table 4). 
By age, the largest proportion of testing events were 
conducted among persons aged 20-29 years (1.4 million, 
41%). By race/ethnicity, the largest proportion of tests 
were conducted among blacks or African Americans (1.5 
million, 45%). However, for transgender persons (2,185, 
35%) and MSM (111,514, 45%), the largest proportion of 
tests were conducted among Hispanics/Latinos and whites, 
respectively. By U.S. geographic region, the majority of tests 
were conducted in the South (2.0 million, 59.1%). However, 
for transgender persons, the largest proportion of tests were 
conducted in the West (2,033, 33%). Lastly, by test technology, 
the majority of testing events were conducted using a rapid 
test (1.9 million, 57%) (Tables 5-13). 
Receipt of test result varied with preliminary HIV-positive test 
results received by individuals more often (97% received) 
than confirmed positive (94% received) results. Missing/ 
invalid data percentages also varied, with most complete 
receipt of test result data submitted for preliminary positive 
test results (4% missing/invalid) (Table 14). 
HIV positivity 
In 2011, 29,540 preliminary or confirmed HIV-positive testing 
events were submitted by the 55 jurisdictions providing test-
level data, for a positivity percentage of 0.9%. HIV positivity 
was highest for San Francisco (1.9%), Arizona, Colorado, 
and Puerto Rico (each 1.7%), Houston (1.6%), Arkansas and 
Washington (both 1.5%). 
Of all 2011 test-level HIV testing events, 18,446 were 
newly identified confirmed HIV-positive testing events, 
representing newly diagnosed individuals, for a positivity 
percentage of 0.6%. The highest newly identified confirmed 
HIV positivity percentages were reported for MSM (2.8%) and 
transgender persons (2.7%) (Figure 1, Tables 21 and 18). By 
health department jurisdiction, newly identified confirmed 
HIV positivity was highest for Arizona (1.3%) and Arkansas 
(1.2%) (Table 1). Groups  with positivity percentages greater 
than the national average of 0.6% are age group 40-49 years 
(0.8%), blacks or African Americans (0.7%), males (0.9%),  
those tested in non-health care facilities (0.8%), and those 
tested in the U.S. Western region (0.7%) (Figure 1, Tables 15­
23). 
testing continuum among 
newly identified confirmed 
HIV-positive individuals 
In 2011, among all newly identified confirmed HIV-positive 
individuals, 93% received their test results, 75% were linked 
to HIV medical care, 77% were referred to partner services, 
and 64% were referred to HIV prevention services (Figure 2, 
Tables 15 and 24). 
Receipt of HIV test results 
The lowest percentages for receipt of HIV test results were 
among persons aged 13-19 years (85%, Figure 3a, Table 
15) and females (76%, Figure 4a, Table 17). Receipt of HIV 
test result percentages were at least 90% for all other client 
characteristics (Tables 15-23, Figures 3a, 4a, 5a, 6a, 7a and 8a). 
Linkage to HIV medical care 
The proportion of newly identified confirmed HIV-positive 
individuals linked to HIV medical care increased over the 
past year from 70% in 2010 to 75% in 2011. Linkage to HIV 
medical care percentages varied by client characteristics: 
y Age – 70% in the 13-19 age group to 77% in the 30-39 
age group (Figure 3a, Table 15); 
y Gender –72% in transgender persons to 76% in 
females (Figure 4a, Tables 16-18); 
y Testing site type – 72% in health care and correctional 
facilities to 80% in non-health care facilities (Figure 5a, 
Tables 19-20); 
y Race/ethnicity – 70% in multi-race individuals to 85% 
in Asians (Figure 6a, Table 15); 
y U.S. geographic region – 57% in the Midwest to 78% in 
the Northeast (Figure 7a, Table 15); and 
y Risk group – 77% in MSM to 82% in high-risk 
heterosexual females (Figure 8a, Tables 21-23). 
The improvement in the proportion of newly identified 
confirmed HIV-positive individuals who were linked to HIV 
medical care from 2010 to 2011 indicates that CDC-funded 
HIV testing programs are making progress towards achieving 
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 the NHAS objective of 85% of newly diagnosed individuals 
being linked to clinical care by 2015 (Figure 2, Table 15). 
Continued improvement is required to ensure CDC-funded 
HIV testing programs meet the NHAS objective. 
Referral to partner services 
The proportion of newly identified confirmed HIV-positive 
individuals referred to partner services increased over 
the past year, from 72% to 77% in 2011, indicating further 
progress in increasing access to partner services nationally 
(Figure 2, Table 24)  Additionally, the 2011 GPRA target for 
this indicator was 72%, and this target was surpassed in 2011. 
Referral to partner services varied by client characteristics: 
y Age – 73% in 40-49 and 50+ age groups to 83% in the 
13-19 age group (Figure 3b, Table 24); 
y Gender – 76% in females to 78% in males (Figure 4b, 
Tables 25-27); 
y Testing site type – 74% in health care and correctional 
facilities to 81% in non-health care facilities (Figure 5b, 
Tables 19-20); 
y Race/ethnicity – 74% in Hispanics/Latinos to 80% in 
multi-race individuals (Figure 6b, Table 24); 
y U.S. geographic region – 60% in the Northeast to 86% 
in the Midwest (Figure 7b, Table 24); and 
y Risk group – 82% in high-risk heterosexual males to 
86% in MSM (Figure 8b, Tables 30-32). 
The percentage of individuals referred to partner services was 
relatively high for individuals aged 13-19 years (83%), blacks 
or African Americans (79%), high-risk heterosexual males 
(82%), and high-risk heterosexual females (84%) suggesting 
that CDC-funded jurisdictions are providing partner services 
activities to prioritized groups (Figures 3b, 6b and 8b, Tables 
24, 31 and 32). The percentage referred to partner services 
was lowest in the Northeast (60% referred, Figure 7b, Table 
24). 
Referral to HIV prevention services 
The proportion of newly identified confirmed HIV-positive 
individuals referred to HIV prevention services increased 
over the past year, from 62% to 64% (Figure 2, Table 24). 
Additionally, the 2011 GPRA target for this indicator was 64%, 
and this target was met in 2011, yet improvement is needed 
among many client groups. Referral to HIV prevention 
services varied by client characteristics: 
y Age – 61% in the 50+ age group to 73% in the 13-19 
age group (Figure 3b, Table 24); 
y Gender – 62% in females to 72% in transgender 
persons (Figure 4b, Tables 25-27); 
y Testing site type – 60% in health care and correctional 
facilities to 70% in non-health care facilities (Figure 5b, 
Tables 19-20); 
y Race/ethnicity – 61% in Hispanics/Latinos to 74% in 
multi-race individuals (Figure 6b, Table 24); 
y U.S. geographic region – 55% in the Northeast to 82% 
in the Midwest (Figure 7b, Table 24); and 
y Risk group – 72% in MSM to 73% in high-risk 
heterosexual females (Figure 8b, Tables 30-32). 
risk category among newly 
identified confirmed HIV-
positive individuals 
The most commonly reported risk category among newly 
identified confirmed HIV-positive individuals was male-to-
male sexual contact, for both all newly identified confirmed 
HIV-positive individuals (37%) and newly identified confirmed 
HIV-positive males (47%). Among newly identified confirmed 
HIV-positive females, the most common risk category was 
high-risk heterosexual contact (47%). Risk data were not 
reported for 26% of newly identified confirmed HIV-positive 
clients due to the client not being asked about risk (13%), 
client declined to discuss risk (0.4%), or data were missing/ 
invalid (13%) (Tables 33-34). 
Missing/invalid indicator 
data among newly identified 
confirmed HIV-positive 
individuals 
Missing/invalid data result from a jurisdiction either not 
collecting required data elements, collecting but not 
reporting required data elements or reporting invalid value 
codes for required data elements. Missing/invalid data 
percentages varied widely by indicator, with result received 
having the least missing/invalid data (14%), followed by 
referral to partner services (29%), linkage to HIV medical care 
(46%) and referral to HIV prevention services (47%) having 
the most (Figure 2, Tables 15 and 24). 
By client characteristic groups, there was little variability 
in the percentage of missing data by indicator among age 
groups (Figures 3a and 3b, Tables 15 and 24) and risk groups 
(Figures 8a and 8b, Tables 21-23 and 30-32). 
Indicator data were more often missing/invalid for health 
care and correctional facilities, compared to non-health care 
facilities (Figures 5a and 5b, Tables 19-20 and 28-29); blacks 
or African Americans compared to other race/ethnicity 
groups (Figures 6a and 6b, Tables 15 and 24); and the South 
compared to other U.S. geographic regions (Figures 7a and 
7b, Tables 15 and 24). 
Indicator data were more often complete for transgender 
persons compared to males or females (Figures 4 and 4b, 
Tables 16-18 and 25-27). 
Missing/invalid indicator data are problematic because 
without complete data, it is difficult to monitor and evaluate 
CDC-funded HIV testing program’s progress on key DHAP 
and NHAS targets, and GPRA goals. Jurisdictions should 
strive to minimize the missing/invalid data submitted to 
CDC’s NHM&E system. 
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National HIV Prevention Monitoring & Evaluation HIV testing data 
collection 
The 2011 National HIV Prevention Program Monitoring & Evaluation (NHM&E) HIV testing data were submitted to CDC by health 
department and community-based organization (CBO) grantees through CDC’s Program Evaluation and Monitoring System 
(PEMS), EvaluationWeb® or CDC’s Secure Data Network (SDN). Health departments and CBOs were required to submit data a 
minimum of twice annually (March and September). This report includes all testing events occurring in 2011 that were reported 
to CDC by April 5, 2013. 
NHM&E data are submitted to CDC in a standard format. A data collection template is provided to all jurisdictions that includes 
required data fields. Health departments and CBOs are able to modify this template to better meet their local programmatic 
needs, however required data fields cannot be omitted. 
Data quality assurance monitoring & grantee feedback 
The Testing Monitoring and Evaluation Team (TMET) of the Program Evaluation Branch in the Division of HIV/AIDS Prevention are 
tasked with ensuring quality and validity of the NHM&E HIV testing data1. To meet this goal, a standardized, robust, data quality 
check is performed bi-annually after each data submission deadline. All required data fields are checked to ensure a minimum 
of missing/invalid data. Additional attention is paid to required data fields utilized in calculation of indicators, including result 
received, linkage to HIV medical care, referral to partner services and referral to HIV prevention services, and the behavioral risk 
hierarchy. Conference calls are scheduled with each health department jurisdiction to review the quality of the data, allow for 
discussion of any areas for improvement, and to instruct on high-priority data fields requiring edits or updates. 
Additionally, grantees are encouraged to develop and use data quality assurance protocols and procedures to improve and 
maintain high-quality data. As required in CDC program announcements that support CDC-funded testing activities, all CDC 
grantees must put in place processes to ensure programmatic quality (e.g., providing HIV test results to clients promptly and 
linking confirmed HIV-positive clients to HIV medical care). 
Interpretation of HIV testing data 
When interpreting data in this report, several points should be considered. First, some findings may be influenced by whether 
testing sites promoted and followed policies of routine or targeted HIV testing. For example, the number of HIV testing events 
may be lower in geographic locations or sites with targeted testing; and correspondingly, the HIV positivity in these locations or 
sites may be higher. Second, the population of persons using CDC-funded sites or other publicly-funded sites for HIV testing is not 
necessarily representative of all persons who are tested in the United States. This report does not include information about HIV 
testing services that were supported by the Departments of Defense, Justice, Labor, and Veterans Affairs; Centers for Medicare and 
Medicaid Services; Health Resources and Services Administration; Substance Abuse and Mental Health Services Administration; 
agencies of the U.S. Public Health Service other than CDC; state and local health departments; and the private sector. Third, it is 
not possible to link the results of repeat HIV testing events for the same person if, for example, a person has more than one testing 
event that is represented in these data. However, the definition of newly identified confirmed HIV positivity used in this report 
minimizes this limitation for persons who are newly identified, because records for which there is a current HIV-positive test result 
and a history of a previous HIV-positive test are excluded. Fourth, the HIV testing data are collected for HIV prevention program 
activities in conjunction with a health service delivery, which means the information collected by service providers is not routinely 
validated through research or epidemiologic investigation. Finally, the comparability of these data across health departments 
may be limited due to differences in data collection, quality assurance, or quality improvement activities that occur at the state or 
local levels. Comparability within a health department may be limited as well. 
1For the data included in this report, the grantee feedback activity was coordinated by Argelia Figueroa. CDC staff (NaTasha Hollis, Erin Sizemore and Tanja 
Walker), Northrup Grumman staff (Nicoline Collins, Courtnee Edgerston, Nadia Ennis, Takiyyah Hamilton, Lisa JeanCharles, Orazie Slayton and Tureka 
Watson) and ICF Macro staff (Alison Newell) worked diligently on this activity. 
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Definitions 
Age 
The age of the client at the testing event and determined by calculating the difference between the year of a client’s birth and 
the year of the HIV testing event. 
Data designation 
Aggregate data 
Total HIV testing events and confirmed HIV-positive test events reported by health department jurisdictions when complete 
test-level data were not submitted to CDC. In this report, aggregate data were reported for Chicago, Illinois (excluding 
Chicago), Nevada and U.S. Virgin Islands. These health department jurisdictions were unable to submit all test-level NHM&E 
data due to local staffing and technical issues. 
Invalid data 
Required data fields with a test-level HIV testing record that were submitted by the health department jurisdiction but do 
not conform to the value codes for a data element stated in the NHM&E Data Variable Set (DVS). 
Missing data 
Required data fields with a test-level valid HIV testing record that were not submitted by the health department jurisdiction. 
These data fields were either not collected by the health department jurisdiction or were collected but not reported to CDC. 
Test-level data 
The data reported by health department jurisdictions for each HIV test conducted, including individual demographics, HIV 
test data, and, when appropriate, behavioral risk, linkage to HIV medical care and referral to partner and HIV prevention 
services data. For this report, test-level data were reported for 55 health department jurisdictions. 
Data variable set (DVS) 
The data dictionary including all NHM&E data elements, including mandatory, required and allowed data elements. Information 
provided in the DVS included variable number, name, schema name, format type, minimum and maximum length, value 
codes, instructions and definitions. 
Gender 
The client’s self-reported current gender identity. This may include one’s social status, self-identification, legal status, and 
biology. Current gender identity is submitted to CDC as male, female, male-to-female transgender (an individual whose 
physical or birth sex is male, but whose gender expression and/or gender identity is female), or female-to-male transgender 
(an individual whose physical or birth sex is female, but whose gender expression and/or gender identity is male). For this 
report, gender is reported as male, female, and transgender. 
Linkage to HIV medical care 
HIV medical care includes medical services for HIV infection including evaluation of immune system function and screening, 
treatment and prevention of opportunistic infections. 
This calculated indictor measures the extent to which clients with a confirmed HIV-positive test result were linked to HIV 
medical care. In order for a client to be linked to care, the client must both be referred to HIV medical care and attend the first 
medical care appointment. Missing/invalid data in either of those fields are excluded when determining the percentage of 
clients linked to HIV medical care. 
Race/Ethnicity 
Race is defined as a client’s self-reported classification of the biological heritage with which they most closely identify. Ethnicity 
is defined as a client’s self-report of whether they are Hispanic or Latino. Up to five races and one ethnicity (i.e., Hispanic or 
Latino) for a client are allowed and submitted to CDC as separate variables. For this report, a “race/ethnicity” variable was 
created by combining the race and ethnicity variables using the following categories and hierarchy: 
•	 Hispanic or Latino (“Hispanic or Latino” in the ethnicity variable regardless of the race variables) 
•	 Remaining clients who selected “Not Hispanic or Latino” for the ethnicity variable were categorized as: 
•	 White 
•	 Black or African American 
•	 Asian 
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•	 American Indian or Alaska Native 
•	 Native Hawaiian or Pacific Islander 
•	 Multi-race (clients who selected more than one race) 
•	 Declined 
•	 Don’t know 
•	 Invalid 
•	 Missing 
Rapid test used in testing event 
This calculated variable indicates whether a rapid test technology was used in an HIV testing event. A value of “yes” indicates 
that at least one test within a testing event was done using a rapid technology but does not mean that all tests were done 
using a rapid technology. 
Referral to HIV prevention services 
HIV prevention services are defined as any service or intervention directly aimed at reducing risk for transmitting or acquiring 
HIV infection (e.g. prevention counseling, diffusion of effective behavioral interventions, risk-reduction counseling). It excludes 
indirect services such as mental health services or housing. 
This calculated indicator measures the extent to which clients with a confirmed HIV-positive test result were given a referral 
to HIV prevention services. Missing/invalid data are excluded when determining the percentage of clients referred to HIV 
prevention services. 
Referral to partner services 
Partner services include a range of available services for newly and previously diagnosed HIV-infected persons, their partners 
and affected communities. Services may include: informing current and past sex partners that a person who is HIV-infected 
has identified them as a sex or injection-drug-paraphernalia-sharing partner and advising them to have HIV counseling and 
testing. Additionally, it can include notifying partners, who may not have suspected that they were at increased risk for HIV, 
that they can be tested for HIV. 
This calculated indicator measures the extent to which clients with a confirmed HIV-positive test result were given a referral to 
partner services. Missing/invalid data are excluded when determining the percentage of clients referred to partner services. 
Results received 
This calculated indicator measures the extent to which clients received HIV test results from the initial testing site or obtained 
the results from another agency for at least one HIV test in the testing event, regardless of the HIV test technology or how many 
tests were conducted. Missing/invalid data for the result received variables are excluded when determining the percentage of 
clients who received test results. 
Risk category 
Risk factor information for NHM&E data are collected from the client for risks during the 12 months prior to the HIV testing 
event. For this report, mutually exclusive risk categories are determined for confirmed HIV-positive individuals using a 
combination of risk behaviors and gender of the client (males and females only). The risk behaviors collected include vaginal, 
anal or oral sex with male or female, sex without using a condom, sex with a person who is an injection drug user, sex with a 
person who has male-to-male-sexual contact (females only), sex with a person who is HIV-positive, use of injection drugs, and 
sharing of injection drug equipment among injection drug users. 
The risk categories are ordered hierarchically based on the most likely presumed risk for exposure to HIV as follows: 
•	 Male-to-male-sexual contact and injection drug use – includes male clients who reported both male-to-male-sexual 
contact and injection drug use 
•	 Male-to-male sexual contact – includes male clients who reported male-to-male-sexual contact 
•	 Injection drug use – includes clients who reported injection drug use 
•	 High-risk heterosexual contact – includes clients who reported heterosexual contact and at least one risk behavior 
(other than injection drug use) 
•	 Low-risk heterosexual contact – includes clients who reported heterosexual contact but did not report any other risk 
behaviors. 
•	 Other – includes female-to-female sexual contact with no report of injection drug use 
•	 No acknowledged risk – includes clients who were asked about risk behaviors but none were identified 
•	 Not asked about risk – includes clients who were not asked about risk behaviors 
•	 Declined to discuss risk – includes clients who declined to discuss risk behaviors 
•	 No data – includes clients in which no risk behavior data were reported despite being asked about risk behaviors 
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Testing events 
HIV testing event 
An HIV testing event is a sequence of one or more HIV tests conducted with a client to determine his or her HIV status. 
During one testing event, a client may be tested once (e.g., one rapid test or one conventional test) or multiple times (e.g., 
one rapid test followed by one conventional test to confirm a preliminary HIV-positive test result). 
Invalid HIV testing event 
An HIV test is considered invalid if all of the following variables have missing data: test election (i.e., anonymous or 
confidential), test technology (i.e. conventional, rapid, or “other”), specimen type (i.e. blood, oral mucosal transudate, or 
urine), test result (i.e., negative, positive, indeterminate, “invalid,” or “no result”), and results received (i.e., yes or no). Such 
records (<0.1% of the total records for 2011) are not included in this report. 
Testing record 
Invalid testing record 
Required data fields within a test-level valid HIV testing record that do not conform to the data structure specified by CDC, 
for example, illogical dates (02/30/2011), incomplete dates (02/2011), future years, unacceptable value codes, or unexpected 
data based upon skip patterns in the data collection form. 
Valid HIV testing record 
A test-level data record that includes the mandatory data fields of session date, agency ID, intervention ID, site ID, site type 
and client ID. A test-level testing record cannot be submitted without the mandatory data fields. 
Test results 
Confirmed HIV-positive result 
A testing event with a positive test result for a conventional HIV test (positive EIA test confirmed by supplemental testing, 
e.g., Western Blot) or a nucleic acid amplification test (NAAT). 
HIV-positive result
 
A testing event with a positive test result regardless of test technology. 

Newly identified confirmed HIV-positive result 
A confirmed HIV-positive test result associated with a client who reports either no data on a previously conducted HIV test, 
no previously conducted HIV test or a previous HIV test without a positive result. 
Preliminary HIV-positive result 
A testing event with a positive test result from a rapid HIV test without a documented positive confirmatory test results. 
Testing site type 
Testing site type is defined as the setting at which HIV testing is provided, and for this report, classified into the following 
categories: 
•	 Healthcare and correctional facilities – includes inpatient facilities, outpatient facilities, emergency rooms and 
correctional facilities 
•	 Non-healthcare facilities – includes HIV counseling and testing sites and community settings 
•	 Other facilities – includes blood banks/plasma centers and any other not previously listed facilities 
•	 Invalid – the site code submitted for the facility is not one of the acceptable site codes 
•	 Missing – no site code is submitted for the testing event 
U.S. geographic region 
The four U.S. geographic regions as designated by the U.S. Census Bureau. Specifically: 
•	 Northeast – Connecticut, Maine, Massachusetts,  New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island 
and Vermont; 
•	 Midwest – Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota 
and Wisconsin; 
•	 South – Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, 
North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia and West Virginia 
•	 West – Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington 
and Wyoming. 
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Figure 1: Newly identified confirmed HIV positivity percentages by characteristics of individuals tested, 55 health
department jurisdictions submitting test-level data in the United States and Puerto Rico, 2011 
Age < 13 years, American Indian/Alaska Natives and Native Hawaiian/Pacific Islanders are omitted due fewer than 100 newly identified confirmed HIV-positive testing events 
conducted and the potential for unreliable estimates.
Puerto Rico is omitted from U.S. geographic region.
Please refer to tables 15-23 for figure data. 
The newly identified confirmed HIV positivity percentage in the 55 CDC-funded health 
department jurisdictions submitting test-level NHM&E data in the United States and 
Puerto Rico in 2011 was 0.6% (18,446/3,301,519), as depicted by the dashed line. 
Red bars indicate client characteristics in which the HIV positivity percentage is greater 
than 0.6%. 
13-19 
Male 
Health care and correctional facilities 
White 
Northeast 
Male-to-male sexual contact 
Hispanic/Latino 
South 
High-risk heterosexual female 
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High-risk heterosexual male 
Asian 
West 
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 Figure 2: Testing continuum indicators among newly identified confirmed HIV-positive individuals, including
indicator and missing/invalid data percentages, 55 health departments submitting test-level data in the United States 
and Puerto Rico, 2011 
test result received: 93.2% Not 
received: 
6.8% 
Missing/invalid: 
14.0% 
linked to HIV medical care: 74.9% 
Not linked: 25.1% 
Missing/invalid: 46.3% 
referred to partner services: 77.4% 
Not referred: 22.6% 
Missing/invalid: 28.6% 
referred to HIV prevention services: 64.0% 
Not referred: 36.0% 
Missing/invalid: 46.7% 
Indicator percentages sum to 100% and exclude missing data.
Denominator for ‘Missing/invalid’ data percentage is all newly identified confirmed HIV-positive test events from 55 jurisdictions providing test-level data:  18,446
Please refer to tables 15 and 24 for figure data. 
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Figure 3a: Receipt of test results and linkage to HIV medical care among newly
identified confirmed HIV-positive individuals, by age group, including indicator 
and missing/invalid percentages, 55 health department jurisdictions submitting
test-level data in the United States and Puerto Rico, 2011 
Not received Result received Missing/invalid Result Received 
13-19 years – 85.1% 
20-29 years  – 92.1% 
30-39 years – 94.5% 
40-49 years – 94.7% 
50+ years – 94.1% 
14.6% 
14.9% 
14.0% 
13.6% 
13.4% 
Not linked Linked Missing/invalid Linkage to HIV Medical Care 
40-49 years – 75.0% 
30-39 years – 76.7% 
20-29 years – 73.8% 
13-19 years – 69.7% 
50+ years – 74.4% 
44.7% 
46.5% 
46.4% 
46.8% 
51.1% 
Age group < 13 years is omitted due to fewer than 100 newly identified confirmed HIV-positive testing events conducted and the potential 
for unreliable estimates. 
Indicator percentages sum to 100% and exclude ‘Missing/invalid’. 
Denominator for ‘Missing/invalid’ percentage is all newly identified confirmed HIV-positive testing events in applicable age group.
Please refer to Table 15 for figure data. 
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Figure 3b: Referrals to partner and HIV prevention services among newly identified 
confirmed HIV-positive individuals, by age group, including indicator and missing/
invalid percentages, 55 health department jurisdictions submitting test-level data in 
the United States and Puerto Rico, 2011 
Not referred Referred Missing/invalid Referral to partner services 
13-19 years – 83.2% 
27.6%
 
20-29 years – 79.6% 
27.8%
 
30-39 years – 77.9% 
27.7%
 
40-49 years – 73.3% 
30.8%
 
50+ years – 73.3% 
30.3%
 
Not referred Referred Missing/invalid Referral to HIV prevention services 
13-19 years – 72.6% 
54.0%
 
20-29 years – 66.6% 
46.6%
 
30-39 years – 63.9% 
45.8%
 
40-49 years – 60.9% 
47.6%
 
50+ years – 60.6% 
47.6%
 
Age group < 13 years is omitted due to fewer than 100 newly identified confirmed HIV-positive testing events conducted and the potential 
for unreliable estimates. 
Indicator percentages sum to 100% and exclude ‘Missing/invalid’. 
Denominator for ‘Missing/invalid’ percentage is all newly identified confirmed HIV-positive testing events in applicable age group.
Please refer to Table 24 for figure data. 
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Figure 4a: Receipt of test results and linkage to HIV medical care among newly identified 
confirmed HIV-positive individuals, by gender, including indicator and missing/invalid 
percentages, 55 health department jurisdictions submitting test-level data in the United 
States and Puerto Rico, 2011 
Not received Result received Missing/invalid Result Received 
Male – 94.2% 
Female – 89.6% 
transgender – 97.0% 
13.3% 
17.1% 
1.2%
 
Not linked Linked Missing/invalid Linked to HIV medical care 
Male – 74.6% 
Female – 76.2% 
transgender – 71.6% 
45.3%
 50.6% 
34.3% 
Indicator percentages sum to 100% and exclude ‘Missing/invalid’. 
Denominator for ‘Missing/invalid’ percentage is all newly identified confirmed HIV-positive testing events in applicable gender group.
Please refer to Tables 16-18 for figure data. 
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Figure 4b: Referrals to partner and HIV prevention services among newly identified 
confirmed HIV-positive individuals, by gender, including indicator and missing/invalid 
percentages, 55 health department jurisdictions submitting test-level data in the United 
States and Puerto Rico, 2011 
Not referred Referred Missing/invalid Referred to partner services 
Male – 77.7% 
28.0%
 
Female – 75.6% 
31.2%
 
transgender– 77.3% 
20.5%
 
Not referred Referred Missing/invalid Referred to HIV prevention services 
Male – 64.4% 
44.9%
 
Female – 61.6% 
53.9%
 
transgender– 71.8% 
29.5%
 
Indicator percentages sum to 100% and exclude ‘Missing/invalid’. 
Denominator for ‘Missing/invalid’ percentage is all newly identified confirmed HIV-positive testing events in applicable gender group.
Please refer to Tables 25-27 for figure data. 
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 Figure 5a: Receipt of test results and linkage to HIV medical care among newly
identified confirmed HIV-positive individuals, by testing site type, including indicator 
and missing/invalid percentages, 55 health department jurisdictions submitting test-
level data in the United States and Puerto Rico, 2011 
Not received Result received Missing/invalid Result Received 
Health care and correctional facilities – 91.0% 
19.5% 
Non-health care facilities – 96.6% 
3.4% 
Not linked Linked Missing/invalid Linked to HIV medical care 
Health care and correctional facilities – 72.4% 
49.0% 
Non-health care facilities – 79.9% 
37.1% 
Indicator percentages sum to 100% and exclude ‘Missing/invalid’. 
Denominator for ‘Missing/invalid’ percentage is all newly identified confirmed HIV-positive testing events in applicable
testing site type group.
Please refer to Tables 19-20 for figure data. 
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Figure 5b: Referrals to partner and HIV prevention services among newly identified 
confirmed HIV-positive individuals, by testing site type, including indicator and missing/ 
invalid percentages, 55 health department jurisdictions submitting test-level data in the 
United States and Puerto Rico, 2011 
Not referred Referred Missing/invalid Referred to partner services 
Health care and correctional facilities – 73.9% 
34.3% 
Non-health care facilities – 81.0% 
18.9% 
Not referred Referred Missing/invalid Referred to HIV prevention services 
Health care and correctional facilities – 60.1% 
50.6% 
Non-health care facilities – 69.6% 
35.6% 
Indicator percentages sum to 100% and exclude ‘Missing/invalid’. 
Denominator for ‘Missing/invalid’ percentage is all newly identified confirmed HIV-positive testing events in applicable testing site type 
group.
Please refer to Tables 28-29 for figure data. 
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Figure 6a: Receipt of test results and linkage to HIV medical care among newly identified 
confirmed HIV-positive testing events, by race/ethnicity, including indicator and missing/ 
invalid percentages, 55 health departments submitting test-level data in the United 
States and Puerto Rico, 2011 
Not received Result received Missing/invalid Result Received 
White – 94.8% 
14.0%
 
Black/African American – 92.2% 
18.3%
 
2.7% 
Hispanic/latino – 97.0% 
Asian – 98.4% 
7.7%
 
Multi-race –  95.2% 
2.4% 
Not linked Linked Missing/invalid Linkage to HIV medical care 
White – 75.7% 
43.2%
 
Black/African American – 72.2% 
50.6%
 
Hispanic/latino – 81.2% 
31.4%
 
Asian – 84.6% 
40.6%
 
Multi-race – 70.4% 
36.2%
 
American Indian/Alaska Natives and Native Hawaiian/Pacific Islanders are omitted due to less than 100 newly identified confirmed HIV-
positive testing events conducted and the potential for unreliable estimates.
Indicator percentages sum to 100% and exclude ‘Missing/invalid’. 
Denominator for ‘Missing/invalid’ percentage is all newly identified confirmed HIV-positive testing events in applicable race/ethnicity 
group.
Please refer to Table 15 for figure data. 
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Figure 6b: Referrals to partner and HIV prevention services among newly identified 
confirmed HIV-positive individuals, by race/ethnicity, including indicator and missing/ 
invalid percentages, 55 health department jurisdictions submitting test-level data in the 
United States and Puerto Rico, 2011 
Referred Not referred Missing/invalid Referral to partner services 
Asian – 75.9% 
21.7% 
White – 76.9% 
26.7% 
Black/African American – 78.5% 
33.6% 
Hispanic/latino – 73.7% 
14.2% 
Multi-race – 79.8% 
22.0% 
Referred Not referred Missing/invalid Referral to HIV prevention services 
Asian – 72.5% 
26.1% 
White – 63.4% 
38.4% 
Black/African American – 65.5% 
54.5% 
Hispanic/latino – 61.4% 
26.5% 
Multi-race – 74.2% 
29.9% 
American Indian/Alaska Natives and Native Hawaiian/Pacific Islanders are omitted due to less than 100 newly identified confirmed HIV-
positive testing events conducted and the potential for unreliable estimates.
Indicator percentages sum to 100% and exclude ‘Missing/invalid’. 
Denominator for ‘Missing/invalid’ percentage is all newly identified confirmed HIV-positive testing events in applicable race/ethnicity 
group.
Please refer to Table 24 for figure data. 
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Figure 7a: Receipt of test results and linkage to HIV medical care among newly identified 
confirmed HIV-positive individuals, by geographic region, including indicator and 
missing/invalid percentages, 54 health department jurisdictions submitting test-level 
data in the United States, 2011 
Not received Result received Missing/invalid Result Received 
Midwest – 93.1% 
Northeast – 97.7% 
2.2% 
0.2%
 
South – 91.1% 
20.4%
 
West – 96.7% 
5.9%
 
Not linked Linked Missing/invalid Linkage to HIV medical care 
Northeast – 77.8% 
33.8%
 
Midwest – 57.0% 
43.3%
 
South – 75.9% 
53.2%
 
West – 74.7% 
36.0%
 
Puerto Rico is omitted. 
Indicator percentages sum to 100% and exclude ‘Missing/invalid’. 
Denominator for ‘Missing/invalid’ percentage is all newly identified confirmed HIV-positive testing events in applicable region group.
Please refer to Table 15 for figure data. 
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Figure 7b: Referral to partner and HIV prevention services among newly identified 
confirmed HIV-positive individuals, by geographic region, including indicator and 
missing/invalid percentages, 54 health department jurisdictions submitting test-level 
data in the United States, 2011 
Referred Not referred Missing/invalid Referral to partner services 
West –  85.3% 
20.1% 
Northeast – 59.5% 
24.0% 
Midwest – 85.8% 
28.1% 
South – 79.6% 
32.2% 
Referral to HIV prevention services Referred Not referred Missing/invalid 
West – 66.5% 
18.5% 
Northeast – 54.6% 
20.9% 
Midwest – 82.1% 
27.5% 
South – 62.1% 
62.2% 
Puerto Rico is omitted. 
Indicator percentages sum to 100% and exclude ‘Missing/invalid’ data.
Denominator for ‘Missing/invalid’ percentage is all newly identified confirmed HIV-positive testing events in applicable region group.
Please refer to Table 24 for figure data. 
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Figure 8a: Receipt of test results and linkage to HIV medical care among newly identified 
confirmed HIV-positive individuals, by risk groups, including indicator and missing/ 
invalid percentages, 55 health department jurisdictions submitting test-level data in the 
United States and Puerto Rico, 2011 
Not received Result received Missing/invalid Result Received 
High-risk heterosexual female – 91.0% 
8.9% 
High-risk heterosexual male – 94.6% 
7.1% 
Male-to-male sexual contact – 97.0% 
8.4% 
Not linked Linked Missing/invalid Linkage to HIV medical care 
Male-to-male sexual contact – 77.3% 
39.0% 
High-risk heterosexual male – 79.4% 
41.5% 
High-risk heterosexual female – 82.0% 
41.0% 
Indicator percentages sum to 100% and exclude ‘Missing/invalid’. 
Denominator for ‘Missing/invalid’ percentage is all newly identified confirmed HIV-positive testing events in applicable risk group.
Please refer to Tables 21-23 for figure data. 
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Figure 8b: Referral to partner and HIV prevention services among newly identified 
confirmed HIV-positive individuals, by risk groups, including indicator and missing/
invalid percentages, 55 health department jurisdictions submitting test-level data in the 
United States and Puerto Rico, 2011 
Referred Not referred Missing/invalid Referral to partner services 
Male-to-male sexual contact – 86.4% 
19.3%
 
High-risk heterosexual male – 81.9% 
20.8%
 
High-risk heterosexual female – 83.7% 
20.8%
 
Referred Not referred Missing/invalid Referral to HIV prevention services 
Male-to-male sexual contact – 72.2% 
36.1%
 
High-risk heterosexual male – 72.4% 
44.0%
 
High-risk heterosexual female – 73.1% 
49.2%
 
Indicator percentages sum to 100% and exclude ‘Missing/invalid’. 
Denominator for ‘Missing/invalid’ percentage is all newly identified confirmed HIV-positive testing events in applicable risk group.
Please refer to Tables 30-32 for figure data. 
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table Section 1 

CDC-funded HIV testing events by 
jurisdiction 
table 1: Number of HIV testing events and HIV positivity percentages by CDC-funded health department jurisdiction, United States, Puerto 
Rico and the U.S. Virgin Islands, 2011 
CDC-funded  
health department jurisdiction 
HIV testing 
events 
Number 
HIV-positive 
testing events 
Number (Positive %) 
Preliminary HIV-positive 
testing events 
Number (Positive %) 
Confirmed HIV-positive 
testing events 
Number (Positive %) 
Newly identified confirmed HIV-
positive testing events 
Number (Positive %) 
Alabama 103,398 606 (0.6) 0 (0) 606 (0.6) 380 (0.4) 
Alaska 1,996 3 (0.2) 1 (0.1) 2 (0.1) 2 (0.1)
 
Arizona 24,002 403 (1.7) 18 (0.1) 385 (1.6) 323 (1.3)
 
Arkansas 44,784 664 (1.5) 36 (0.1) 618 (1.4) 544 (1.2) 
California 
Los Angeles 91,302 1,131 (1.2) 311 (0.3) 820 (0.9) 692 (0.8) 
San Francisco 42,059 809 (1.9) 166 (0.4) 643 (1.5) 384 (0.9) 
California  
  (excludes Los Angeles and  
  San Francisco) 
49,202 516 (1.0) 200 (0.4) 316 (0.6) 279 (0.6) 
Colorado 13,692 237 (1.7) 64 (0.5) 173 (1.3) 130 (0.9) 
Connecticut 28,271 99 (0.4) 13 (0) 86 (0.3) 71 (0.3) 
Delawarea 10,676 67 (0.6) 15 (0.1) 52 (0.5) 40 (0.4) 
District of Columbia 129,464 897 (0.7) 714 (0.6) 183 (0.1) 169 (0.1) 
Florida 417,274 4,981 (1.2) 429 (0.1) 4,552 (1.1) 2,734 (0.7) 
Georgia 117,110 1,089 (0.9) 145 (0.1) 944 (0.8) 672 (0.6) 
Hawaii 8,347 39 (0.5) 7 (0.1) 32 (0.4) 31 (0.4) 
Idaho 6,162 19 (0.3) 11 (0.2) 8 (0.1) 8 (0.1) 
Illinois 
Chicagob 56,612 ... ... ... ... 385 (0.7) ... ... 
Illinois (excludes Chicago)b 13,445 ... ... ... ... 153 (1.1) ... ... 
Indiana 15,534 140 (0.9) 30 (0.2) 110 (0.7) 101 (0.7) 
Iowa 6,091 39 (0.6) 6 (0.1) 33 (0.5) 30 (0.5) 
Kansas 30,028 80 (0.3) 9 (0) 71 (0.2) 61 (0.2) 
Kentucky 17,774 139 (0.8) 60 (0.3) 78 (0.4) 68 (0.4) 
Louisiana 102,841 1,315 (1.3) 104 (0.1) 1,211 (1.2) 1,127 (1.1) 
Maine 4,709 30 (0.6) 12 (0.3) 18 (0.4) 17 (0.4) 
Maryland 102,595 1,121 (1.1) 329 (0.3) 792 (0.8) 693 (0.7) 
Massachusetts 66,463 387 (0.6) 162 (0.2) 221 (0.3) 158 (0.2) 
Michigan 73,410 491 (0.7) 82 (0.1) 409 (0.6) 334 (0.5) 
Minnesota 13,821 95 (0.7) 40 (0.3) 55 (0.4) 48 (0.3) 
Mississippi 93,131 1,052 (1.1) 7 (0) 1,045 (1.1) 1,044 (1.1) 
Missouri 68,923 470 (0.7) 35 (0.1) 435 (0.6) 387 (0.6) 
Montanac 4,600 17 (0.4) 13 (0.3) 4 (0.1) 4 (0.1) 
Nebraskad 8,001 43 (0.5) 13 (0.2) 30 (0.4) 29 (0.4) 
Nevadab 25,399 ... ... ... ... 303 (1.2) ... ... 
New Hampshire 2,659 10 (0.4) 3 (0.1) 7 (0.3) 6 (0.2) 
New Jersey 103,710 681 (0.7) 122 (0.1) 559 (0.5) 492 (0.5) 
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CDC-funded jurisdiction 
HIV testing 
events 
Number 
HIV-positive 
testing events 
Number (Positive %) 
Preliminary HIV-positive 
testing events 
Number (Positive %) 
Confirmed HIV-positive 
testing events 
Number (Positive %) 
Newly identified confirmed HIV-
positive testing events 
Number (Positive %) 
New Mexicoe 9,234 53 (0.6) 12 (0.1) 41 (0.4) 24 (0.3) 
New York 
New York City 150,047 1,191 (0.8) 327 (0.2) 864 (0.6) 742 (0.5) 
New York (excludes New York City) 173,360 1,041 (0.6) 156 (0.1) 883 (0.5) 685 (0.4) 
North Carolinaf 232,829 1,122 (0.5) 76 (0) 1,046 (0.4) 799 (0.3) 
North Dakota 3,739 17 (0.5) 0 (0) 17 (0.5) 15 (0.4) 
Ohiog 59,283 399 (0.7) 195 (0.3) 203 (0.3) 185 (0.3) 
Oklahoma 21,960 200 (0.9) 34 (0.2) 166 (0.8) 125 (0.6) 
Oregon 13,382 130 (1.0) 36 (0.3) 94 (0.7) 84 (0.6) 
Pennsylvania 
Philadelphia 98,766 863 (0.9) 271 (0.3) 592 (0.6) 473 (0.5) 
Pennsylvania (excludes Philadelphia) 84,262 405 (0.5) 46 (0.1) 359 (0.4) 297 (0.4) 
Rhode Island 2,159 22 (1.0) 11 (0.5) 11 (0.5) 11 (0.5) 
South Carolina 77,853 794 (1.0) 203 (0.3) 591 (0.8) 579 (0.7) 
South Dakota 1,105 1 (0.1) 0 (0) 1 (0.1) 1 (0.1) 
Tennessee 135,306 1,190 (0.9) 59 (0) 1,131 (0.8) 823 (0.6) 
Texas 
Houston 71,643 1,148 (1.6) 75 (0.1) 1,073 (1.5) 299 (0.4) 
Texas (excludes Houston) 195,286 1,835 (0.9) 97 (0) 1,738 (0.9) 1,290 (0.7) 
Utah 7,617 34 (0.4) 15 (0.2) 19 (0.2) 15 (0.2) 
Vermont 3,105 5 (0.2) 3 (0.1) 2 (0.1) 2 (0.1) 
Virginia 72,983 322 (0.4) 16 (0) 306 (0.4) 258 (0.4) 
Washington 16,242 245 (1.5) 20 (0.1) 225 (1.4) 144 (0.9) 
West Virginia 5,356 29 (0.5) 6 (0.1) 23 (0.4) 23 (0.4) 
Wisconsin 14,490 105 (0.7) 19 (0.1) 86 (0.6) 74 (0.5) 
Wyoming 6,725 6 (0.1) 3 (<0.1) 3 (<0.1) 3 (<0.1) 
Puerto Rico 42,758 713 (1.7) 27 (0.1) 686 (1.6) 437 (1.0) 
U.S. Virgin Islandsb 4,033 ... ... ... ... 15 (0.4) ... ... 
total 3,401,008 29,540 (0.9)h 4,864 (0.1)h 25,514 (0.8) 18,446 (0.6)h 
Note: Ellipses (...) indicate data not available
 
a 1,409 HIV testing events are missing due to PEMS data extraction issue. 

b Represents only aggregate level data.  Jurisdictions reporting aggregate level data reported only total testing events and confirmed HIV-positive testing events. 
c 416 HIV testing events are missing, including 4 HIV-positive testing events due to a PEMS data extraction issue.
 
d 440 HIV testing events are missing, including 3 HIV-positive testing events due to a PEMS data extraction issue.
 
e 287 HIV testing events are missing, including 16 HIV-positive testing events due to a PEMS data extraction issue.
 
f HIV testing events are missing data from the North Carolina HIV Prevention Program due to non-submission from that agency.
 
g 40 confirmed HIV-positive testing events are missing. 
H Denominator for these percentages is 3,301,519 and includes only test-level data. 
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table 2: Number of HIV testing events and HIV positivity percentages by CDC-funded health department jurisdiction and 
gender, 55 health department jurisdictions submitting test-level data in the United States and Puerto Rico, 2011 
CDC-funded  
health department jurisdiction 
Alabama 
Alaska 
Arizona 
Arkansas 
California 
Los Angeles 
San Francisco 
California (excludes Los Angeles and 
San Francisco) 
Colorado 
Connecticut 
Delaware 
District of Columbia 
Florida 
Georgia 
Hawaii 
Idaho 
Indiana 
Iowa 
Kansas 
Kentucky 
Louisiana 
Maine 
Maryland 
Massachusetts 
Michigan 
Minnesota 
Mississippi 
Missouri 
Montana 
Nebraska 
New Hampshire 
New Jersey 
New Mexico 
New York 
New York City 
New York (excludes New York City) 
North Carolina 
North Dakota 
Ohio 
Oklahoma 
Oregon 
Pennsylvania
Philadelphia 
Pennsylvania (excludes Philadelphia) 
Rhode Island 
South Carolina 
South Dakota 
Tennessee 
Texas 
Houston 
Texas (excludes Houston) 
Utah 
Vermont 
Virginia 
Washington 
West Virginia 
Wisconsin 
Wyoming 
Puerto Rico 
Male 
HIV-positive testing HIV testing events 
events 
Number (Juris. %) Number (Positive %) 
43,135 (41.7) 463 (1.1) 
1,166 (58.4) 3 (0.3) 
15,627 (65.1) 371 (2.4) 
11,625 (26.0) 378 (3.3) 
59,720 (65.4) 999 (1.7) 
27,156 (64.6) 690 (2.5) 
32,133 (65.3) 434 (1.4) 
8,821 (64.4) 214 (2.4) 
18,399 (65.1) 80 (0.4) 
5,188 (48.6) 50 (1.0) 
64,785 (50.0) 584 (0.9) 
185,143 (44.4) 3,619 (2.0) 
43,705 (37.3) 865 (2.0) 
5,541 (66.4) 31 (0.6) 
3,313 (53.8) 18 (0.5) 
8,568 (55.2) 124 (1.4) 
3,895 (63.9) 32 (0.8) 
9,365 (31.2) 68 (0.7) 
7,670 (43.2) 99 (1.3) 
52,998 (51.5) 1,010 (1.9) 
3,099 (65.8) 24 (0.8) 
55,639 (54.2) 836 (1.5) 
37,691 (56.7) 277 (0.7) 
39,552 (53.9) 419 (1.1) 
9,384 (67.9) 79 (0.8) 
31,137 (33.4) 748 (2.4) 
31,339 (45.5) 393 (1.3) 
2,551 (55.5) 12 (0.5) 
4,238 (53.0) 37 (0.9) 
1,355 (51.0) 8 (0.6) 
48,805 (47.1) 455 (0.9) 
5,555 (60.2) 46 (0.8) 
77,375 (51.6) 895 (1.2) 
81,751 (47.2) 699 (0.9) 
70,978 (30.5) 840 (1.2) 
1,750 (46.8) 10 (0.6) 
33,300 (56.2) 321 (1.0) 
11,530 (52.5) 171 (1.5) 
8,599 (64.3) 114 (1.3) 
52,860 (53.5) 643 (1.2) 
49,513 (58.8) 298 (0.6) 
1,383 (64.1) 19 (1.4) 
29,626 (38.1) 606 (2.0) 
653 (59.1) 0 (0.0) 
69,441 (51.3) 889 (1.3) 
34,675 (48.4) 802 (2.3) 
106,708 (54.6) 1,476 (1.4) 
5,165 (67.8) 27 (0.5) 
1,479 (47.6) 5 (0.3) 
30,313 (41.5) 266 (0.9) 
12,293 (75.7) 226 (1.8) 
2,684 (50.1) 25 (0.9) 
10,410 (71.8) 89 (0.9) 
3,070 (45.7) 5 (0.2) 
20,260 (47.4) 507 (2.5) 
HIV testing events 
Number (%) 
60,190 (58.2) 
829 (41.5) 
8,264 (34.4) 
30,969 (69.2) 
30,712 (33.6) 
14,284 (34.0) 
16,603 (33.7) 
4,839 (35.3) 
9,788 (34.6) 
5,449 (51.0) 
64,097 (49.5) 
227,893 (54.6) 
73,261 (62.6) 
2,687 (32.2) 
2,835 (46.0) 
6,926 (44.6) 
2,191 (36.0) 
20,634 (68.7) 
9,955 (56.0) 
48,837 (47.5) 
1,543 (32.8) 
45,080 (43.9) 
28,100 (42.3) 
33,692 (45.9) 
4,401 (31.8) 
61,864 (66.4) 
36,954 (53.6) 
2,036 (44.3) 
3,754 (46.9) 
1,302 (49.0) 
54,488 (52.5) 
3,573 (38.7) 
72,191 (48.1) 
90,942 (52.5) 
161,008 (69.2) 
1,959 (52.4) 
25,779 (43.5) 
10,421 (47.5) 
4,668 (34.9) 
45,099 (45.7) 
33,916 (40.3) 
765 (35.4) 
48,070 (61.7) 
451 (40.8) 
65,819 (48.6) 
36,938 (51.6) 
88,178 (45.2) 
2,419 (31.8) 
1,616 (52.0) 
42,484 (58.2) 
3,851 (23.7) 
2,672 (49.9) 
3,987 (27.5) 
3,654 (54.3) 
22,397 (52.4) 
Female 
HIV-positive testing 
events 
Number (Positive %) 
143 (0.2) 
0 (0.0) 
32 (0.4) 
271 (0.9) 
70 (0.2) 
110 (0.8) 
72 (0.4) 
21 (0.4) 
18 (0.2) 
17 (0.3) 
284 (0.4) 
1,266 (0.6) 
215 (0.3) 
6 (0.2) 
1 (0.0) 
13 (0.2) 
7 (0.3) 
12 (0.1) 
39 (0.4) 
291 (0.6) 
6 (0.4) 
268 (0.6) 
105 (0.4) 
67 (0.2) 
15 (0.3) 
300 (0.5) 
73 (0.2) 
5 (0.2) 
6 (0.2) 
2 (0.2) 
213 (0.4) 
6 (0.2) 
271 (0.4) 
322 (0.4) 
277 (0.2) 
7 (0.4) 
77 (0.3) 
28 (0.3) 
14 (0.3) 
198 (0.4) 
103 (0.3) 
3 (0.4) 
184 (0.4) 
1 (0.2) 
299 (0.5) 
338 (0.9) 
344 (0.4) 
7 (0.3) 
0 (0.0) 
52 (0.1) 
18 (0.5) 
4 (0.1) 
14 (0.4) 
1 (0.0) 
203 (0.9) 
transgender 
HIV-positive testing 
HIV testing events 
events 
Number (%) Number (Positive %) 
3 (0.0) 0 (0.0) 
0 (0.0) 0 (0.0) 
111 (0.5) 0 (0.0)
36 (0.1) 2 (5.6) 
868 (1.0) 62 (7.1)
279 (0.7) 9 (3.2) 
412 (0.8) 9 (2.2) 
9 (0.1) 1 (11.1)
79 (0.3) 1 (1.3) 
2 (0.0) 0 (0.0) 
250 (0.2) 27 (10.8)
311 (0.1) 23 (7.4) 
144 (0.1) 9 (6.3) 
119 (1.4) 2 (1.7)
12 (0.2) 0 (0.0) 
40 (0.3) 3 (7.5) 
5 (0.1) 0 (0.0)
26 (0.1) 0 (0.0) 
13 (0.1) 0 (0.0) 
121 (0.1) 9 (7.4)
23 (0.5) 0 (0.0) 
102 (0.1) 9 (8.8) 
188 (0.3) 4 (2.1)
166 (0.2) 5 (3.0) 
36 (0.3) 1 (2.8) 
12 (0.0) 0 (0.0)
26 (0.0) 2 (7.7) 
13 (0.3) 0 (0.0) 
5 (0.1) 0 (0.0)
2 (0.1) 0 (0.0) 
52 (0.1) 7 (13.5) 
51 (0.6) 1 (2.0)
462 (0.3) 25 (5.4) 
667 (0.4) 20 (3.0)
0 (0.0) 0 (0.0) 
0 (0.0) 0 (0.0) 
75 (0.1) 1 (1.3)
9 (0.0) 1 (11.1) 
61 (0.5) 2 (3.3) 
423 (0.4) 19 (4.5) 
71 (0.1) 2 (2.8) 
9 (0.4) 0 (0.0)
26 (0.0) 2 (7.7) 
1 (0.1) 0 (0.0) 
44 (0.0) 2 (4.5)
26 (0.0) 7 (26.9) 
323 (0.2) 14 (4.3)
29 (0.4) 0 (0.0) 
7 (0.2) 0 (0.0) 
180 (0.2) 4 (2.2)
68 (0.4) 1 (1.5) 
0 (0.0) 0 (0.0) 
93 (0.6) 2 (2.2)
1 (0.0) 0 (0.0) 
101 (0.2) 3 (3.0) 
total 1,594,114 (48.3) 22,399 (1.4) 1,687,314 (51.1) 6,719 (0.4) 6,192 (0.2) 291 (4.7) 
Notes: Jurisdictions submitting aggregate level data are excluded.  See Technical Notes for definition of HIV-positive testing event. Jurisdiction percentage is of total test events in each jurisdiction presented on Table 1. 
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table 3: Number of HIV testing events and HIV positivity percentages by CDC-funded health department jurisdiction 

by testing site type, 55 health department jurisdictions submitting test-level data in the United States and Puerto 

Rico, 2011 
Health care and correctional facilities Non-health care facilities 
CDC-funded  
HIV testing events HIV-positive testing events HIV testing events HIV-positive testing events health department jurisdiction 
Number (Jurisdiction %) Number (Positive %) Number (Jurisdiction %) Number (Positive %) 
Alabama 90,417 (87.4) 542 (0.6) 0 (0) 0 (0)
Alaska 409 (20.5) 0 (0) 1,587 (79.5) 3 (0.2) 
Arizona 15,318 (63.8) 245 (1.6) 7,352 (30.6) 152 (2.1) 
Arkansas 42,199 (94.2) 622 (1.5) 2,583 (5.8) 40 (1.5)
California 
Los Angeles 40,761 (44.6) 244 (0.6) 49,684 (54.4) 876 (1.8) 
San Francisco 27,404 (65.2) 567 (2.1) 14,655 (34.8) 242 (1.7)

California (excludes Los Angeles and  28,027 (57.0) 301 (1.1) 18,450 (37.5) 156 (0.8)

San Francisco) 
Colorado 7,883 (57.6) 149 (1.9) 5,809 (42.4) 88 (1.5) 
Connecticut 24,738 (87.5) 66 (0.3) 3,489 (12.3) 33 (0.9)
Delaware 6,194 (58.0) 41 (0.7) 4,394 (41.2) 26 (0.6) 
District of Columbia 98,438 (76.0) 498 (0.5) 31,018 (24.0) 399 (1.3) 
Florida 273,191 (65.5) 2,724 (1.0) 144,025 (34.5) 2,256 (1.6)
Georgia 95,222 (81.3) 750 (0.8) 16,185 (13.8) 211 (1.3) 
Hawaii 5,113 (61.3) 10 (0.2) 3,163 (37.9) 28 (0.9) 
Idaho 3,226 (52.4) 11 (0.3) 2,827 (45.9) 7 (0.2)
Indiana 9,111 (58.7) 60 (0.7) 6,045 (38.9) 78 (1.3) 
Iowa 3,669 (60.2) 19 (0.5) 2,417 (39.7) 20 (0.8) 
Kansas 23,478 (78.2) 48 (0.2) 2,459 (8.2) 30 (1.2)
Kentucky 16,412 (92.3) 112 (0.7) 1,358 (7.6) 27 (2.0) 
Louisiana 88,853 (86.4) 1,065 (1.2) 13,889 (13.5) 249 (1.8) 
Maine 2,548 (54.1) 13 (0.5) 2,147 (45.6) 17 (0.8)
Maryland 79,599 (77.6) 794 (1.0) 22,741 (22.2) 325 (1.4) 
Massachusetts 57,121 (85.9) 302 (0.5) 9,342 (14.1) 85 (0.9) 
Michigan 58,573 (79.8) 300 (0.5) 14,837 (20.2) 191 (1.3)
Minnesota 11,160 (80.7) 79 (0.7) 2,648 (19.2) 13 (0.5) 
Mississippi 92,863 (99.7) 1,052 (1.1) 268 (0.3) 0 (0) 
Missouri 58,453 (84.8) 308 (0.5) 10,470 (15.2) 162 (1.5)
Montana 2,681 (58.3) 10 (0.4) 1,876 (40.8) 7 (0.4) 
Nebraska 3,657 (45.7) 15 (0.4) 2,471 (30.9) 23 (0.9) 
New Hampshire 2,428 (91.3) 7 (0.3) 230 (8.6) 3 (1.3) 
New Jersey 63,570 (61.3) 353 (0.6) 36,782 (35.5) 282 (0.8) 
New Mexico 7,315 (79.2) 46 (0.6) 1,917 (20.8) 7 (0.4) 
New York 
New York City 85,645 (57.1) 599 (0.7) 47,832 (31.9) 557 (1.2) 
New York (excludes New York City) 117,037 (67.5) 661 (0.6) 37,964 (21.9) 376 (1.0) 
North Carolina 131,718 (56.6) 457 (0.3) 8,723 (3.7) 42 (0.5)
North Dakota 3,312 (88.6) 16 (0.5) 364 (9.7) 0 (0) 
Ohio 47,162 (79.6) 301 (0.6) 12,099 (20.4) 98 (0.8) 
Oklahoma 16,914 (77.0) 106 (0.6) 5,041 (23.0) 94 (1.9)
Oregon 10,133 (75.7) 74 (0.7) 3,244 (24.2) 56 (1.7) 
Pennsylvania
 
Philadelphia 76,842 (77.8) 535 (0.7) 21,681 (22.0) 328 (1.5)
 
Pennsylvania (excludes Philadelphia) 73,109 (86.8) 277 (0.4) 11,099 (13.2) 128 (1.2) 
Rhode Island 633 (29.3) 11 (1.7) 1,179 (54.6) 9 (0.8) 
South Carolina 68,880 (88.5) 658 (1.0) 8,777 (11.3) 134 (1.5)
South Dakota 992 (89.8) 1 (0.1) 113 (10.2) 0 (0) 
Tennessee 121,188 (89.6) 1,039 (0.9) 8,777 (6.5) 117 (1.3) 
Texas 
Houston 62,028 (86.6) 952 (1.5) 9,495 (13.3) 188 (2.0) 
Texas (excludes Houston) 154,320 (79.0) 1,259 (0.8) 38,246 (19.6) 543 (1.4) 
Utah 5,793 (76.1) 26 (0.4) 1,778 (23.3) 8 (0.4)
Vermont 2,075 (66.8) 3 (0.1) 1,030 (33.2) 2 (0.2) 
Virginia 57,340 (78.6) 236 (0.4) 15,643 (21.4) 86 (0.5) 
Washington 9,231 (56.8) 157 (1.7) 7,010 (43.2) 88 (1.3)
West Virginia 3,896 (72.7) 17 (0.4) 1,460 (27.3) 12 (0.8) 
Wisconsin 8,518 (58.8) 40 (0.5) 5,746 (39.7) 62 (1.1) 
Wyoming 6,415 (95.4) 6 (0.1) 310 (4.6) 0 (0)
Puerto Rico 23,482 (54.9) 524 (2.2) 18,196 (42.6) 180 (1.0) 
total 2,426,694 (73.5) 19,308 (0.8) 702,925 (21.3) 9,144 (1.3) 
Notes: Jurisdictions submitting aggregate level data are excluded.  See Technical Notes for definition of HIV-positive testing event. Jurisdiction percentage is of total test events in each jurisdiction presented on Table 1. 
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table 4: Number of HIV testing events and HIV positivity percentages by CDC-funded health department jurisdiction by 
risk groups, 55 health department jurisdictions submitting test-level data in the United States and Puerto Rico, 2011 
Men who have sex with men High-risk heterosexual males High-risk heterosexual females 
CDC-funded  HIV-positive HIV-positive HIV-positive HIV testing events HIV testing events HIV testing events heath department jurisdiction testing events testing events testing events 
No. (Juris. %) No. (pos. %) No. (Juris. %) No. (pos. %) No. (Juris. %) No. (pos. %) 
Alabama 3,529 (3.4) 239 (6.8) 23,924 (23.1) 96 (0.4) 37,266 (36.0) 88 (0.2)
Alaska 237 (11.9) 1 (0.4) 708 (35.5) 2 (0.3) 573 (28.7) 0 (0)
Arizona 6,703 (27.9) 284 (4.2) 5,497 (22.9) 33 (0.6) 4,913 (20.5) 17 (0.3)
Arkansas 1,334 (3.0) 88 (6.6) 8,394 (18.7) 58 (0.7) 25,139 (56.1) 156 (0.6)
California 
Los Angeles 21,562 (23.6) 710 (3.3) 9,157 (10.0) 59 (0.6) 8,822 (9.7) 32 (0.4)
San Francisco 10,395 (24.7) 289 (2.8) 1,546 (3.7) 22 (1.4) 962 (2.3) 14 (1.5)
California (excludes Los Angeles and  10,193 (20.7) 203 (2.0) 11,023 (22.4) 40 (0.4) 8,406 (17.1) 29 (0.3) 
San Francisco) 
Colorado 3,292 (24.0) 124 (3.8) 1,282 (9.4) 5 (0.4) 1,761 (12.9) 10 (0.6)
Connecticut 1,479 (5.2) 40 (2.7) 10,629 (37.6) 24 (0.2) 4,948 (17.5) 16 (0.3)
Delaware 1,052 (9.9) 33 (3.1) 2,497 (23.4) 8 (0.3) 3,751 (35.1) 11 (0.3)
District of Columbia 10,735 (8.3) 191 (1.8) 7,769 (6.0) 70 (0.9) 10,332 (8.0) 88 (0.9)
Florida 33,726 (8.1) 1,985 (5.9) 105,248 (25.2) 693 (0.7) 168,941 (40.5) 729 (0.4)
Georgia 11,175 (9.5) 612 (5.5) 28,197 (24.1) 200 (0.7) 61,273 (52.3) 179 (0.3)
Hawaii 1,762 (21.1) 24 (1.4) 2,904 (34.8) 6 (0.2) 2,123 (25.4) 3 (0.1)
Idaho 876 (14.2) 14 (1.6) 1,383 (22.4) 4 (0.3) 1,560 (25.3) 0 (0)
Indiana 2,923 (18.8) 89 (3.0) 3,270 (21.1) 15 (0.5) 4,345 (28.0) 9 (0.2)
Iowa 999 (16.4) 20 (2.0) 2,229 (36.6) 10 (0.4) 1,729 (28.4) 7 (0.4)
Kansas 1,964 (6.5) 46 (2.3) 5,442 (18.1) 16 (0.3) 16,591 (55.3) 11 (0.1)
Kentucky 1,469 (8.3) 55 (3.7) 5,027 (28.3) 32 (0.6) 8,610 (48.4) 29 (0.3)
Louisiana 3,976 (3.9) 243 (6.1) 13,218 (12.9) 95 (0.7) 22,052 (21.4) 105 (0.5)
Maine 1,255 (26.7) 19 (1.5) 1,064 (22.6) 2 (0.2) 941 (20.0) 4 (0.4)
Maryland 3,752 (3.7) 275 (7.3) 16,796 (16.4) 129 (0.8) 17,569 (17.1) 97 (0.6)
Massachusetts 7,335 (11.0) 144 (2.0) 17,801 (26.8) 88 (0.5) 13,516 (20.3) 68 (0.5)
Michigan 5,503 (7.5) 321 (5.8) 24,422 (33.3) 56 (0.2) 24,479 (33.3) 54 (0.2)
Minnesota 3,554 (25.7) 64 (1.8) 4,064 (29.4) 7 (0.2) 3,013 (21.8) 8 (0.3)
Mississippi 1,631 (1.8) 251 (15.4) 6,063 (6.5) 69 (1.1) 15,154 (16.3) 88 (0.6)
Missouri 2,760 (4.0) 157 (5.7) 7,287 (10.6) 34 (0.5) 7,506 (10.9) 20 (0.3)
Montana 651 (14.2) 9 (1.4) 1,290 (28.0) 1 (0.1) 1,422 (30.9) 2 (0.1)
Nebraska 1,177 (14.7) 31 (2.6) 2,680 (33.5) 6 (0.2) 3,245 (40.6) 6 (0.2)
New Hampshire 275 (10.3) 7 (2.5) 702 (26.4) 1 (0.1) 986 (37.1) 1 (0.1)
New Jersey 5,414 (5.2) 225 (4.2) 33,977 (32.8) 150 (0.4) 40,735 (39.3) 160 (0.4)
New Mexico 1,905 (20.6) 35 (1.8) 2,344 (25.4) 5 (0.2) 2,477 (26.8) 5 (0.2)
New York 
New York City 8,582 (5.7) 404 (4.7) 3,885 (2.6) 72 (1.9) 3,932 (2.6) 51 (1.3)
New York (excludes New York City) 9,382 (5.4) 356 (3.8) 21,439 (12.4) 197 (0.9) 23,300 (13.4) 194 (0.8)
North Carolina 6,198 (2.7) 383 (6.2) 10,511 (4.5) 59 (0.6) 8,467 (3.6) 49 (0.6)
North Dakota 3 (0.1) 0 (0) 31 (0.8) 0 (0) 20 (0.5) 0 (0)
Ohio 7,080 (11.9) 206 (2.9) 19,334 (32.6) 69 (0.4) 19,132 (32.3) 58 (0.3)
Oklahoma 2,473 (11.3) 133 (5.4) 3,337 (15.2) 8 (0.2) 3,712 (16.9) 13 (0.4)
Oregon 3,343 (25.0) 94 (2.8) 3,215 (24.0) 1 (0) 2,961 (22.1) 6 (0.2)
Pennsylvania 
Philadelphia 9,602 (9.7) 310 (3.2) 18,449 (18.7) 155 (0.8) 28,179 (28.5) 121 (0.4)
Pennsylvania (excludes Philadelphia) 4,669 (5.5) 131 (2.8) 21,796 (25.9) 81 (0.4) 19,368 (23.0) 37 (0.2)
Rhode Island 680 (31.5) 14 (2.1) 472 (21.9) 5 (1.1) 585 (27.1) 2 (0.3)
South Carolina 1,953 (2.5) 96 (4.9) 2,425 (3.1) 34 (1.4) 2,884 (3.7) 39 (1.4)
South Dakota 98 (8.9) 0 (0) 395 (35.7) 0 (0) 297 (26.9) 1 (0.3)
Tennessee 2,924 (2.2) 257 (8.8) 4,775 (3.5) 46 (1.0) 4,835 (3.6) 34 (0.7)
Texas 
Houston 2,880 (4.0) 134 (4.7) 1,412 (2.0) 25 (1.8) 1,376 (1.9) 17 (1.2)
Texas (excludes Houston) 4,734 (2.4) 291 (6.1) 5,065 (2.6) 55 (1.1) 4,914 (2.5) 39 (0.8)
Utah 1,627 (21.4) 18 (1.1) 2,454 (32.2) 4 (0.2) 1,686 (22.1) 4 (0.2)
Vermont 405 (13.0) 3 (0.7) 857 (27.6) 2 (0.2) 1,376 (44.3) 0 (0)
Virginia 4,727 (6.5) 177 (3.7) 19,563 (26.8) 54 (0.3) 33,163 (45.4) 46 (0.1)
Washington 6,537 (40.2) 200 (3.1) 3,185 (19.6) 13 (0.4) 2,491 (15.3) 10 (0.4)
West Virginia 439 (8.2) 16 (3.6) 1,772 (33.1) 8 (0.5) 2,198 (41.0) 3 (0.1)
Wisconsin 3,903 (26.9) 70 (1.8) 5,280 (36.4) 9 (0.2) 3,120 (21.5) 7 (0.2)
Wyoming 353 (5.2) 3 (0.8) 1,313 (19.5) 1 (0.1) 2,764 (41.1) 1 (0)
Puerto Rico 3,322 (7.8) 193 (5.8) 8,934 (20.9) 135 (1.5) 14,754 (34.5) 123 (0.8)
total 250,507 (7.6) 10,317 (4.1) 527,733 (16.0) 3,069 (0.6) 710,654 (21.5) 2,901 (0.4) 
Notes: Jurisdictions submitting aggregate level data are excluded.  See Technical Notes for definition of HIV-positive testing event. Jurisdiction percentage is of total test events in each jurisdiction presented on Table 1. 
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table Section 2
 
HIV positivity and receipt of test results 
table 5: Number of HIV testing events and HIV positivity percentages by characteristics of individuals tested, 55 health 
department jurisdictions submitting test-level data in the United States and Puerto Rico, 2011 
Characteristic 
HIV testing events 
Number (Column %) 
HIV-positive 
testing events 
Number (Positive %) 
Preliminary HIV-positive 
testing events 
Number (Positive %) 
Confirmed HIV-positive 
testing events 
Number (Positive %) 
Age at test (years) 
<13 
13-19 
20-29 
30-39 
40-49 
50+ 
Missing/invalid 
race/Ethnicity 
White 
Black or African American 
Hispanic or Latino 
Asian 
American Indian or Alaska Native 
Native Hawaiian or Pacific Islander 
Multi-race 
Declined 
Don’t know 
Missing/invalid 
u.S. geographic region (Puerto rico excluded) 
Northeast 
Midwest 
South 
West 
testing site type 
Health care and correctional facilities 
Non-health care facilities 
Other facilities 
Missing/invalid 
rapid test used in testing event 
Yes 
No 
Missing/invalid 
6,846 
336,445 
1,354,752 
701,989 
473,392 
400,995 
27,100 
893,130 
1,470,846 
683,379 
54,416 
16,502 
8,447 
26,427 
21,528 
59,478 
67,366 
717,511 
294,425 
1,952,263 
294,562 
2,426,694 
702,925 
130,120 
41,780 
1,876,926 
1,419,657 
4,936 
(0.2) 
(10.2) 
(41.0) 
(21.3) 
(14.3) 
(12.1) 
(0.8) 
(27.1) 
(44.6) 
(20.7) 
(1.6) 
(0.5) 
(0.3) 
(0.8) 
(0.7) 
(1.8) 
(2.0) 
(21.7) 
(8.9) 
(59.1) 
(8.9) 
(73.5) 
(21.3) 
(3.9) 
(1.3) 
(56.9) 
(43.0) 
(0.1) 
42 
919 
9,914 
6,952 
6,773 
4,614 
326 
6,095 
16,056 
5,513 
326 
90 
67 
208 
219 
472 
494 
4,734 
1,880 
18,571 
3,642 
19,308 
9,144 
926 
162 
17,804 
11,719 
18 
(0.6) 
(0.3) 
(0.7) 
(1.0) 
(1.4) 
(1.2) 
(1.2) 
(0.7) 
(1.1) 
(0.8) 
(0.6) 
(0.5) 
(0.8) 
(0.8) 
(1.0) 
(0.8) 
(0.7) 
(0.7) 
(0.6) 
(1.0) 
(1.2) 
(0.8) 
(1.3) 
(0.7) 
(0.4) 
(0.9) 
(0.8) 
(0.3) 
11 
200 
1,553 
1,049 
1,125 
845 
81 
980 
2,662 
879 
55 
31 
14 
60 
58 
102 
23 
1,126 
429 
2,405 
877 
2,628 
2,118 
102 
16 
4,864 
... 
... 
(0.2) 
(0.1) 
(0.1) 
(0.1) 
(0.2) 
(0.2) 
(0.3) 
(0.1) 
(0.2) 
(0.1) 
(0.1) 
(0.2) 
(0.2) 
(0.2) 
(0.3) 
(0.2) 
(0) 
(0.2) 
(0.1) 
(0.1) 
(0.3) 
(0.1) 
(0.3) 
(0.1) 
(0) 
(0.3) 
... 
... 
30 
716 
8,354 
5,899 
5,647 
3,768 
244 
5,110 
13,384 
4,632 
271 
59 
52 
148 
161 
370 
471 
3,602 
1,450 
16,155 
2,765 
16,663 
7,025 
824 
146 
12,939 
11,719 
... 
(0.4) 
(0.2) 
(0.6) 
(0.8) 
(1.2) 
(0.9) 
(0.9) 
(0.6) 
(0.9) 
(0.7) 
(0.5) 
(0.4) 
(0.6) 
(0.6) 
(0.7) 
(0.6) 
(0.7) 
(0.5) 
(0.5) 
(0.8) 
(0.9) 
(0.7) 
(1.0) 
(0.6) 
(0.3) 
(0.7) 
(0.8) 
... 
total 3,301,519 (100.0) 29,540 (0.9) 4,864 (0.1) 24,658 (0.7) 
Notes: Ellipses (...) indicate not applicable.  
Preliminary HIV-positive and confirmed HIV-positive testing events do not sum to HIV-positive testing events due to missing HIV test technology for 18 testing events. 
Please refer to Technical Notes for definitions of HIV-positive testing event and preliminary and confirmed HIV-positive testing events. 
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table 6: Number of HIV testing events and HIV positivity percentage by characteristics of individuals tested, among males, 
55 health department jurisdictions submitting test-level data in the United States and Puerto Rico, 2011 
Characteristic 
HIV testing events 
Number (Column %) 
HIV-positive 
testing events 
Number (Positive %) 
Preliminary HIV-positive 
testing events 
Number (Positive %) 
Confirmed HIV-positive 
testing events 
Number (Positive %) 
Age at test (years) 
<13 
13-19 
20-29 
30-39 
40-49 
50+ 
Missing/invalid 
race/Ethnicity 
White 
Black or African American 
Hispanic or Latino 
Asian 
American Indian or Alaska Native 
Native Hawaiian or Pacific Islander 
Multi-race 
Declined 
Don’t know 
Missing/invalid 
u.S. geographic region (Puerto rico excluded) 
Northeast 
Midwest 
South 
West 
testing site type 
Health care and correctional facilities 
Non-health care facilities 
Other facilities 
Missing/invalid 
rapid test used in testing event 
Yes 
No 
Missing/invalid 
3,177 
124,414 
614,811 
343,074 
258,078 
236,635 
13,925 
457,486 
696,159 
322,877 
29,424 
7,932 
5,064 
13,930 
11,796 
26,239 
23,207 
373,710 
152,454 
856,980 
190,710 
1,113,488 
408,790 
53,872 
17,964 
1,019,468 
573,337 
1,309 
(0.2) 
(7.8) 
(38.6) 
(21.5) 
(16.2) 
(14.8) 
(0.9) 
(28.7) 
(43.7) 
(20.3) 
(1.8) 
(0.5) 
(0.3) 
(0.9) 
(0.7) 
(1.6) 
(1.5) 
(23.4) 
(9.6) 
(53.8) 
(12.0) 
(69.8) 
(25.6) 
(3.4) 
(1.1) 
(64.0) 
(36.0) 
(0.1) 
20 
668 
8,076 
5,150 
4,952 
3,290 
243 
5,071 
11,506 
4,409 
271 
63 
52 
164 
174 
317 
372 
3,403 
1,572 
13,727 
3,190 
14,265 
7,288 
726 
120 
13,830 
8,561 
9 
(0.6) 
(0.5) 
(1.3) 
(1.5) 
(1.9) 
(1.4) 
(1.7) 
(1.1) 
(1.7) 
(1.4) 
(0.9) 
(0.8) 
(1.0) 
(1.2) 
(1.5) 
(1.2) 
(1.6) 
(0.9) 
(1.0) 
(1.6) 
(1.7) 
(1.3) 
(1.8) 
(1.3) 
(0.7) 
(1.4) 
(1.5) 
(0.6) 
4 
131 
1,176 
749 
795 
590 
56 
791 
1,829 
649 
40 
17 
8 
43 
46 
68 
10 
754 
337 
1,684 
706 
1,834 
1,586 
72 
9 
3,501 
... 
... 
(0.1) 
(0.1) 
(0.2) 
(0.2) 
(0.3) 
(0.2) 
(0.4) 
(0.2) 
(0.3) 
(0.2) 
(0.1) 
(0.2) 
(0.2) 
(0.3) 
(0.4) 
(0.3) 
(0) 
(0.2) 
(0.2) 
(0.2) 
(0.4) 
(0.2) 
(0.4) 
(0.1) 
(0.1) 
(0.3) 
... 
... 
15 
536 
6,894 
4,400 
4,157 
2,700 
187 
4,278 
9,672 
3,758 
231 
46 
44 
121 
128 
249 
362 
2,645 
1,234 
12,039 
2,484 
12,423 
5,701 
654 
111 
10,328 
8,561 
... 
(0.5) 
(0.4) 
(1.1) 
(1.3) 
(1.6) 
(1.1) 
(1.3) 
(0.9) 
(1.4) 
(1.2) 
(0.8) 
(0.6) 
(0.9) 
(0.9) 
(1.1) 
(0.9) 
(1.6) 
(0.7) 
(0.8) 
(1.4) 
(1.3) 
(1.1) 
(1.4) 
(1.2) 
(0.6) 
(1.0) 
(1.5) 
... 
total 1,594,114 (100.0) 22,399 (1.4) 3,501 (0.2) 18,889 (1.2) 
Notes: Ellipses (...) indicate not applicable.  
Preliminary HIV-positive and confirmed HIV-positive testing events do not sum to HIV-positive testing events due to missing HIV test technology for 9 testing events. 
See Technical Notes for definitions of HIV-positive testing event and preliminary and confirmed HIV-positive testing events. 
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table 7: Number of HIV testing events and HIV positivity percentage by characteristics of individuals tested, among females, 
55 health department jurisdictions submitting test-level data in the United States and Puerto Rico, 2011 
Characteristic 
HIV testing events 
Number (Column %) 
HIV-positive 
testing events 
Number (Positive %) 
Preliminary HIV-positive 
testing events 
Number (Positive %) 
Confirmed HIV-positive 
testing events 
Number (Positive %) 
Age at test (years) 
<13 
13-19 
20-29 
30-39 
40-49 
50+ 
Missing/invalid 
race/Ethnicity 
White 
Black or African American 
Hispanic or Latino 
Asian 
American Indian or Alaska Native 
Native Hawaiian or Pacific Islander 
Multi-race 
Declined 
Don’t know 
Missing/invalid 
u.S. geographic region (Puerto rico excluded) 
Northeast 
Midwest 
South 
West 
testing site type 
Health care and correctional facilities 
Non-health care facilities 
Other facilities 
Missing/invalid 
rapid test used in testing event 
Yes 
No 
Missing/invalid 
3,553 
210,033 
731,073 
354,739 
212,936 
162,435 
12,545 
432,347 
769,020 
356,946 
24,699 
8,454 
3,246 
12,213 
9,330 
27,836 
43,223 
339,750 
140,728 
1,083,185 
101,254 
1,299,721 
288,112 
75,842 
23,639 
846,221 
838,713 
2,380 
(0.2) 
(12.4) 
(43.3) 
(21.0) 
(12.6) 
(9.6) 
(0.7) 
(25.6) 
(45.6) 
(21.2) 
(1.5) 
(0.5) 
(0.2) 
(0.7) 
(0.6) 
(1.6) 
(2.6) 
(20.1) 
(8.3) 
(64.2) 
(6.0) 
(77.0) 
(17.1) 
(4.5) 
(1.4) 
(50.2) 
(49.7) 
(0.1) 
21 
234 
1,659 
1,707 
1,749 
1,275 
74 
993 
4,353 
1,015 
50 
25 
12 
33 
39 
86 
113 
1,241 
292 
4,620 
363 
4,839 
1,647 
191 
42 
3,664 
3,046 
9 
(0.6) 
(0.1) 
(0.2) 
(0.5) 
(0.8) 
(0.8) 
(0.6) 
(0.2) 
(0.6) 
(0.3) 
(0.2) 
(0.3) 
(0.4) 
(0.3) 
(0.4) 
(0.3) 
(0.3) 
(0.4) 
(0.2) 
(0.4) 
(0.4) 
(0.4) 
(0.6) 
(0.3) 
(0.2) 
(0.4) 
(0.4) 
(0.4) 
7 
66 
338 
278 
312 
242 
20 
184 
780 
206 
15 
13 
4 
14 
10 
28 
9 
344 
90 
676 
147 
760 
468 
28 
7 
1,263 
... 
... 
(0.2) 
(<0.1) 
(<0.1) 
(0.1) 
(0.1) 
(0.1) 
(0.2) 
(<0.1) 
(0.1) 
(0.1) 
(0.1) 
(0.2) 
(0.1) 
(0.1) 
(0.1) 
(0.1) 
(<0.1) 
(0.1) 
(0.1) 
(0.1) 
(0.1) 
(0.1) 
(0.2) 
(<0.1) 
(<0.1) 
(0.1) 
... 
... 
14 
166 
1,320 
1,426 
1,436 
1,032 
53 
806 
3,568 
809 
35 
12 
7 
19 
29 
58 
104 
895 
202 
3,937 
216 
4,070 
1,179 
163 
35 
2,401 
3,046 
... 
(0.4) 
(0.1) 
(0.2) 
(0.4) 
(0.7) 
(0.6) 
(0.4) 
(0.2) 
(0.5) 
(0.2) 
(0.1) 
(0.1) 
(0.2) 
(0.2) 
(0.3) 
(0.2) 
(0.2) 
(0.3) 
(0.1) 
(0.4) 
(0.2) 
(0.3) 
(0.4) 
(0.2) 
(0.1) 
(0.3) 
(0.4) 
... 
total 1,687,314 (100.0) 6,719 (0.4) 1,263 (0.1) 5,447 (0.3) 
Notes: Ellipses (...) indicate not applicable.  
Preliminary HIV-positive and confirmed HIV-positive testing events do not sum to HIV-positive testing events due to missing HIV test technology for 9 testing events. 
See Technical Notes for definitions of HIV-positive testing event and preliminary and confirmed HIV-positive testing events. 
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table 8: Number of testing events and HIV positivity percentages by characteristics of individuals tested, among transgender 
persons, 51 health department jurisdictions submitting test-level data in the United States and Puerto Rico, 2011 
Characteristic HIV testing events 
Number (Column %) 
HIV-positive 
testing events 
Number (Positive %) 
Preliminary HIV-positive 
testing events 
Number (Positive %) 
Confirmed HIV-positive 
testing events 
Number (Positive %) 
Age at test (years) 
<13 14 (0.2) 1 (7.1) 0 (0) 1 (7.1) 
13-19 420 (6.8) 11 (2.6) 3 (0.7) 8 (1.9) 
20-29 2,988 (48.3) 136 (4.6) 37 (1.2) 99 (3.3) 
30-39 1,459 (23.6) 70 (4.8) 18 (1.2) 52 (3.6) 
40-49 768 (12.4) 44 (5.7) 14 (1.8) 30 (3.9) 
50+ 450 (7.3) 25 (5.6) 11 (2.4) 14 (3.1) 
Missing/invalid 93 (1.5) 4 (4.3) 2 (2.2) 2 (2.2) 
race/Ethnicity 
White 1,271 (20.5) 19 (1.5) 3 (0.2) 16 (1.3) 
Black or African American 1,888 (30.5) 166 (8.8) 49 (2.6) 117 (6.2) 
Hispanic or Latino 2,185 (35.3) 78 (3.6) 22 (1.0) 56 (2.6) 
Asian 186 (3.0) 5 (2.7) 0 (0) 5 (2.7) 
American Indian or Alaska Native 90 (1.5) 2 (2.2) 1 (1.1) 1 (1.1) 
Native Hawaiian or Pacific Islander 107 (1.7) 3 (2.8) 2 (1.9) 1 (0.9) 
Multi-race 182 (2.9) 10 (5.5) 3 (1.6) 7 (3.8) 
Declined 102 (1.6) 3 (2.9) 1 (1.0) 2 (2.0) 
Don’t know 180 (2.9) 5 (2.8) 4 (2.2) 1 (0.6) 
Missing/invalid 1 (0) 0 (0) ... ... ... ... 
u.S. geographic region (Puerto rico excluded) 
Northeast 1,983 (32.0) 78 (3.9) 24 (1.2) 54 (2.7) 
Midwest 473 (7.6) 14 (3.0) 2 (0.4) 12 (2.5) 
South 1,602 (25.9) 109 (6.8) 34 (2.1) 75 (4.7) 
West 2,033 (32.8) 87 (4.3) 24 (1.2) 63 (3.1) 
testing site type 
Health care and correctional facilities 2,380 (38.4) 110 (4.6) 26 (1.1) 84 (3.5) 
Non-health care facilities 3,556 (57.4) 174 (4.9) 58 (1.6) 116 (3.3) 
Other facilities 216 (3.5) 7 (3.2) 1 (0.5) 6 (2.8) 
Missing/invalid 40 (0.6) 0 (0) ... ... ... ... 
rapid test used in testing event 
Yes 5,677 (91.7) 260 (4.6) 85 (1.5) 175 (3.1) 
No 509 (8.2) 31 (6.1) ... ... 31 (6.1) 
Missing/invalid 6 (0.1) 0 (0.0) ... ... ... ... 
total 6,192 (100.0) 291 (4.7) 85 (1.4) 206 (3.3) 
Notes: 51 health department jurisdictions are included because Alaska, North Dakota, North Carolina and West Virginia did not report any testing events for transgender persons. 
Ellipses (...) indicate not applicable.
See Technical Notes for definitions of preliminary and confirmed HIV-positive testing event. 
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table 9:  Number of HIV testing events and HIV positivity percentage by characteristics of individuals tested, among health 
care and correctional facility testing sites, 55 health department jurisdictions submitting test-level data in the United States 
and Puerto Rico, 2011 
Characteristic HIV testing events 
Number (Column %) 
HIV-positive 
testing events 
Number (Positive %) 
Preliminary HIV-positive 
testing events 
Number (Positive %) 
Confirmed HIV-positive 
testing events
Number (Positive %) 
Age at test (years) 
<13 
13-19 
20-29 
30-39 
40-49 
50+ 
Missing/invalid 
gender 
Male 
Female 
Transgender 
Declined 
Missing/invalid 
race/Ethnicity 
White 
Black or African American 
Hispanic or Latino 
Asian 
American Indian or Alaska Native 
Native Hawaiian or Pacific Islander 
Multi-race 
Declined 
Don’t know 
Missing/invalid 
u.S. geographic region (Puerto rico excluded) 
Northeast 
Midwest 
South 
West 
risk category 
Male-to-male sexual contact and injection drug use 
Male-to-male sexual contact 
Injection drug use 
High-risk heterosexual contact 
Low-risk heterosexual contact 
Other 
No acknowledged risk 
Not asked about risk 
Declined to discuss risk 
Missing/invalid 
rapid test used in testing event 
Yes 
No 
Missing/invalid 
5,230 
252,486 
1,019,319 
517,092 
332,027 
280,510 
20,030 
1,113,488 
1,299,721 
2,380 
2,557 
8,548 
673,551 
1,108,866 
474,605 
36,224 
9,605 
5,990 
17,137 
14,700 
45,435 
40,581 
505,746 
228,085 
1,499,672 
169,709 
2,783 
100,662 
53,126 
909,697 
361,202 
18,687 
127,014 
570,437 
5,495 
277,591 
1,214,582 
1,207,372 
4,740 
(0.2) 
(10.4) 
(42.0) 
(21.3) 
(13.7) 
(11.6) 
(0.8) 
(45.9) 
(53.6) 
(0.1) 
(0.1) 
(0.4) 
(27.8) 
(45.7) 
(19.6) 
(1.5) 
(0.4) 
(0.2) 
(0.7) 
(0.6) 
(1.9) 
(1.7) 
(20.8) 
(9.4) 
(61.8) 
(7.0) 
(0.1) 
(4.1) 
(2.2) 
(37.5) 
(14.9) 
(0.8) 
(5.2) 
(23.5) 
(0.2) 
(11.4) 
(50.1) 
(49.8) 
(0.2) 
27 
603 
6,349 
4,568 
4,477 
3,050 
234 
14,265 
4,839 
110 
15 
79 
3,774 
11,239 
3,165 
179 
43 
41 
92 
133 
349 
293 
2,827 
1,187 
12,924 
1,846 
182 
5,027 
375 
3,956 
1,735 
61 
942 
3,641 
122 
3,267 
9,988 
9,304 
17 
(0.5) 
(0.2) 
(0.6) 
(0.9) 
(1.3) 
(1.1) 
(1.2) 
(1.3) 
(0.4) 
(4.6) 
(0.6) 
(0.9) 
(0.6) 
(1.0) 
(0.7) 
(0.5) 
(0.4) 
(0.7) 
(0.5) 
(0.9) 
(0.8) 
(0.7) 
(0.6) 
(0.5) 
(0.9) 
(1.1) 
(6.5) 
(5.0) 
(0.7) 
(0.4) 
(0.5) 
(0.3) 
(0.7) 
(0.6) 
(2.2) 
(1.2) 
(0.8) 
(0.8) 
(0.3) 
7 
106 
809 
592 
591 
473 
50 
1,834 
760 
26 
1 
7 
554 
1,472 
417 
33 
10 
5 
27 
40 
57 
13 
630 
269 
1,246 
482 
26 
501 
117 
620 
175 
15 
128 
371 
39 
636 
2,628 
... 
... 
(0.1) 
(<0.1) 
(0.1) 
(0.1) 
(0.2) 
(0.2) 
(0.2) 
(0.2) 
(0.1) 
(1.1) 
(<0.1) 
(0.1) 
(0.1) 
(0.1) 
(0.1) 
(0.1) 
(0.1) 
(0.1) 
(0.2) 
(0.3) 
(0.1) 
(<0.1) 
(0.1) 
(0.1) 
(0.1) 
(0.3) 
(0.9) 
(0.5) 
(0.2) 
(0.1) 
(<0.1) 
(0.1) 
(0.1) 
(0.1) 
(0.7) 
(0.2) 
(0.2) 
... 
... 
20 
494 
5,533 
3,972 
3,885 
2,576 
183 
12,423 
4,070 
84 
14 
72 
3,215 
9,757 
2,747 
146 
33 
35 
65 
93 
292 
280 
2,192 
917 
11,667 
1,364 
156 
4,524 
258 
3,327 
1,558 
46 
814 
3,270 
83 
2,627 
7,359 
9,304 
... 
(0.4) 
(0.2) 
(0.5) 
(0.8) 
(1.2) 
(0.9) 
(0.9) 
(1.1) 
(0.3) 
(3.5) 
(0.5) 
(0.8) 
(0.5) 
(0.9) 
(0.6) 
(0.4) 
(0.3) 
(0.6) 
(0.4) 
(0.6) 
(0.6) 
(0.7) 
(0.4) 
(0.4) 
(0.8) 
(0.8) 
(5.6) 
(4.5) 
(0.5) 
(0.4) 
(0.4) 
(0.2) 
(0.6) 
(0.6) 
(1.5) 
(0.9) 
(0.6) 
(0.8) 
... 
total 2,426,694 (100.0) 19,308 (0.8) 2,628 (0.1) 16,663 (0.7) 
Notes:  Ellipses (...) indicate not applicable.
Preliminary HIV-positive and confirmed HIV-positive testing events do not sum to HIV-positive testing events due to missing HIV test technology for 17 testing events.  
See Technical Notes for definitions of preliminary and confirmed HIV-positive testing event.
Risk data not required for HIV-negative testing events conducted in health care testing site types. 
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table 10: Number of HIV Testing events and HIV positivity percentages by characteristics of individuals tested, among 
non-health care testing sites, 54 health department jurisdictions submitting test-level data in the United States and Puerto 
Rico, 2011 
Characteristic HIV testing events 
Number (Column %) 
HIV-positive 
testing events 
Number (Positive %) 
Preliminary HIV-positive 
testing events 
Number (Positive %) 
Confirmed HIV-positive 
testing events 
Number (Positive %) 
<13 1,014 (0.1) 12 (1.2) 4 (0.4) 7 (0.7) 
13-19 67,633 (9.6) 279 (0.4) 83 (0.1) 196 (0.3) 
20-29 261,779 (37.2) 3,144 (1.2) 689 (0.3) 2,455 (0.9) 
30-39 146,443 (20.8) 2,110 (1.4) 432 (0.3) 1,678 (1.1) 
40-49 117,809 (16.8) 2,073 (1.8) 520 (0.4) 1,553 (1.3) 
50+ 102,023 (14.5) 1,440 (1.4) 360 (0.4) 1,080 (1.1) 
Missing/invalid 6,224 (0.9) 86 (1.4) 30 (0.5) 56 (0.9) 
gender 
Male 408,790 (58.2) 7,288 (1.8) 1,586 (0.4) 5,701 (1.4) 
Female 288,112 (41.0) 1,647 (0.6) 468 (0.2) 1,179 (0.4) 
Transgender 3,556 (0.5) 174 (4.9) 58 (1.6) 116 (3.3) 
Declined 313 (0) 2 (0.6) 2 (0.6) 0 (0) 
Missing/invalid 2,154 (0.3) 33 (1.5) 4 (0.2) 29 (1.3) 
race/Ethnicity 
White 185,120 (26.3) 2,170 (1.2) 411 (0.2) 1,759 (1.0) 
Black or African American 297,137 (42.3) 4,248 (1.4) 1,145 (0.4) 3,103 (1.0) 
Hispanic or Latino 171,328 (24.4) 2,221 (1.3) 438 (0.3) 1,782 (1.0) 
Asian 15,680 (2.2) 137 (0.9) 19 (0.1) 118 (0.8) 
American Indian or Alaska Native 6,046 (0.9) 43 (0.7) 21 (0.3) 22 (0.4) 
Native Hawaiian or Pacific Islander 2,228 (0.3) 24 (1.1) 7 (0.3) 17 (0.8) 
Multi-race 8,626 (1.2) 104 (1.2) 30 (0.3) 74 (0.9) 
Declined 6,253 (0.9) 86 (1.4) 18 (0.3) 68 (1.1) 
Don’t know 7,374 (1.0) 101 (1.4) 28 (0.4) 73 (1.0) 
Missing/invalid 3,133 (0.4) 10 (0.3) 1 (<0.1) 9 (0.3) 
u.S. geographic region (Puerto rico excluded) 
Northeast 172,775 (24.6) 1,820 (1.1) 459 (0.3) 1,360 (0.8) 
Midwest 59,669 (8.5) 677 (1.1) 154 (0.3) 523 (0.9) 
South 332,623 (47.3) 4,749 (1.4) 1,095 (0.3) 3,654 (1.1) 
West 119,662 (17.0) 1,718 (1.4) 384 (0.3) 1,334 (1.1) 
risk category 
Male-to-male sexual contact and injection drug use 4,256 (0.6) 200 (4.7) 49 (1.2) 151 (3.5) 
Male-to-male sexual contact 134,075 (19.1) 4,457 (3.3) 861 (0.6) 3,596 (2.7) 
Injection drug use 26,324 (3.7) 301 (1.1) 97 (0.4) 204 (0.8) 
High-risk heterosexual contact 299,469 (42.6) 1,840 (0.6) 466 (0.2) 1,373 (0.5) 
Low-risk heterosexual contact 86,193 (12.3) 624 (0.7) 128 (0.1) 496 (0.6) 
Other 10,618 (1.5) 28 (0.3) 10 (0.1) 18 (0.2) 
No acknowledged risk 60,263 (8.6) 549 (0.9) 230 (0.4) 319 (0.5) 
Not asked about risk 29,287 (4.2) 203 (0.7) 50 (0.2) 153 (0.5) 
Declined to discuss risk 2,560 (0.4) 53 (2.1) 23 (0.9) 30 (1.2) 
Missing/invalid 49,880 (7.1) 889 (1.8) 204 (0.4) 685 (1.4) 
rapid test used in testing event 
Yes 600,525 (85.4) 7,357 (1.2) 2,118 (0.4) 5,239 (0.9) 
No 102,226 (14.5) 1,786 (1.7) ... ... 1,786 (1.7) 
Missing/invalid 174 (0) 1 (0.6) ... ... ... ... 
total 702,925 (100.0) 9,144 (1.3) 2,118 (0.3) 7,025 (1.0) 
Age at test (years) 
Notes:  54 health department jurisdictions are included because Alabama did not submit any testing events conducted in non-health care settings. Ellipses (...) indicate not applicable.
Preliminary HIV-positive and confirmed HIV-positive testing events do not sum to HIV-positive testing events due to missing HIV test technology for 1 testing event. 
See Technical Notes for definitions of preliminary and confirmed HIV-positive testing event. 
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table 11: Number of testing events and HIV positivity percentages by characteristics of individuals tested, among men 

who have sex with men, 55 health department jurisdictions submitting test-level data in the United States and Puerto Rico, 

2011 
HIV-positive Preliminary HIV-positive Confirmed HIV-positive 
HIV testing events Characteristic testing events testing events testing events 
Number (Column %) Number (Positive %) Number (Positive %) Number (Positive %) 
Age at test (years) 
<13 322 (0.1) 5 (1.6) 0 (0) 5 (1.6) 
13-19 15,173 (6.1) 398 (2.6) 65 (0.4) 333 (2.2) 
20-29 108,079 (43.1) 4,984 (4.6) 647 (0.6) 4,335 (4.0) 
30-39 56,985 (22.7) 2,426 (4.3) 332 (0.6) 2,094 (3.7) 
40-49 40,655 (16.2) 1,711 (4.2) 259 (0.6) 1,452 (3.6) 
50+ 27,969 (11.2) 760 (2.7) 158 (0.6) 602 (2.2) 
Missing/invalid 1,324 (0.5) 33 (2.5) 14 (1.1) 19 (1.4) 
race/Ethnicity 
White 111,514 (44.5) 2,992 (2.7) 429 (0.4) 2,563 (2.3) 
Black or African American 59,849 (23.9) 4,423 (7.4) 659 (1.1) 3,762 (6.3) 
Hispanic or Latino 56,575 (22.6) 2,288 (4.0) 301 (0.5) 1,987 (3.5) 
Asian 8,903 (3.6) 153 (1.7) 15 (0.2) 138 (1.6) 
American Indian or Alaska Native 1,459 (0.6) 34 (2.3) 6 (0.4) 28 (1.9) 
Native Hawaiian or Pacific Islander 1,215 (0.5) 38 (3.1) 7 (0.6) 31 (2.6) 
Multi-race 3,990 (1.6) 118 (3.0) 28 (0.7) 90 (2.3) 
Declined 2,294 (0.9) 66 (2.9) 14 (0.6) 52 (2.3) 
Don’t know 2,976 (1.2) 86 (2.9) 15 (0.5) 71 (2.4) 
Missing/invalid 1,732 (0.7) 119 (6.9) 1 (0.1) 118 (6.8) 
u.S. geographic region (Puerto rico excluded) 
Northeast 49,078 (19.6) 1,653 (3.4) 271 (0.6) 1,382 (2.8) 
Midwest 29,964 (12.0) 1,004 (3.4) 199 (0.7) 805 (2.7) 
South 98,707 (39.4) 5,459 (5.5) 668 (0.7) 4,789 (4.9) 
West 69,436 (27.7) 2,008 (2.9) 332 (0.5) 1,676 (2.4) 
testing site type 
Health care and correctional facilities 103,445 (41.3) 5,209 (5.0) 527 (0.5) 4,680 (4.5) 
Non-health care facilities 138,331 (55.2) 4,657 (3.4) 910 (0.7) 3,747 (2.7) 
Other facilities 7,290 (2.9) 405 (5.6) 36 (0.5) 369 (5.1) 
Missing/invalid 1,441 (0.6) 46 (3.2) 2 (0.1) 44 (3.1) 
rapid test used in testing event 
Yes 206,496 (82.4) 7,177 (3.5) 1,475 (0.7) 5,702 (2.8) 
No 43,831 (17.5) 3,138 (7.2) ... ... 3,138 (7.2) 
Missing/invalid 180 (0.1) 2 (1.1) ... ... ... ... 
total 250,507 (100.0) 10,317 (4.1) 1,475 (0.6) 8,840 (3.5) 
Notes:  Ellipses (...) indicate not applicable.
Preliminary HIV-positive and confirmed HIV-positive testing events do not sum to HIV-positive testing events due to missing HIV test technology for 2 testing events.  
See Technical Notes for definitions of preliminary and confirmed HIV-positive testing event. 
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table 12: Number of testing events and HIV positivity percentage by characteristics of individuals tested, among high-risk 

heterosexual males, 55 health department jurisdictions submitting test-level data in the United States and Puerto Rico, 

Characteristic HIV testing events 
Number (Column %) 
HIV-positive 
testing events 
Number (Positive %) 
Preliminary HIV-positive 
testing events 
Number (Positive %) 
Confirmed HIV-positive 
testing events 
Number (Positive %) 
<13 602 (0.1) 6 (1.0) 2 (0.3) 3 (0.5) 
13-19 48,681 (9.2) 85 (0.2) 35 (0.1) 50 (0.1) 
20-29 219,372 (41.6) 763 (0.3) 159 (0.1) 601 (0.3) 
30-39 113,841 (21.6) 706 (0.6) 123 (0.1) 582 (0.5) 
40-49 78,395 (14.9) 828 (1.1) 140 (0.2) 688 (0.9) 
50+ 63,004 (11.9) 640 (1.0) 118 (0.2) 522 (0.8) 
Missing/invalid 3,838 (0.7) 41 (1.1) 4 (0.1) 37 (1.0) 
race/Ethnicity 
White 136,698 (25.9) 355 (0.3) 89 (0.1) 265 (0.2) 
Black or African American 266,326 (50.5) 1,992 (0.7) 377 (0.1) 1,612 (0.6) 
Hispanic or Latino 95,863 (18.2) 612 (0.6) 93 (0.1) 518 (0.5) 
Asian 6,635 (1.3) 20 (0.3) 3 (<0.1) 17 (0.3) 
American Indian or Alaska Native 3,226 (0.6) 8 (0.2) 3 (0.1) 5 (0.2) 
Native Hawaiian or Pacific Islander 1,674 (0.3) 7 (0.4) 0 (0) 7 (0.4) 
Multi-race 6,506 (1.2) 20 (0.3) 6 (0.1) 14 (0.2) 
Declined 3,413 (0.6) 18 (0.5) 3 (0.1) 15 (0.4) 
Don’t know 4,541 (0.9) 25 (0.6) 6 (0.1) 19 (0.4) 
Missing/invalid 2,851 (0.5) 12 (0.4) 1 (<0.1) 11 (0.4) 
u.S. geographic region (Puerto rico excluded) 
Northeast 131,071 (24.8) 777 (0.6) 167 (0.1) 606 (0.5) 
Midwest 74,434 (14.1) 222 (0.3) 72 (0.1) 150 (0.2) 
South 265,993 (50.4) 1,739 (0.7) 292 (0.1) 1,446 (0.5) 
West 47,301 (9.0) 196 (0.4) 48 (0.1) 148 (0.3) 
testing site type 
Health care and correctional facilities 375,830 (71.2) 2,025 (0.5) 324 (0.1) 1,697 (0.5) 
Non-health care facilities 137,509 (26.1) 949 (0.7) 244 (0.2) 704 (0.5) 
Other facilities 10,373 (2.0) 76 (0.7) 12 (0.1) 64 (0.6) 
Missing/invalid 4,021 (0.8) 19 (0.5) 1 (<0.1) 18 (0.4) 
rapid test used in testing event 
Yes 337,145 (63.9) 2,015 (0.6) 581 (0.2) 1,433 (0.4) 
No 189,897 (36.0) 1,050 (0.6) ... ... 1,050 (0.6) 
Missing/invalid 691 (0.1) 5 (0.6) ... ... ... ... 
Age at test (years) 
total 527,733 (100.0) 3,069 (0.6) 581 (0.1) 2,483 (0.5) 
Notes:  Ellipses (...) indicate not applicable.
Preliminary HIV-positive and confirmed HIV-positive testing events do not sum to HIV-positive testing events due to missing HIV test technology for 5 testing events.  
See Technical Notes for definitions of preliminary and confirmed HIV-positive testing event. 
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table 13: Number of testing events and HIV positivity percentage by characteristics of individuals tested, among high-risk 

 heterosexual females, 55 health department jurisdictions submitting test-level data in the United States and Puerto Rico, 2011
 
HIV-positive Preliminary HIV-positive Confirmed HIV-positive 
HIV testing events Characteristic testing events testing events testing events 
Number (Column %) Number (Positive %) Number (Positive %) Number (Positive %) 
Age at test (years) 
<13 907 (0.1) 9 (1.0) 3 (0.3) 6 (0.7) 
13-19 92,751 (13.1) 118 (0.1) 28 (<0.1) 89 (0.1) 
20-29 332,890 (46.8) 851 (0.3) 168 (0.1) 683 (0.2) 
30-39 153,245 (21.6) 742 (0.5) 132 (0.1) 608 (0.4) 
40-49 81,920 (11.5) 727 (0.9) 129 (0.2) 597 (0.7) 
50+ 44,584 (6.3) 443 (1.0) 65 (0.1) 377 (0.8) 
Missing/invalid 4,357 (0.6) 11 (0.3) 3 (0.1) 8 (0.2) 
race/Ethnicity 
White 201,547 (28.4) 453 (0.2) 84 (<0.1) 368 (0.2) 
Black or African American 330,239 (46.5) 1,885 (0.6) 339 (0.1) 1,543 (0.5) 
Hispanic or Latino 140,969 (19.8) 458 (0.3) 83 (0.1) 375 (0.3) 
Asian 9,519 (1.3) 17 (0.2) 2 (<0.1) 15 (0.2) 
American Indian or Alaska Native 4,276 (0.6) 10 (0.2) 8 (0.2) 2 (<0.1) 
Native Hawaiian or Pacific Islander 1,759 (0.2) 6 (0.3) 0 (0) 5 (0.3) 
Multi-race 8,148 (1.1) 16 (0.2) 4 (<0.1) 12 (0.1) 
Declined 4,562 (0.6) 21 (0.5) 5 (0.1) 16 (0.4) 
Don’t know 7,383 (1.0) 16 (0.2) 3 (<0.1) 13 (0.2) 
Missing/invalid 2,252 (0.3) 19 (0.8) 0 (0) 19 (0.8) 
u.S. geographic region (Puerto rico excluded) 
Northeast 137,866 (19.4) 654 (0.5) 158 (0.1) 494 (0.4) 
Midwest 83,477 (11.7) 181 (0.2) 60 (0.1) 121 (0.1) 
South 431,636 (60.7) 1,810 (0.4) 270 (0.1) 1,537 (0.4) 
West 42,921 (6.0) 133 (0.3) 38 (0.1) 95 (0.2) 
testing site type 
Health care and correctional facilities 533,867 (75.1) 1,931 (0.4) 296 (0.1) 1,630 (0.3) 
Non-health care facilities 161,960 (22.8) 891 (0.6) 222 (0.1) 669 (0.4) 
Other facilities 9,436 (1.3) 66 (0.7) 10 (0.1) 56 (0.6) 
Missing/invalid 5,391 (0.8) 13 (0.2) 0 (0) 13 (0.2) 
rapid test used in testing event 
Yes 374,108 (52.6) 1,785 (0.5) 528 (0.1) 1,257 (0.3) 
No 335,339 (47.2) 1,111 (0.3) ... ... 1,111 (0.3) 
Missing/invalid 1,207 (0.2) 5 (0.4) ... ... ... ... 
total 710,654 (100.0) 2,901 (0.4) 528 (0.1) 2,368 (0.3) 
Notes:  Ellipses (...) indicate not applicable.
Preliminary HIV-positive and confirmed HIV-positive testing events do not sum to HIV-positive testing events due to missing HIV test technology for 5 testing events.  
See Technical Notes for definitions of preliminary and confirmed HIV-positive testing event. 
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table 14: Receipt of HIV test results by characteristics of individuals tested and test result, 55 health department 
jurisdictions submitting test-level data in the United States and Puerto Rico, 2011 
Characteristic Test result 
received 
Preliminary HIV-positive testing events 
Test result not  Missing/ (Indicator %) received invalid 
(Missing/
invalid %) 
Test result 
received 
Confirmed HIV-positive testing events 
Test result not  Missing/ (Indicator %) received invalid 
(Missing/
invalid %) 
Age at test (years) 
<13 
13-19 
20-29 
30-39 
40-49 
50+ 
Missing/invalid 
gender 
Male 
Female 
Transgender 
Declined 
Missing/invalid 
race/Ethnicity 
White 
Black or African  
American 
Hispanic or Latino 
Asian 
American Indian or Alaska Native 
Native Hawaiian or Pacific Islander 
Multi-race 
Declined 
Don’t know 
Missing/invalid 
u.S. geographic region (Puerto rico excluded) 
Northeast 
Midwest 
South 
West 
testing site type 
Health care and correctional facilities 
Non-health care facilities 
Other facilities 
Missing/invalid 
rapid test used in testing event 
Yes 
No 
9 
180 
1,420 
972 
1,046 
786 
81 
3,269 
1,130 
81 
3 
11 
901 
2,490 
816 
46 
27 
13 
55 
48 
91 
7 
1,046 
382 
2,240 
799 
2,351 
2,057 
78 
8 
4,494 
... 
0 
5 
54 
35 
42 
27 
0 
113 
46 
3 
0 
1 
26 
104 
19 
0 
0 
0 
4 
4 
5 
1 
43 
44 
62 
14 
117 
42 
2 
2 
163 
... 
2 
15 
79 
42 
37 
32 
0 
119 
87 
1 
0 
0 
53 
68 
44 
9 
4 
1 
1 
6 
6 
15 
37 
3 
103 
64 
160 
19 
22 
6 
207 
... 
(100.0) 
(97.3) 
(96.3) 
(96.5) 
(96.1) 
(96.7) 
(100.0) 
(96.7) 
(96.1) 
(96.4) 
(100.0) 
(91.7) 
(97.2) 
(96.0) 
(97.7) 
(100.0) 
(100.0) 
(100.0) 
(93.2) 
(92.3) 
(94.8) 
(87.5) 
(96.1) 
(89.7) 
(97.3) 
(98.3) 
(95.3) 
(98.0) 
(97.5) 
(80.0) 
(96.5) 
... 
(18.2) 
(7.5) 
(5.1) 
(4.0) 
(3.3) 
(3.8) 
(0) 
(3.4) 
(6.9) 
(1.2) 
(0) 
(0) 
(5.4) 
(2.6) 
(5.0) 
(16.4) 
(12.9) 
(7.1) 
(1.7) 
(10.3) 
(5.9) 
(65.2) 
(3.3) 
(0.7) 
(4.3) 
(7.3) 
(6.1) 
(0.9) 
(21.6) 
(37.5) 
(4.3) 
... 
26 
540 
6,699 
4,836 
4,672 
3,165 
226 
15,622 
4,250 
198 
7 
87 
4,212 
10,330 
4,369 
251 
49 
49 
136 
132 
277 
359 
3,424 
1,331 
12,241 
2,525 
12,761 
6,521 
738 
144 
12,020 
8,144 
2 
81 
542 
277 
245 
150 
17 
925 
365 
6 
3 
15 
225 
758 
152 
3 
3 
2 
9 
24 
26 
112 
111 
116 
951 
94 
1,000 
290 
23 
1 
141 
1,173 
2 
95 
1,113 
786 
730 
453 
1 
2,342 
832 
2 
4 
0 
673 
2,296 
111 
17 
7 
1 
3 
5 
67 
0 
67 
3 
2,963 
146 
2,902 
214 
63 
1 
778 
2,402 
(92.9) 
(87.0) 
(92.5) 
(94.6) 
(95.0) 
(95.5) 
(93.0) 
(94.4) 
(92.1) 
(97.1) 
(70.0) 
(85.3) 
(94.9) 
(93.2) 
(96.6) 
(98.8) 
(94.2) 
(96.1) 
(93.8) 
(84.6) 
(91.4) 
(76.2) 
(96.9) 
(92.0) 
(92.8) 
(96.4) 
(92.7) 
(95.7) 
(97.0) 
(99.3) 
(98.8) 
(87.4) 
(6.7) 
(13.3) 
(13.3) 
(13.3) 
(12.9) 
(12.0) 
(0.4) 
(12.4) 
(15.3) 
(1.0) 
(28.6) 
(0) 
(13.2) 
(17.2) 
(2.4) 
(6.3) 
(11.9) 
(1.9) 
(2.0) 
(3.1) 
(18.1) 
(0) 
(1.9) 
(0.2) 
(18.3) 
(5.3) 
(17.4) 
(3.0) 
(7.6) 
(0.7) 
(6.0) 
(20.5) 
total 4,494 163 207 (96.5) (4.3) 20,164 1,314 3,180 (93.9) (12.9) 
 
Notes: Ellipses (...) indicate not applicable.
See Technical Notes for definitions of preliminary HIV-positive and confirmed HIV-positive testing events.
Indicator percentages exclude ‘Missing/invalid’ data from denominators.  ‘Missing/invalid’ percentages include all data in denominators. 
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table Section 3 
Continuum of HIV-testing related activities 
among newly identified confirmed HIV-positive 

individuals 
 table 15: Testing continuum of testing event, receipt of result and linkage to HIV medical care, among newly identified
confirmed HIV-positive individuals, 55 health department jurisdictions submitting test-level data in the United States and 
Puerto Rico, 2011 
HIV testing events 
Characteristic All testing Positive tests (Positive %) events 
Age at test (years) 
<13 6,846 26 (0.4) 
13-19 336,445 626 (0.2) 
20-29 1,354,752 6,978 (0.5) 
30-39 701,989 4,439 (0.6) 
40-49 473,392 3,777 (0.8) 
50+ 400,995 2,412 (0.6) 
Missing/invalid 27,100 188 (0.7) 
race/Ethnicity 
White 893,130 3,800 (0.4) 
Black or African American 1,470,846 10,201 (0.7) 
Hispanic or Latino 683,379 3,239 (0.5) 
Asian 54,416 207 (0.4) 
American Indian or Alaska 16,502 47 (0.3) 
Native 
Native Hawaiian or Pacific 8,447 35 (0.4) 
Islander 
Multi-race 26,427 127 (0.5) 
Declined 21,528 127 (0.6) 
Don’t know 59,478 270 (0.5) 
Missing/invalid 67,366 393 (0.6) 
u.S. geographic region (Puerto rico excluded) 
Northeast 717,511 2,954 (0.4) 
Midwest 294,425 1,265 (0.4) 
South 1,952,263 11,667 (0.6) 
West 294,562 2,123 (0.7) 
testing site type 
Health care facilities  2,426,694 12,052 (0.5) 
including correctional  
facility clinics 
Non-health care facilities 702,925 5,630 (0.8) 
Other facilities 130,120 632 (0.5) 
Missing/invalid 41,780 132 (0.3) 
rapid test used in testing event 
Yes 1,876,926 10,714 (0.6) 
No 1,419,657 7,732 (0.5) 
Missing/invalid 4,936 0 (0.0) 
Test result 
received 
23 
461 
5,550 
3,606 
3,042 
1,939 
171 
3,098 
7,680 
3,058 
188 
39 
32 
118 
112 
186 
281 
2,823 
1,175 
8,456 
1,932 
8,825 
5,255 
581 
131 
10,072 
4,720 
... 
receipt of test result 
Test result  Missing/ (Indicator 
not received invalid %) 
2 1 (92.0) 
81 84 (85.1) 
477 951 (92.1) 
211 622 (94.5) 
171 564 (94.7) 
121 352 (94.1) 
16 1 (91.4) 
169 533 (94.8) 
653 1,868 (92.2) 
95 86 (97.0) 
3 16 (98.4) 
2 6 (95.1) 
2 1 (94.1) 
6 3 (95.2) 
14 1 (88.9) 
23 61 (89.0) 
112 0 (71.5) 
67 64 (97.7) 
87 3 (93.1) 
829 2,382 (91.1) 
65 126 (96.7) 
875 2,352 (91.0) 
186 189 (96.6) 
18 33 (97.0) 
0 1 (100.0) 
82 560 (99.2) 
997 2,015 (82.6) 
... ... ... 
(Missing/
invalid%) 
(3.8) 
(13.4) 
(13.6) 
(14.0) 
(14.9) 
(14.6) 
(0.5) 
(14.0) 
(18.3) 
(2.7) 
(7.7) 
(12.8) 
(2.9) 
(2.4) 
(0.8) 
(22.6) 
(0.0) 
(2.2) 
(0.2) 
(20.4) 
(5.9) 
(19.5) 
(3.4) 
(5.2) 
(0.8) 
(5.2) 
(26.1) 
... 
Linked 
13 
209 
2,742 
1,827 
1,515 
992 
119 
1,636 
3,634 
1,806 
104 
16 
19 
57 
52 
92 
1 
1,521 
409 
4,143 
1,015 
4,453 
2,831 
101 
32 
5,199 
2,218 
... 
linkage to HIV medical care 
 Missing/ (Indicator Not linked invalid %) 
5 8 (72.2) 
91 326 (69.7) 
972 3,264 (73.8) 
554 2,058 (76.7) 
505 1,757 (75.0) 
341 1,079 (74.4) 
12 57 (90.8) 
524 1,640 (75.7) 
1,401 5,166 (72.2) 
417 1,016 (81.2) 
19 84 (84.6) 
6 25 (72.7) 
4 12 (82.6) 
24 46 (70.4) 
30 45 (63.4) 
55 123 (62.6) 
0 392 (100.0) 
434 999 (77.8) 
308 548 (57.0) 
1,315 6,209 (75.9) 
344 764 (74.7) 
1,698 5,901 (72.4) 
712 2,087 (79.9) 
62 469 (62.0) 
8 92 (80.0) 
1,487 4,028 (77.8) 
993 4,521 (69.1) 
... ... ... 
(Missing/
invalid%) 
(30.8) 
(52.1) 
(46.8) 
(46.4) 
(46.5) 
(44.7) 
(30.3) 
(43.2) 
(50.6) 
(31.4) 
(40.6) 
(53.2) 
(34.3) 
(36.2) 
(35.4) 
(45.6) 
(99.7) 
(33.8) 
(43.3) 
(53.2) 
(36.0) 
(49.0) 
(37.1) 
(74.2) 
(69.7) 
(37.6) 
(58.5) 
... 
total 3,301,519 18,446 (0.6) 14,792 1,079 2,575 (93.2) (14.0) 7,417 2,480 8,549 (74.9) (46.3) 
 
Notes:  Ellipses (...) indicate not applicable.
See Technical Notes for definition of newly identified confirmed HIV-positive testing event.
Indicator percentages exclude ‘Missing/invalid’ from denominators.  ‘Missing/invalid’ percentages include all data in denominators. 
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table 16: Testing continuum of testing event, receipt of result and linkage to HIV medical care, among newly identified 
confirmed HIV-positive males, 55 health department jurisdictions submitting test-level data in the United States and Puerto 
Rico, 2011 
Characteristic All testing 
events 
HIV testing events 
Positive tests (Positive %) Test result received 
receipt of test result 
Test result  Missing/ (Indicator 
not received invalid %) 
(Missing/
invalid %) Linked 
linkage to HIV medical care 
 Missing/ (Indicator Not linked invalid %) 
(Missing/
invalid %) 
Age at test (years) 
<13 3,177 
13-19 124,414 
20-29 614,811 
30-39 343,074 
40-49 258,078 
50+ 236,635 
Missing/invalid 13,925 
race/Ethnicity 
White 457,486 
Black or African American 696,159 
Hispanic or Latino 322,877 
Asian 29,424 
American Indian or Alaska Native 7,932 
Native Hawaiian or Pacific 5,064 
Islander 
Multi-race 13,930 
Declined 11,796 
Don’t know 26,239 
Missing/invalid 23,207 
u.S. geographic region (Puerto rico excluded) 
Northeast 373,710 
Midwest 152,454 
South 856,980 
West 190,710 
testing site type 
Health care and correctional 1,113,488 
facilities 
Non-health care facilities 408,790 
Other facilities 53,872 
Missing/invalid 17,964 
rapid test used in testing event 
Yes 1,019,468 
No 573,337 
Missing/invalid 1,309 
14 
467 
5,801 
3,373 
2,786 
1,754 
149 
3,198 
7,525 
2,669 
180 
37 
29 
103 
100 
195 
308 
2,182 
1,076 
8,868 
1,914 
9,085 
4,644 
513 
102 
8,650 
5,694 
0 
(0.4) 
(0.4) 
(0.9) 
(1.0) 
(1.1) 
(0.7) 
(1.1) 
(0.7) 
(1.1) 
(0.8) 
(0.6) 
(0.5) 
(0.6) 
(0.7) 
(0.8) 
(0.7) 
(1.3) 
(0.6) 
(0.7) 
(1.0) 
(1.0) 
(0.8) 
(1.1) 
(1.0) 
(0.6) 
(0.8) 
(1.0) 
(0.0) 
14 
366 
4,710 
2,806 
2,280 
1,401 
135 
2,685 
5,727 
2,534 
164 
32 
28 
95 
88 
141 
218 
2,099 
1,002 
6,574 
1,754 
6,777 
4,355 
478 
102 
8,144 
3,568 
... 
0 
36 
324 
140 
123 
88 
14 
96 
442 
66 
3 
0 
0 
5 
11 
12 
90 
50 
71 
538 
45 
575 
139 
11 
0 
70 
655 
... 
0 
65 
767 
427 
383 
265 
0 
417 
1,356 
69 
13 
5 
1 
3 
1 
42 
0 
33 
3 
1,756 
115 
1,733 
150 
24 
0 
436 
1,471 
... 
(100.0) 
(91.0) 
(93.6) 
(95.2) 
(94.9) 
(94.1) 
(90.6) 
(96.5) 
(92.8) 
(97.5) 
(98.2) 
(100.0) 
(100.0) 
(95.0) 
(88.9) 
(92.2) 
(70.8) 
(97.7) 
(93.4) 
(92.4) 
(97.5) 
(92.2) 
(96.9) 
(97.8) 
(100.0) 
(99.1) 
(84.5) 
... 
(0.0) 
(13.9) 
(13.2) 
(12.7) 
(13.7) 
(15.1) 
(0.0) 
(13.0) 
(18.0) 
(2.6) 
(7.2) 
(13.5) 
(3.4) 
(2.9) 
(1.0) 
(21.5) 
(0.0) 
(1.5) 
(0.3) 
(19.8) 
(6.0) 
(19.1) 
(3.2) 
(4.7) 
(0.0) 
(5.0) 
(25.8) 
... 
9 
170 
2,320 
1,418 
1,142 
695 
95 
1,420 
2,661 
1,502 
93 
13 
15 
45 
38 
62 
0 
1,136 
347 
3,201 
936 
3,374 
2,361 
89 
25 
4,199 
1,650 
... 
2 
66 
848 
438 
371 
257 
9 
453 
1,080 
344 
16 
5 
3 
17 
26 
47 
0 
320 
272 
1,032 
309 
1,335 
596 
53 
7 
1,224 
767 
... 
3 
231 
2,633 
1,517 
1,273 
802 
45 
1,325 
3,784 
823 
71 
19 
11 
41 
36 
86 
308 
726 
457 
4,635 
669 
4,376 
1,687 
371 
70 
3,227 
3,277 
... 
(81.8) 
(72.0) 
(73.2) 
(76.4) 
(75.5) 
(73.0) 
(91.3) 
(75.8) 
(71.1) 
(81.4) 
(85.3) 
(72.2) 
(83.3) 
(72.6) 
(59.4) 
(56.9) 
(0.0) 
(78.0) 
(56.1) 
(75.6) 
(75.2) 
(71.7) 
(79.8) 
(62.7) 
(78.1) 
(77.4) 
(68.3) 
... 
(21.4) 
(49.5) 
(45.4) 
(45.0) 
(45.7) 
(45.7) 
(30.2) 
(41.4) 
(50.3) 
(30.8) 
(39.4) 
(51.4) 
(37.9) 
(39.8) 
(36.0) 
(44.1) 
(100.0) 
(33.3) 
(42.5) 
(52.3) 
(35.0) 
(48.2) 
(36.3) 
(72.3) 
(68.6) 
(37.3) 
(57.6) 
... 
total 1,594,114 14,344 (0.9) 11,712 725 1,907 (94.2) (13.3) 5,849 1,991 6,504 (74.6) (45.3) 
 
Notes:  Ellipses (...) indicate not applicable.
See Technical Notes for definition of newly identified confirmed HIV-positive testing event.
Indicator percentages exclude ‘Missing/invalid’ from denominators. ‘Missing/invalid’ percentages include all data in denominators. 
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table 17: Testing continuum of testing event, receipt of result and linkage to HIV medical care, among newly identified 
confirmed HIV-positive females, 55 health department jurisdictions submitting test-level data in the United States and 
Puerto Rico, 2011 
Characteristic All testing 
events 
HIV testing events 
Positive tests (Positive %) Test result received 
receipt of test result 
Test result  Missing/ (Indicator 
not received invalid %) 
(Missing/
invalid %) Linked 
linkage to HIV medical care 
 Missing/ (Indicator Not linked invalid %) 
(Missing/
invalid %) 
Age at test (years) 
<13 3,553 
13-19 210,033 
20-29 731,073 
30-39 354,739 
40-49 212,936 
50+ 162,435 
Missing/invalid 12,545 
race/Ethnicity 
White 432,347 
Black or African American 769,020 
Hispanic or Latino 356,946 
Asian 24,699 
American Indian or Alaska Native 8,454 
Native Hawaiian or Pacific 3,246 
Islander 
Multi-race 12,213 
Declined 9,330 
Don’t know 27,836 
Missing/invalid 43,223 
u.S. geographic region (Puerto rico excluded) 
Northeast 339,750 
Midwest 140,728 
South 1,083,185 
West 101,254 
testing site type 
Health care and correctional 1,299,721 
facilities 
Non-health care facilities 288,112 
Other facilities 75,842 
Missing/invalid 23,639 
rapid test used in testing event 
Yes 846,221 
No 838,713 
Missing/invalid 2,380 
11 
145 
1,065 
1,013 
962 
637 
36 
582 
2,568 
516 
22 
10 
5 
16 
23 
46 
81 
716 
176 
2,693 
153 
2,851 
875 
113 
30 
1,896 
1,973 
0 
(0.3) 
(0.1) 
(0.1) 
(0.3) 
(0.5) 
(0.4) 
(0.3) 
(0.1) 
(0.3) 
(0.1) 
(0.1) 
(0.1) 
(0.2) 
(0.1) 
(0.2) 
(0.2) 
(0.2) 
(0.2) 
(0.1) 
(0.2) 
(0.2) 
(0.2) 
(0.3) 
(0.1) 
(0.1) 
(0.2) 
(0.2) 
(0.0) 
8 
85 
739 
754 
734 
520 
33 
399 
1,857 
470 
19 
7 
3 
15 
20 
24 
59 
668 
160 
1,797 
127 
1,953 
791 
100 
29 
1,763 
1,110 
... 
2 
41 
143 
67 
47 
32 
2 
68 
200 
29 
0 
2 
2 
1 
3 
7 
22 
17 
16 
275 
16 
284 
46 
4 
0 
11 
323 
... 
1 
19 
183 
192 
181 
85 
1 
115 
511 
17 
3 
1 
0 
0 
0 
15 
0 
31 
0 
621 
10 
614 
38 
9 
1 
122 
540 
... 
(80.0) 
(67.5) 
(83.8) 
(91.8) 
(94.0) 
(94.2) 
(94.3) 
(85.4) 
(90.3) 
(94.2) 
(100.0) 
(77.8) 
(60.0) 
(93.8) 
(87.0) 
(77.4) 
(72.8) 
(97.5) 
(90.9) 
(86.7) 
(88.8) 
(87.3) 
(94.5) 
(96.2) 
(100.0) 
(99.4) 
(77.5) 
... 
(9.1) 
(13.1) 
(17.2) 
(19.0) 
(18.8) 
(13.3) 
(2.8) 
(19.8) 
(19.9) 
(3.3) 
(13.6) 
(10.0) 
(0.0) 
(0.0) 
(0.0) 
(32.6) 
(0.0) 
(4.3) 
(0.0) 
(23.1) 
(6.5) 
(21.5) 
(4.3) 
(8.0) 
(3.3) 
(6.4) 
(27.4) 
... 
3 
38 
359 
389 
357 
288 
23 
210 
930 
271 
8 
3 
3 
7 
10 
14 
1 
355 
59 
889 
56 
1,017 
424 
9 
7 
919 
538 
... 
3 
23 
110 
107 
128 
82 
3 
68 
303 
63 
3 
1 
1 
5 
4 
8 
0 
104 
33 
278 
20 
351 
97 
7 
1 
236 
220 
... 
5 
84 
596 
517 
477 
267 
10 
304 
1,335 
182 
11 
6 
1 
4 
9 
24 
80 
257 
84 
1,526 
77 
1,483 
354 
97 
22 
741 
1,215 
... 
(50.0) 
(62.3) 
(76.5) 
(78.4) 
(73.6) 
(77.8) 
(88.5) 
(75.5) 
(75.4) 
(81.1) 
(72.7) 
(75.0) 
(75.0) 
(58.3) 
(71.4) 
(63.6) 
(100.0) 
(77.3) 
(64.1) 
(76.2) 
(73.7) 
(74.3) 
(81.4) 
(56.3) 
(87.5) 
(79.6) 
(71.0) 
... 
(45.5) 
(57.9) 
(56.0) 
(51.0) 
(49.6) 
(41.9) 
(27.8) 
(52.2) 
(52.0) 
(35.3) 
(50.0) 
(60.0) 
(20.0) 
(25.0) 
(39.1) 
(52.2) 
(98.8) 
(35.9) 
(47.7) 
(56.7) 
(50.3) 
(52.0) 
(40.5) 
(85.8) 
(73.3) 
(39.1) 
(61.6) 
... 
total 1,687,314 3,869 (0.2) 2,873 334 662 (89.6) (17.1) 1,457 456 1,956 (76.2) (50.6) 
 
Notes:  Ellipses (...) indicate not applicable.  
See Technical Notes for definition of newly identified confirmed HIV-positive testing event.
Indicator percentages exclude ‘Missing/invalid’ from denominators. ‘Missing/invalid’ percentages include all data in denominators. 
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table 18: Testing continuum of testing event, receipt of result and linkage to HIV medical care, among newly 
identified confirmed HIV-positive transgender persons, 51 health department jurisdictions submitting test-level data in 
the United States and Puerto Rico, 2011 
Characteristic All testing 
events 
HIV testing events 
Positive tests (Positive %) Test result received 
receipt of test result 
Test result  Missing/ (Indicator 
not received invalid %) 
(Missing/
invalid %) Linked 
linkage to HIV medical care 
 Missing/ (Indicator Not linked invalid %) 
(Missing/
invalid %) 
Age at test (years) 
<13 14 
13-19 420 
20-29 2,988 
30-39 1,459 
40-49 768 
50+ 450 
Missing/invalid 93 
race/Ethnicity 
White 1,271 
Black or African American 1,888 
Hispanic or Latino 2,185 
Asian 186 
American Indian or Alaska 90 
Native 
Native Hawaiian or Pacific 107 
Islander 
Multi-race 182 
Declined 102 
Don’t know 180 
Missing/invalid 1 
u.S. geographic region (Puerto rico excluded) 
Northeast 1,983 
Midwest 473 
South 1,602 
West 2,033 
testing site type 
Health care and correctional 2,380 
facilities 
Non-health care facilities 3,556 
Other facilities 216 
Missing/invalid 40 
rapid test used in testing event 
Yes 5,677 
No 509 
Missing/invalid 6 
1 
8 
83 
41 
22 
10 
1 
13 
90 
48 
5 
0 
1 
7 
2 
0 
0 
48 
11 
51 
54 
61 
99 
6 
0 
147 
19 
0 
(7.1) 
(1.9) 
(2.8) 
(2.8) 
(2.9) 
(2.2) 
(1.1) 
(1.0) 
(4.8) 
(2.2) 
(2.7) 
(0) 
(0.9) 
(3.8) 
(2.0) 
(0) 
(0) 
(2.4) 
(2.3) 
(3.2) 
(2.7) 
(2.6) 
(2.8) 
(2.8) 
(0) 
(2.6) 
(3.7) 
(0) 
1 
7 
80 
39 
22 
9 
1 
11 
85 
48 
5 
... 
1 
7 
2 
... 
... 
48 
11 
49 
49 
58 
98 
3 
... 
145 
14 
... 
0 
1 
2 
2 
0 
0 
0 
1 
4 
0 
0 
... 
0 
0 
0 
... 
... 
0 
0 
1 
4 
2 
0 
3 
... 
0 
5 
... 
0 
0 
1 
0 
0 
1 
0 
1 
1 
0 
0 
... 
0 
0 
0 
... 
... 
0 
0 
1 
1 
1 
1 
0 
... 
2 
0 
... 
(100.0) 
(87.5) 
(97.6) 
(95.1) 
(100.0) 
(100.0) 
(100.0) 
(91.7) 
(95.5) 
(100.0) 
(100.0) 
... 
(100.0) 
(100.0) 
(100.0) 
... 
... 
(100.0) 
(100.0) 
(98.0) 
(92.5) 
(96.7) 
(100.0) 
(50.0) 
... 
(100.0) 
(73.7) 
... 
(0) 
(0) 
(1.2) 
(0) 
(0) 
(10.0) 
(0) 
(7.7) 
(1.1) 
(0) 
(0) 
... 
(0) 
(0) 
(0) 
... 
... 
(0) 
(0) 
(2.0) 
(1.9) 
(1.6) 
(1.0) 
(0) 
... 
(1.4) 
(0) 
... 
1 
0 
46 
16 
10 
4 
1 
4 
36 
28 
3 
... 
1 
4 
2 
... 
... 
26 
1 
28 
21 
35 
40 
3 
... 
68 
10 
... 
0 
2 
13 
8 
6 
2 
0 
2 
17 
10 
0 
... 
0 
2 
0 
... 
... 
10 
3 
3 
15 
10 
19 
2 
... 
27 
4 
... 
0 
6 
24 
17 
6 
4 
0 
7 
37 
10 
2 
... 
0 
1 
0 
... 
... 
12 
7 
20 
18 
16 
40 
1 
... 
52 
5 
... 
(100.0) 
(0) 
(78.0) 
(66.7) 
(62.5) 
(66.7) 
(100.0) 
(66.7) 
(67.9) 
(73.7) 
(100.0) 
... 
(100.0) 
(66.7) 
(100.0) 
... 
... 
(72.2) 
(25.0) 
(90.3) 
(58.3) 
(77.8) 
(67.8) 
(60.0) 
... 
(71.6) 
(71.4) 
... 
(0) 
(75.0) 
(28.9) 
(41.5) 
(27.3) 
(40.0) 
(0) 
(53.8) 
(41.1) 
(20.8) 
(40.0) 
... 
(0) 
(14.3) 
(0) 
... 
... 
(25.0) 
(63.6) 
(39.2) 
(33.3) 
(26.2) 
(40.4) 
(16.7) 
... 
(35.4) 
(26.3) 
... 
total 6,192 166 (2.7) 159 5 2 (97.0) (1.2) 78 31 57 (71.6) (34.3) 
Notes:  51 health department jurisdictions are included because Alaska, North Dakota, North Carolina and West Virginia did not report any testing events for transgender persons. 
Ellipses (...) indicate not applicable.  
See Technical Notes for definition of newly identified confirmed HIV-positive testing event.
Indicator percentages exclude ‘Missing/invalid’ from denominators. ‘Missing/invalid’ percentages include all data in denominators. 
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 table 19: Testing continuum of testing event, receipt of result and linkage to HIV medical care, among newly identified
confirmed HIV-positive individuals tested in health care and correctional facility testing sites, 55 health department 
jurisdictions submitting test-level data in the United States and Puerto Rico, 2011 
HIV testing events receipt of test result linkage to HIV medical care 
Characteristic All testing Test result Test result  Missing/ (Indicator (Missing/  Missing/ (Indicator (Missing/Positive tests (Positive %) Linked Not linked events received not received invalid %) invalid) invalid %) invalid) 
Age at test (years) 
<13 5,230 18 (0.3) 15 2 1 (88.2) (5.6) 9 5 4 (64.3) (22.2) 
13-19 252,486 429 (0.2) 275 75 79 (78.6) (18.4) 123 65 241 (65.4) (56.2) 
20-29 1,019,319 4,563 (0.4) 3,247 414 902 (88.7) (19.8) 1,591 706 2,266 (69.3) (49.7) 
30-39 517,092 2,848 (0.6) 2,106 167 575 (92.7) (20.2) 1,068 380 1,400 (73.8) (49.2) 
40-49 332,027 2,507 (0.8) 1,867 132 508 (93.4) (20.3) 964 327 1,216 (74.7) (48.5) 
50+ 280,510 1,550 (0.6) 1,192 72 286 (94.3) (18.5) 611 204 735 (75.0) (47.4) 
Missing/invalid 20,030 137 (0.7) 123 13 1 (90.4) (0.7) 87 11 39 (88.8) (28.5) 
gender 
Male 1,113,488 9,085 (0.8) 6,777 575 1,733 (92.2) (19.1) 3,374 1,335 4,376 (71.7) (48.2) 
Female 1,299,721 2,851 (0.2) 1,953 284 614 (87.3) (21.5) 1,017 351 1,483 (74.3) (52.0) 
Transgender 2,380 61 (2.6) 58 2 1 (96.7) (1.6) 35 10 16 (77.8) (26.2) 
Declined 2,557 14 (0.5) 7 3 4 (70.0) (28.6) 6 2 6 (75.0) (42.9) 
Missing/invalid 8,548 41 (0.5) 30 11 0 (73.2) (0) 21 0 20 (100.0) (48.8) 
race/Ethnicity 
White 673,551 2,298 (0.3) 1,694 125 479 (93.1) (20.8) 865 338 1,095 (71.9) (47.7) 
Black or African American 1,108,866 7,290 (0.7) 5,031 542 1,717 (90.3) (23.6) 2,445 1,043 3,802 (70.1) (52.2) 
Hispanic or Latino 474,605 1,732 (0.4) 1,594 63 75 (96.2) (4.3) 958 227 547 (80.8) (31.6) 
Asian 36,224 98 (0.3) 80 2 16 (97.6) (16.3) 44 10 44 (81.5) (44.9) 
American Indian or Alaska Native 9,605 27 (0.3) 22 0 5 (100.0) (18.5) 11 3 13 (78.6) (48.1) 
Native Hawaiian or Pacific 5,990 20 (0.3) 17 2 1 (89.5) (5.0) 12 2 6 (85.7) (30.0) 
Islander 
Multi-race 17,137 53 (0.3) 50 1 2 (98.0) (3.8) 26 9 18 (74.3) (34.0) 
Declined 14,700 66 (0.4) 54 11 1 (83.1) (1.5) 28 20 18 (58.3) (27.3) 
Don’t know 45,435 211 (0.5) 138 17 56 (89.0) (26.5) 63 46 102 (57.8) (48.3) 
Missing/invalid 40,581 257 (0.6) 145 112 0 (56.4) (0) 1 0 256 (100.0) (99.6) 
u.S. geographic region (Puerto rico excluded) 
Northeast 505,746 1,769 (0.3) 1,663 43 63 (97.5) (3.6) 917 276 576 (76.9) (32.6) 
Midwest 228,085 807 (0.4) 747 59 1 (92.7) (0.1) 287 170 350 (62.8) (43.4) 
South 1,499,672 8,293 (0.6) 5,381 728 2,184 (88.1) (26.3) 2,613 1,072 4,608 (70.9) (55.6) 
West 169,709 874 (0.5) 746 24 104 (96.9) (11.9) 394 131 349 (75.0) (39.9) 
risk category 
Male-to-male sexual contact and 2,783 98 (3.5) 90 2 6 (97.8) (6.1) 54 18 26 (75.0) (26.5) 
injection drug use 
Male-male sexual contact 100,662 3,401 (3.4) 2,781 118 502 (95.9) (14.8) 1,526 505 1,370 (75.1) (40.3) 
Injection drug use 53,126 164 (0.3) 142 11 11 (92.8) (6.7) 83 23 58 (78.3) (35.4) 
High-risk heterosexual contact 909,697 2,550 (0.3) 2,054 202 294 (91.0) (11.5) 1,155 304 1,091 (79.2) (42.8) 
Low-risk heterosexual contact 361,202 1,076 (0.3) 543 21 512 (96.3) (47.6) 368 121 587 (75.3) (54.6) 
Other 18,687 32 (0.2) 24 0 8 (100.0) (25.0) 7 4 21 (63.6) (65.6) 
No acknowledged risk 127,014 594 (0.5) 490 17 87 (96.6) (14.6) 239 151 204 (61.3) (34.3) 
Not asked about risk 570,437 2,174 (0.4) 1,469 20 685 (98.7) (31.5) 344 314 1,516 (52.3) (69.7) 
Declined to discuss risk 5,495 58 (1.1) 47 1 10 (97.9) (17.2) 19 10 29 (65.5) (50.0) 
Missing/invalid 277,591 1,905 (0.7) 1,185 483 237 (71.0) (12.4) 658 248 999 (72.6) (52.4) 
rapid test used in testing event 
Yes 1,214,582 5,881 (0.5) 5,323 47 511 (99.1) (8.7) 2,745 910 2,226 (75.1) (37.9) 
No 1,207,372 6,171 (0.5) 3,502 828 1,841 (80.9) (29.8) 1,708 788 3,675 (68.4) (59.6) 
Missing/invalid 4,740 0 (0) ... ... ... ... ... ... ... ... ... ... 
total 2,426,694 12,052 (0.5) 8,825 875 2,352 (91.0) (19.5) 4,453 1,698 5,901 (72.4) (49.0) 
Notes:  Ellipses (...) indicate not applicable.  
See Technical Notes for definition of newly identified confirmed HIV-positive testing event.
Indicator percentages exclude ‘Missing/invalid’ from denominators. ‘Missing/invalid’ percentages include all data in denominators. 
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table 20: Testing continuum of testing event, receipt of result and linkage to HIV medical care, among newly identified 
confirmed HIV-positive individuals tested in non-health care testing sites, 54 health department jurisdictions submitting 
test-level data in the United States and Puerto Rico, 2011 
HIV testing events receipt of test result linkage to HIV medical care 
Characteristic All testing Test result Test result Missing/ (Indicator (Missing/ Missing/ (Indicator (Missing/Positive tests (Positive %) Linked Not linked events received not received invalid %) invalid %) invalid %) invalid %) 
Age at test (years) 
<13 1,014 6 (0.6) 6 0 0 (100.0) (0) 4 0 2 (100.0) (33.3) 
13-19 67,633 172 (0.3) 163 5 4 (97.0) (2.3) 85 23 64 (78.7) (37.2) 
20-29 261,779 2,108 (0.8) 2,007 59 42 (97.1) (2.0) 1,090 234 784 (82.3) (37.2) 
30-39 146,443 1,391 (0.9) 1,319 38 34 (97.2) (2.4) 727 153 511 (82.6) (36.7) 
40-49 117,809 1,128 (1.0) 1,047 34 47 (96.9) (4.2) 530 168 430 (75.9) (38.1) 
50+ 102,023 779 (0.8) 670 47 62 (93.4) (8.0) 367 133 279 (73.4) (35.8) 
Missing/invalid 6,224 
gender 
46 (0.7) 43 3 0 (93.5) (0) 28 1 17 (96.6) (37.0) 
Male 408,790 4,644 (1.1) 4,355 139 150 (96.9) (3.2) 2,361 596 1,687 (79.8) (36.3) 
Female 288,112 875 (0.3) 791 46 38 (94.5) (4.3) 424 97 354 (81.4) (40.5) 
Transgender 3,556 99 (2.8) 98 0 1 (100.0) (1.0) 40 19 40 (67.8) (40.4) 
Declined 313 0 (0) ... ... ... ... ... ... ... ... ... ... 
Missing/invalid 2,154 
race/Ethnicity 
12 (0.6) 11 1 0 (91.7) (0) 6 0 6 (100.0) (50.0) 
White 185,120 1,396 (0.8) 1,310 41 45 (97.0) (3.2) 744 172 480 (81.2) (34.4) 
Black or African American 297,137 2,483 (0.8) 2,252 101 130 (95.7) (5.2) 1,115 316 1,052 (77.9) (42.4) 
Hispanic or Latino 171,328 1,425 (0.8) 1,386 28 11 (98.0) (0.8) 820 181 424 (81.9) (29.8) 
Asian 15,680 103 (0.7) 102 1 0 (99.0) (0) 58 9 36 (86.6) (35.0) 
American Indian or Alaska Native 6,046 19 (0.3) 16 2 1 (88.9) (5.3) 5 3 11 (62.5) (57.9) 
Native Hawaiian or Pacific Islander 2,228 15 (0.7) 15 0 0 (100.0) (0) 7 2 6 (77.8) (40.0) 
Multi-race 8,626 66 (0.8) 60 5 1 (92.3) (1.5) 30 10 26 (75.0) (39.4) 
Declined 6,253 61 (1.0) 58 3 0 (95.1) (0) 24 10 27 (70.6) (44.3) 
Don’t know 7,374 54 (0.7) 48 5 1 (90.6) (1.9) 28 9 17 (75.7) (31.5) 
Missing/invalid 3,133 
u.S. geographic region (Puerto rico excluded) 
8 (0.3) 8 0 0 (100.0) (0) 0 0 8 (0) (100.0) 
Northeast 172,775 1,138 (0.7) 1,115 23 0 (98.0) (0) 580 152 406 (79.2) (35.7) 
Midwest 59,669 451 (0.8) 421 28 2 (93.8) (0.4) 122 135 194 (47.5) (43.0) 
South 332,623 2,724 (0.8) 2,463 96 165 (96.2) (6.1) 1,452 199 1,073 (87.9) (39.4) 
West 119,662 
risk category 
1,196 (1.0) 1,145 29 22 (97.5) (1.8) 592 197 407 (75.0) (34.0) 
Male-to-male sexual contact and 
injection drug use 
4,256 117 (2.7) 113 3 1 (97.4) (0.9) 52 19 46 (73.2) (39.3) 
Male-male sexual contact 134,075 3,020 (2.3) 2,893 63 64 (97.9) (2.1) 1,567 379 1,074 (80.5) (35.6) 
Injection drug use 26,324 166 (0.6) 157 7 2 (95.7) (1.2) 68 46 52 (59.6) (31.3) 
High-risk heterosexual contact 299,469 1,116 (0.4) 1,071 43 2 (96.1) (0.2) 571 108 437 (84.1) (39.2) 
Low-risk heterosexual contact 86,193 372 (0.4) 256 27 89 (90.5) (23.9) 124 54 194 (69.7) (52.2) 
Other 10,618 14 (0.1) 10 0 4 (100.0) (28.6) 8 0 6 (100.0) (42.9) 
No acknowledged risk 60,263 253 (0.4) 245 8 0 (96.8) (0) 169 31 53 (84.5) (20.9) 
Not asked about risk 29,287 126 (0.4) 124 2 0 (98.4) (0) 56 15 55 (78.9) (43.7) 
Declined to discuss risk 2,560 18 (0.7) 16 2 0 (88.9) (0) 11 3 4 (78.6) (22.2) 
Missing/invalid 49,880 
rapid test used in testing event 
428 (0.9) 370 31 27 (92.3) (6.3) 205 57 166 (78.2) (38.8) 
Yes 600,525 4,527 (0.8) 4,444 35 48 (99.2) (1.1) 2,348 524 1,655 (81.8) (36.6) 
No 102,226 1,103 (1.1) 811 151 141 (84.3) (12.8) 483 188 432 (72.0) (39.2) 
Missing/invalid 174 0 (0) ... ... ... ... ... ... ... ... ... ... 
total 702,925 5,630 (0.8) 5,255 186 189 (96.6) (3.4) 2,831 712 2,087 (79.9) (37.1) 
Notes:  54 health department jurisdictions are included because Alabama did not submit any testing events conducted in non-health care settings. Ellipses (...) indicate not applicable.  
See Technical Notes for definition of newly identified confirmed HIV-positive testing event.
Indicator percentages exclude ‘Missing/invalid’ from denominators. ‘Missing/invalid’ percentages include all data in denominators. 
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 table 21: Testing continuum of testing event, receipt of result and linkage to HIV medical care, among newly identified
confirmed HIV-positive men who have sex with men, 55 health department jurisdictions submitting test-level data in the 
United States and Puerto Rico, 2011 
Characteristic All testing 
events 
HIV testing events 
Positive tests (Positive %) Test result received 
receipt of test result 
Test result  Missing/ (Indicator 
not received invalid %) 
(Missing/
invalid %) Linked 
linkage to HIV medical care 
 Missing/ (Indicator Not linked invalid %) 
(Missing/
invalid %) 
Age at test (years) 
<13 322 
13-19 15,173 
20-29 108,079 
30-39 56,985 
40-49 40,655 
50+ 27,969 
Missing/invalid 1,324 
race/Ethnicity 
White 111,514 
Black or African American 59,849 
Hispanic or Latino 56,575 
Asian 8,903 
American Indian or Alaska  1,459 
Native 
Native Hawaiian or Pacific 1,215 
Islander 
Multi-race 3,990 
Declined 2,294 
Don’t know 2,976 
Missing/invalid 1,732 
u.S. geographic region (Puerto rico excluded) 
Northeast 49,078 
Midwest 29,964 
South 98,707 
West 69,436 
testing site type 
Health care and correctional 103,445 
facilities 
Non-health care facilities 138,331 
Other facilities 7,290 
Missing/invalid 1,441 
rapid test used in testing event 
Yes 206,496 
No 43,831 
Missing/invalid 180 
5 
284 
3,631 
1,639 
981 
413 
12 
1,992 
3,017 
1,536 
116 
21 
21 
75 
46 
55 
86 
1,163 
704 
3,567 
1,392 
3,499 
3,137 
291 
38 
4,896 
2,069 
0 
(1.6) 
(1.9) 
(3.4) 
(2.9) 
(2.4) 
(1.5) 
(0.9) 
(1.8) 
(5.0) 
(2.7) 
(1.3) 
(1.4) 
(1.7) 
(1.9) 
(2.0) 
(1.8) 
(5.0) 
(2.4) 
(2.3) 
(3.6) 
(2.0) 
(3.4) 
(2.3) 
(4.0) 
(2.6) 
(2.4) 
(4.7) 
(0) 
5 
250 
3,196 
1,500 
871 
362 
6 
1,788 
2,511 
1,496 
110 
18 
20 
70 
46 
45 
86 
1,143 
655 
2,931 
1,325 
2,871 
3,006 
275 
38 
4,736 
1,454 
... 
0 
6 
102 
35 
25 
17 
6 
35 
122 
25 
2 
0 
0 
3 
0 
4 
0 
20 
47 
100 
21 
120 
66 
5 
0 
42 
149 
... 
0 
28 
333 
104 
85 
34 
0 
169 
384 
15 
4 
3 
1 
2 
0 
6 
0 
0 
2 
536 
46 
508 
65 
11 
0 
118 
466 
... 
(100.0) 
(97.7) 
(96.9) 
(97.7) 
(97.2) 
(95.5) 
(50.0) 
(98.1) 
(95.4) 
(98.4) 
(98.2) 
(100.0) 
(100.0) 
(95.9) 
(100.0) 
(91.8) 
(100.0) 
(98.3) 
(93.3) 
(96.7) 
(98.4) 
(96.0) 
(97.9) 
(98.2) 
(100.0) 
(99.1) 
(90.7) 
... 
(0) 
(9.9) 
(9.2) 
(6.3) 
(8.7) 
(8.2) 
(0) 
(8.5) 
(12.7) 
(1.0) 
(3.4) 
(14.3) 
(4.8) 
(2.7) 
(0) 
(10.9) 
(0) 
(0) 
(0.3) 
(15.0) 
(3.3) 
(14.5) 
(2.1) 
(3.8) 
(0) 
(2.4) 
(22.5) 
... 
4 
118 
1,645 
840 
466 
210 
2 
999 
1,199 
925 
68 
9 
10 
33 
16 
26 
0 
651 
173 
1,606 
739 
1,580 
1,619 
69 
17 
2,520 
765 
... 
0 
41 
511 
214 
130 
70 
0 
270 
479 
173 
11 
2 
2 
14 
8 
7 
0 
177 
218 
324 
230 
523 
398 
41 
4 
714 
252 
... 
1 
125 
1,475 
585 
385 
133 
10 
723 
1,339 
438 
37 
10 
9 
28 
22 
22 
86 
335 
313 
1,637 
423 
1,396 
1,120 
181 
17 
1,662 
1,052 
... 
(100.0) 
(74.2) 
(76.3) 
(79.7) 
(78.2) 
(75.0) 
(100.0) 
(78.7) 
(71.5) 
(84.2) 
(86.1) 
(81.8) 
(83.3) 
(70.2) 
(66.7) 
(78.8) 
(0) 
(78.6) 
(44.2) 
(83.2) 
(76.3) 
(75.1) 
(80.3) 
(62.7) 
(81.0) 
(77.9) 
(75.2) 
... 
(20.0) 
(44.0) 
(40.6) 
(35.7) 
(39.2) 
(32.2) 
(83.3) 
(36.3) 
(44.4) 
(28.5) 
(31.9) 
(47.6) 
(42.9) 
(37.3) 
(47.8) 
(40.0) 
(100.0) 
(28.8) 
(44.5) 
(45.9) 
(30.4) 
(39.9) 
(35.7) 
(62.2) 
(44.7) 
(33.9) 
(50.8) 
... 
total 250,507 6,965 (2.8) 6,190 191 584 (97.0) (8.4) 3,285 966 2,714 (77.3) (39.0) 
Notes:  Ellipses (...) indicate not applicable.
See Technical Notes for definition of newly identified confirmed HIV-positive testing event.
Indicator percentages exclude ‘Missing/invalid’ from denominators. ‘Missing/invalid’ percentages include all data in denominators. 
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table 22: Testing continuum of testing event, receipt of result and linkage to HIV medical care, among newly identified 
confirmed HIV-positive high-risk heterosexual males, 55 health department jurisdictions submitting test-level data in the 
United States and Puerto Rico, 2011 
Characteristic All testing 
events 
HIV testing events 
Positive tests (Positive %) Test result received 
receipt of test result 
Test result  Missing/ (Indicator 
not received invalid %) 
(Missing/
invalid %) Linked 
linkage to HIV medical care 
 Missing/ (Indicator Not linked invalid %) 
(Missing/
invalid %) 
Age at test (years) 
<13 602 
13-19 48,681 
20-29 219,372 
30-39 113,841 
40-49 78,395 
50+ 63,004 
Missing/invalid 3,838 
race/Ethnicity 
White 136,698 
Black or African American 266,326 
Hispanic or Latino 95,863 
Asian 6,635 
American Indian or Alaska Native 3,226 
Native Hawaiian or Pacific 1,674 
Islander 
Multi-race 6,506 
Declined 3,413 
Don’t know 4,541 
Missing/invalid 2,851 
u.S. geographic region (Puerto rico excluded) 
Northeast 131,071 
Midwest 74,434 
South 265,993 
West 47,301 
testing site type 
Health care and correctional 375,830 
facilities 
Non-health care facilities 137,509 
Other facilities 10,373 
Missing/invalid 4,021 
rapid test used in testing event 
Yes 337,145 
No 189,897 
Missing/invalid 691 
3 
48 
532 
467 
500 
377 
30 
206 
1,302 
375 
14 
5 
5 
13 
15 
13 
9 
495 
128 
1,124 
123 
1,306 
580 
54 
17 
1,204 
753 
0 
(0.5) 
(0.1) 
(0.2) 
(0.4) 
(0.6) 
(0.6) 
(0.8) 
(0.2) 
(0.5) 
(0.4) 
(0.2) 
(0.2) 
(0.3) 
(0.2) 
(0.4) 
(0.3) 
(0.3) 
(0.4) 
(0.2) 
(0.4) 
(0.3) 
(0.3) 
(0.4) 
(0.5) 
(0.4) 
(0.4) 
(0.4) 
(0) 
3 
40 
443 
416 
447 
342 
29 
176 
1,119 
356 
14 
5 
5 
12 
15 
9 
9 
481 
111 
930 
120 
1,096 
558 
49 
17 
1,189 
531 
... 
0 
5 
33 
26 
19 
14 
1 
14 
67 
16 
0 
0 
0 
1 
0 
0 
0 
14 
17 
56 
2 
74 
22 
2 
0 
14 
84 
... 
0 
3 
56 
25 
34 
21 
0 
16 
116 
3 
0 
0 
0 
0 
0 
4 
0 
0 
0 
138 
1 
136 
0 
3 
0 
1 
138 
... 
(100.0) 
(88.9) 
(93.1) 
(94.1) 
(95.9) 
(96.1) 
(96.7) 
(92.6) 
(94.4) 
(95.7) 
(100.0) 
(100.0) 
(100.0) 
(92.3) 
(100.0) 
(100.0) 
(100.0) 
(97.2) 
(86.7) 
(94.3) 
(98.4) 
(93.7) 
(96.2) 
(96.1) 
(100.0) 
(98.8) 
(86.3) 
... 
(0) 
(6.3) 
(10.5) 
(5.4) 
(6.8) 
(5.6) 
(0) 
(7.8) 
(8.9) 
(0.8) 
(0) 
(0) 
(0) 
(0) 
(0) 
(30.8) 
(0) 
(0) 
(0) 
(12.3) 
(0.8) 
(10.4) 
(0) 
(5.6) 
(0) 
(0.1) 
(18.3) 
... 
2 
22 
223 
208 
242 
196 
16 
76 
583 
222 
7 
0 
4 
6 
8 
3 
0 
254 
30 
504 
58 
596 
300 
7 
6 
633 
276 
... 
0 
1 
62 
59 
68 
42 
4 
20 
154 
51 
1 
2 
0 
2 
3 
3 
0 
69 
26 
101 
20 
170 
59 
5 
2 
151 
85 
... 
1 
25 
247 
200 
190 
139 
10 
110 
565 
102 
6 
3 
1 
5 
4 
7 
9 
172 
72 
519 
45 
540 
221 
42 
9 
420 
392 
... 
(100.0) 
(95.7) 
(78.2) 
(77.9) 
(78.1) 
(82.4) 
(80.0) 
(79.2) 
(79.1) 
(81.3) 
(87.5) 
(0) 
(100.0) 
(75.0) 
(72.7) 
(50.0) 
(0) 
(78.6) 
(53.6) 
(83.3) 
(74.4) 
(77.8) 
(83.6) 
(58.3) 
(75.0) 
(80.7) 
(76.5) 
... 
(33.3) 
(52.1) 
(46.4) 
(42.8) 
(38.0) 
(36.9) 
(33.3) 
(53.4) 
(43.4) 
(27.2) 
(42.9) 
(60.0) 
(20.0) 
(38.5) 
(26.7) 
(53.8) 
(100.0) 
(34.7) 
(56.3) 
(46.2) 
(36.6) 
(41.3) 
(38.1) 
(77.8) 
(52.9) 
(34.9) 
(52.1) 
... 
total 527,733 1,957 (0.4) 1,720 98 139 (94.6) (7.1) 909 236 812 (79.4) (41.5) 
Notes:  Ellipses (...) indicate not applicable.  
See Technical Notes for definition of newly identified confirmed HIV-positive testing event.
Indicator percentages exclude ‘Missing/invalid’ from denominators. ‘Missing/invalid’ percentages include all data in denominators. 
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 table 23: Testing continuum of testing event, receipt of result and linkage to HIV medical care, among newly identified
confirmed HIV-positive high-risk heterosexual females, 55 health department jurisdictions submitting test-level data in the 
United States and Puerto Rico, 2011 
Characteristic All testing 
events 
HIV testing events 
Positive tests (Positive %) Test result received 
receipt of test result 
Test result  Missing/ (Indicator 
not received invalid %) 
(Missing/
invalid %) Linked 
linkage to HIV medical care 
 Missing/ (Indicator Not linked invalid %) 
(Missing/
invalid %) 
Age at test (years) 
<13 907 
13-19 92,751 
20-29 332,890 
30-39 153,245 
40-49 81,920 
50+ 44,584 
Missing/invalid 4,357 
race/Ethnicity 
White 201,547 
Black or African American 330,239 
Hispanic or Latino 140,969 
Asian 9,519 
American Indian or Alaska Native 4,276 
Native Hawaiian or Pacific 1,759 
Islander 
Multi-race 8,148 
Declined 4,562 
Don’t know 7,383 
Missing/invalid 2,252 
u.S. geographic region (Puerto rico excluded) 
Northeast 137,866 
Midwest 83,477 
South 431,636 
West 42,921 
testing site type 
Health care and correctional 533,867 
facilities 
Non-health care facilities 161,960 
Other facilities 9,436 
Missing/invalid 5,391 
rapid test used in testing event 
Yes 374,108 
No 335,339 
Missing/invalid 1,207 
5 
77 
566 
474 
431 
273 
7 
281 
1,211 
280 
8 
2 
3 
10 
15 
10 
13 
396 
107 
1,171 
75 
1,244 
536 
42 
11 
1,042 
791 
0 
(0.6) 
(0.1) 
(0.2) 
(0.3) 
(0.5) 
(0.6) 
(0.2) 
(0.1) 
(0.4) 
(0.2) 
(0.1) 
(<0.1) 
(0.2) 
(0.1) 
(0.3) 
(0.1) 
(0.6) 
(0.3) 
(0.1) 
(0.3) 
(0.2) 
(0.2) 
(0.3) 
(0.4) 
(0.2) 
(0.3) 
(0.2) 
(0) 
3 
47 
430 
412 
375 
245 
7 
213 
995 
256 
8 
2 
2 
9 
15 
6 
13 
388 
100 
889 
63 
958 
513 
38 
10 
1,021 
498 
... 
2 
27 
78 
21 
13 
9 
0 
43 
82 
21 
0 
0 
1 
1 
0 
2 
0 
6 
7 
123 
9 
128 
21 
1 
0 
7 
143 
... 
0 
3 
58 
41 
43 
19 
0 
25 
134 
3 
0 
0 
0 
0 
0 
2 
0 
2 
0 
159 
3 
158 
2 
3 
1 
14 
150 
... 
(60.0) 
(63.5) 
(84.6) 
(95.2) 
(96.6) 
(96.5) 
(100.0) 
(83.2) 
(92.4) 
(92.4) 
(100.0) 
(100.0) 
(66.7) 
(90.0) 
(100.0) 
(75.0) 
(100.0) 
(98.5) 
(93.5) 
(87.8) 
(87.5) 
(88.2) 
(96.1) 
(97.4) 
(100.0) 
(99.3) 
(77.7) 
... 
(0) 
(3.9) 
(10.2) 
(8.6) 
(10.0) 
(7.0) 
(0) 
(8.9) 
(11.1) 
(1.1) 
(0) 
(0) 
(0) 
(0) 
(0) 
(20.0) 
(0) 
(0.5) 
(0) 
(13.6) 
(4.0) 
(12.7) 
(0.4) 
(7.1) 
(9.1) 
(1.3) 
(19.0) 
... 
0 
26 
236 
232 
202 
144 
1 
121 
534 
161 
5 
1 
2 
5 
8 
3 
1 
203 
30 
508 
35 
559 
271 
6 
5 
558 
283 
... 
1 
11 
48 
45 
48 
31 
1 
21 
126 
32 
0 
0 
1 
2 
2 
1 
0 
53 
21 
87 
11 
134 
49 
2 
0 
108 
77 
... 
4 
40 
282 
197 
181 
98 
5 
139 
551 
87 
3 
1 
0 
3 
5 
6 
12 
140 
56 
576 
29 
551 
216 
34 
6 
376 
431 
... 
(0) 
(70.3) 
(83.1) 
(83.8) 
(80.8) 
(82.3) 
(50.0) 
(85.2) 
(80.9) 
(83.4) 
(100.0) 
(100.0) 
(66.7) 
(71.4) 
(80.0) 
(75.0) 
(100.0) 
(79.3) 
(58.8) 
(85.4) 
(76.1) 
(80.7) 
(84.7) 
(75.0) 
(100.0) 
(83.8) 
(78.6) 
... 
(80.0) 
(51.9) 
(49.8) 
(41.6) 
(42.0) 
(35.9) 
(71.4) 
(49.5) 
(45.5) 
(31.1) 
(37.5) 
(50.0) 
(0) 
(30.0) 
(33.3) 
(60.0) 
(92.3) 
(35.4) 
(52.3) 
(49.2) 
(38.7) 
(44.3) 
(40.3) 
(81.0) 
(54.5) 
(36.1) 
(54.5) 
... 
total 710,654 1,833 (0.3) 1,519 150 164 (91.0) (8.9) 841 185 807 (82.0) (44.0) 
Notes:  Ellipses (...) indicate not applicable.  
See Technical Notes for definition of newly iden
Indicator percentages exclude ‘Missing/invalid’ f
tified confirmed H
rom denominato
IV-positive tes
rs. ‘Missing/inv
ting event.
alid’ percentages include all data in denominators. 
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table 24: Partner and HIV prevention services referrals among newly identified confirmed HIV-positive individuals, 55 
health department jurisdictions submitting test-level data in the United States and Puerto Rico, 2011 
Characteristic 
Age at test (years) 
<13 
13-19 
20-29 
30-39 
40-49 
50+ 
Missing/invalid 
race/Ethnicity 
White 
Black or African American 
Hispanic or Latino 
Asian 
American Indian or Alaska Native 
Native Hawaiian or Pacific Islander 
Multi-race 
Declined 
Don’t know 
Missing/invalid 
u.S. geographic region (Puerto rico excluded) 
Northeast 
Midwest 
South 
West 
testing site type 
Health care facilities including correctional   
facility clinics 
Non-health care facilities 
Other facilities 
Missing/invalid 
rapid test used in testing event 
Yes 
No 
Referred 
17 
376 
4,015 
2,501 
1,916 
1,233 
137 
2,145 
5,318 
2,048 
123 
28 
25 
79 
47 
127 
255 
1,335 
780 
6,294 
1,438 
5,852 
3,700 
543 
100 
6,564 
3,631 
referred to partner services 
 Missing/Not referred (Indicator %) invalid 
6 3 (73.9) 
76 174 (83.2) 
1,026 1,937 (79.6) 
709 1,229 (77.9) 
697 1,164 (73.3) 
448 731 (73.3) 
20 31 (87.3) 
643 1,012 (76.9) 
1,457 3,426 (78.5) 
731 460 (73.7) 
39 45 (75.9) 
9 10 (75.7) 
4 6 (86.2) 
20 28 (79.8) 
19 61 (71.2) 
60 83 (67.9) 
0 138 (100.0) 
910 709 (59.5) 
129 356 (85.8) 
1,615 3,758 (79.6) 
248 437 (85.3) 
2,066 4,134 (73.9) 
868 1,062 (81.0) 
29 60 (94.9) 
19 13 (84.0) 
1,700 2,450 (79.4) 
1,282 2,819 (73.9) 
(Missing/
invalid %) 
(11.5) 
(27.8) 
(27.8) 
(27.7) 
(30.8) 
(30.3) 
(16.5) 
(26.6) 
(33.6) 
(14.2) 
(21.7) 
(21.3) 
(17.1) 
(22.0) 
(48.0) 
(30.7) 
(35.1) 
(24.0) 
(28.1) 
(32.2) 
(20.6) 
(34.3) 
(18.9) 
(9.5) 
(9.8) 
(22.9) 
(36.5) 
Referred 
11 
209 
2,482 
1,539 
1,206 
766 
80 
1,482 
3,041 
1,461 
111 
20 
17 
66 
16 
78 
1 
1,277 
753 
2,741 
1,151 
3,578 
2,520 
167 
28 
4,488 
1,805 
referred to HIV prevention services 
 Missing/Not referred (Indicator %) invalid 
8 7 (57.9) 
79 338 (72.6) 
1,243 3,253 (66.6) 
868 2,032 (63.9) 
775 1,796 (60.9) 
498 1,148 (60.6) 
63 45 (55.9) 
857 1,461 (63.4) 
1,602 5,558 (65.5) 
919 859 (61.4) 
42 54 (72.5) 
8 19 (71.4) 
9 9 (65.4) 
23 38 (74.2) 
7 104 (69.6) 
67 125 (53.8) 
0 392 (100.0) 
1,060 617 (54.6) 
164 348 (82.1) 
1,673 7,253 (62.1) 
580 392 (66.5) 
2,377 6,097 (60.1) 
1,103 2,007 (69.6) 
39 426 (81.1) 
15 89 (65.1) 
2,095 4,131 (68.2) 
1,439 4,488 (55.6) 
 (Missing/
invalid %) 
(26.9) 
(54.0) 
(46.6) 
(45.8) 
(47.6) 
(47.6) 
(23.9) 
(38.4) 
(54.5) 
(26.5) 
(26.1) 
(40.4) 
(25.7) 
(29.9) 
(81.9) 
(46.3) 
(99.7) 
(20.9) 
(27.5) 
(62.2) 
(18.5) 
(50.6) 
(35.6) 
(67.4) 
(67.4) 
(38.6) 
(58.0) 
total 10,195 2,982 5,269 (77.4) (28.6) 6,293 3,534 8,619 (64.0) (46.7) 
 Notes:  See Technical Notes for definition of newly identified confirmed HIV-positive testing event.
Indicator percentages exclude ‘Missing/invalid’ from denominators. ‘Missing/invalid’ percentages include all data in denominators. 
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table 25: Partner and HIV prevention services referrals, among newly identified confirmed HIV-positive males, 55 health 
department jurisdictions submitting test-level data in the United States and Puerto Rico, 2011 
referred to partner services referred to HIV prevention services 
Characteristic 
Referred Not referred Missing/invalid (Indicator %) (Missing/invalid %) Referred Not referred Missing/invalid (Indicator %) 
(Missing/
invalid %) 
<13 10 2 2 (83.3) (14.3) 7 4 3 (63.6) (21.4) 
13-19 278 56 133 (83.2) (28.5) 167 63 237 (72.6) (50.7) 
20-29 3,377 848 1,576 (79.9) (27.2) 2,146 1,074 2,581 (66.6) (44.5) 
30-39 1,945 535 893 (78.4) (26.5) 1,252 682 1,439 (64.7) (42.7) 
40-49 1,420 524 842 (73.0) (30.2) 899 585 1,302 (60.6) (46.7) 
50+ 893 317 544 (73.8) (31.0) 552 355 847 (60.9) (48.3) 
White 1,822 554 822 (76.7) (25.7) 1,299 759 1,140 (63.1) (35.6) 
Black or African American 3,973 1,023 2,529 (79.5) (33.6) 2,351 1,152 4,022 (67.1) (53.4) 
Hispanic or Latino 1,699 601 369 (73.9) (13.8) 1,183 775 711 (60.4) (26.6) 
Asian 111 33 36 (77.1) (20.0) 98 37 45 (72.6) (25.0) 
American Indian or Alaska Native 25 6 6 (80.6) (16.2) 17 7 13 (70.8) (35.1) 
Native Hawaiian or Pacific Islander 20 3 6 (87.0) (20.7) 14 7 8 (66.7) (27.6) 
Multi-race 66 14 23 (82.5) (22.3) 54 19 30 (74.0) (29.1) 
Declined 34 17 49 (66.7) (49.0) 12 5 83 (70.6) (83.0) 
Don’t know 85 49 61 (63.4) (31.3) 59 54 82 (52.2) (42.1) 
Northeast 1,024 658 500 (60.9) (22.9) 980 768 434 (56.1) (19.9) 
Midwest 679 102 295 (86.9) (27.4) 658 132 286 (83.3) (26.6) 
South 4,767 1,273 2,828 (78.9) (31.9) 2,163 1,342 5,363 (61.7) (60.5) 
Health care facilities including correctional    
facility clinics 
4,408 1,564 3,113 (73.8) (34.3) 2,793 1,832 4,460 (60.4) (49.1) 
Non-health care facilities 3,101 696 847 (81.7) (18.2) 2,126 937 1,581 (69.4) (34.0) 
Other facilities 443 25 45 (94.7) (8.8) 145 35 333 (80.6) (64.9) 
No 2,629 977 2,088 (72.9) (36.7) 1,352 1,132 3,210 (54.4) (56.4) 
total 8,031 2,300 4,013 (77.7) (28.0) 5,087 2,815 6,442 (64.4) (44.9) 
Age at test (years) 
Missing/invalid 108 18 23 (85.7) (15.4) 64 52 33 (55.2) (22.1) 
race/Ethnicity 
Missing/invalid 196 0 112 (100.0) (36.4) 0 0 308 (0) (100.0) 
u.S. geographic region (Puerto rico excluded) 
West 1,317 212 385 (86.1) (20.1) 1,028 532 354 (65.9) (18.5) 
testing site type 
Missing/invalid 79 15 8 (84.0) (7.8) 23 11 68 (67.6) (66.7) 
rapid test used in testing event 
Yes 5,402 1,323 1,925 (80.3) (22.3) 3,735 1,683 3,232 (68.9) (37.4) 
Notes:  See Technical Notes for definition of newly identified confirmed HIV-positive testing event.
Indicator percentages exclude ‘Missing/invalid’ from denominators. ‘Missing/invalid’ percentages include all data in denominators. 
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table 26: Partner and HIV prevention services referrals, among newly identified confirmed HIV-positive females, 55 health 
department jurisdictions submitting test-level data in the United States and Puerto Rico, 2011 
referred to partner services referred to HIV prevention services 
Characteristic 
Referred Not referred Missing/invalid (Indicator %) (Missing/invalid %) Referred Not referred Missing/invalid (Indicator %) 
(Missing/
invalid %) 
<13 6 4 1 (60.0) (9.1) 3 4 4 (42.9) (36.4) 
13-19 89 20 36 (81.7) (24.8) 38 16 91 (70.4) (62.8) 
20-29 561 163 341 (77.5) (32.0) 283 151 631 (65.2) (59.2) 
30-39 527 165 321 (76.2) (31.7) 262 177 574 (59.7) (56.7) 
40-49 477 167 318 (74.1) (33.1) 294 184 484 (61.5) (50.3) 
50+ 324 130 183 (71.4) (28.7) 203 142 292 (58.8) (45.8) 
White 310 87 185 (78.1) (31.8) 176 95 311 (64.9) (53.4) 
Black or African American 1,282 415 871 (75.5) (33.9) 643 434 1,491 (59.7) (58.1) 
Hispanic or Latino 311 121 84 (72.0) (16.3) 246 130 140 (65.4) (27.1) 
Asian 8 6 8 (57.1) (36.4) 10 4 8 (71.4) (36.4) 
American Indian or Alaska Native 3 3 4 (50.0) (40.0) 3 1 6 (75.0) (60.0) 
Native Hawaiian or Pacific Islander 4 1 0 (80.0) (0) 2 2 1 (50.0) (20.0) 
Multi-race 7 5 4 (58.3) (25.0) 6 4 6 (60.0) (37.5) 
Declined 10 2 11 (83.3) (47.8) 4 1 18 (80.0) (78.3) 
Don’t know 19 11 16 (63.3) (34.8) 8 13 25 (38.1) (54.3) 
Northeast 286 237 193 (54.7) (27.0) 272 274 170 (49.8) (23.7) 
Midwest 95 25 56 (79.2) (31.8) 89 30 57 (74.8) (32.4) 
South 1,453 336 904 (81.2) (33.6) 542 325 1,826 (62.5) (67.8) 
Health care facilities including correctional    
facility clinics 
1,366 488 997 (73.7) (35.0) 742 527 1,582 (58.5) (55.5) 
Non-health care facilities 531 155 189 (77.4) (21.6) 336 149 390 (69.3) (44.6) 
Other facilities 94 4 15 (95.9) (13.3) 16 4 93 (80.0) (82.3) 
No 954 301 718 (76.0) (36.4) 430 301 1,242 (58.8) (62.9) 
total 2,012 651 1,206 (75.6) (31.2) 1,099 684 2,086 (61.6) (53.9) 
Age at test (years) 
Missing/invalid 28 2 6 (93.3) (16.7) 16 10 10 (61.5) (27.8) 
race/Ethnicity 
Missing/invalid 58 0 23 (100.0) (28.4) 1 0 80 (100.0) (98.8) 
u.S. geographic region (Puerto rico excluded) 
West 76 28 49 (73.1) (32.0) 85 39 29 (68.5) (19.0) 
testing site type 
Missing/invalid 21 4 5 (84.0) (16.7) 5 4 21 (55.6) (70.0) 
rapid test used in testing event 
Yes 1,058 350 488 (75.1) (25.7) 669 383 844 (63.6) (44.5) 
Notes: See Technical Notes for definition of newly identified confirmed HIV-positive testing event.
Indicator percentages exclude ‘Missing/invalid’ from denominators. ‘Missing/invalid’ percentages include all data in denominators. 
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table 27: Partner and HIV prevention services referrals, among newly identified confirmed HIV-positive transgender 
persons, 51 health department jurisdictions submitting test-level data in the United States and Puerto Rico, 2011 
Characteristic 
Referred 
referred to partner services 
Not referred Missing/invalid (Indicator %)  (Missing/invalid %) Referred 
referred to HIV prevention services 
Not referred Missing/invalid (Indicator %)  (Missing/invalid %) 
Age at test (years) 
<13 1 0 0 (100.0) (0) 1 0 0 (100.0) (0) 
13-19 4 0 4 (100.0) (50.0) 3 0 5 (100.0) (62.5) 
20-29 54 14 15 (79.4) (18.1) 42 16 25 (72.4) (30.1) 
30-39 23 9 9 (71.9) (22.0) 21 9 11 (70.0) (26.8) 
40-49 12 6 4 (66.7) (18.2) 9 6 7 (60.0) (31.8) 
50+ 7 1 2 (87.5) (20.0) 8 1 1 (88.9) (10.0) 
Missing/invalid 1 0 0 (100.0) (0) 0 1 0 (0) (0) 
race/Ethnicity 
White 8 2 3 (80.0) (23.1) 6 3 4 (66.7) (30.8) 
Black or African American 51 18 21 (73.9) (23.3) 43 15 32 (74.1) (35.6) 
Hispanic or Latino 32 9 7 (78.0) (14.6) 26 14 8 (65.0) (16.7) 
Asian 4 0 1 (100.0) (20.0) 3 1 1 (75.0) (20.0) 
Native Hawaiian or Pacific Islander 1 0 0 (100.0) (0) 1 0 0 (100.0) (0) 
Multi-race 5 1 1 (83.3) (14.3) 5 0 2 (100.0) (28.6) 
Declined 1 0 1 (100.0) (50.0) 0 0 2 (0) (100.0) 
u.S. geographic region (Puerto rico excluded) 
Northeast 22 15 11 (59.5) (22.9) 22 17 9 (56.4) (18.8) 
Midwest 4 2 5 (66.7) (45.5) 4 2 5 (66.7) (45.5) 
South 31 5 15 (86.1) (29.4) 20 5 26 (80.0) (51.0) 
West 43 8 3 (84.3) (5.6) 36 9 9 (80.0) (16.7) 
testing site type 
Health care and correctional facilities 37 13 11 (74.0) (18.0) 25 16 20 (61.0) (32.8) 
Non-health care facilities 59 17 23 (77.6) (23.2) 53 17 29 (75.7) (29.3) 
Other facilities 6 0 0 (100.0) (0) 6 0 0 (100.0) (0) 
rapid test used in testing event 
Yes 89 27 31 (76.7) (21.1) 77 28 42 (73.3) (28.6) 
No 13 3 3 (81.3) (15.8) 7 5 7 (58.3) (36.8) 
total 102 30 34 (77.3) (20.5) 84 33 49 (71.8) (29.5) 
Notes:  51 health department jurisdictions are included because Alaska, North Dakota, North Carolina and West Virginia did not report any testing events for transgender persons. 
Ellipses (...) indicate not applicable.  
See Technical Notes for definition of newly identified confirmed HIV-positive testing event.
Indicator percentages exclude ‘Missing/invalid’ from denominators. ‘Missing/invalid’ percentages include all data in denominators. 
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table 28: Partner and HIV prevention services referrals, among newly identified confirmed HIV-positive individuals tested 
in health care and correctional facility testing sites, 55 health department jurisdictions submitting test-level data in the 
United States and Puerto Rico, 2011 
Characteristic 
Referred 
referred to partner services 
Not referred Missing/invalid (Indicator %)  (Missing/invalid %) Referred 
referred to HIV prevention services 
Not referred Missing/invalid (Indicator %)  (Missing/invalid %) 
Age at test (years) 
<13 
13-19 
20-29 
30-39 
40-49 
50+ 
Missing/invalid 
gender 
Male 
Female 
Transgender 
Declined 
Missing/invalid 
race/Ethnicity 
White 
Black or African American 
Hispanic or Latino 
Asian 
American Indian or Alaska Native 
Native Hawaiian or Pacific Islander 
Multi-race 
Declined 
Don’t know 
Missing/invalid 
u.S. geographic region (Puerto rico excluded) 
Northeast 
Midwest 
South 
West 
risk category 
Male-to-male sexual contact and injection drug 
use 
Male-to-male sexual contact 
Injection drug use 
High-risk heterosexual contact 
Low-risk heterosexual contact 
Other 
No acknowledged risk 
Not asked about risk 
Declined to discuss risk 
Missing/invalid 
rapid test used in testing event 
Yes 
No 
12 
239 
2,323 
1,382 
1,105 
687 
104 
4,408 
1,366 
37 
6 
35 
1,100 
3,402 
1,004 
42 
20 
15 
30 
30 
89 
120 
774 
521 
3,805 
505 
57 
2,222 
100 
1,657 
513 
16 
166 
271 
22 
828 
3,325 
2,527 
4 
52 
714 
486 
486 
318 
6 
1,564 
488 
13 
0 
1 
421 
1,095 
448 
24 
2 
2 
12 
14 
48 
0 
537 
68 
1,300 
107 
24 
391 
22 
329 
128 
4 
351 
627 
17 
173 
932 
1,134 
2 
138 
1,526 
980 
916 
545 
27 
3,113 
997 
11 
8 
5 
777 
2,793 
280 
32 
5 
3 
11 
22 
74 
137 
458 
218 
3,188 
262 
17 
788 
42 
564 
435 
12 
77 
1,276 
19 
904 
1,624 
2,510 
(75.0) 
(82.1) 
(76.5) 
(74.0) 
(69.5) 
(68.4) 
(94.5) 
(73.8) 
(73.7) 
(74.0) 
(100.0) 
(97.2) 
(72.3) 
(75.7) 
(69.1) 
(63.6) 
(90.9) 
(88.2) 
(71.4) 
(68.2) 
(65.0) 
(100.0) 
(59.0) 
(88.5) 
(74.5) 
(82.5) 
(70.4) 
(85.0) 
(82.0) 
(83.4) 
(80.0) 
(80.0) 
(32.1) 
(30.2) 
(56.4) 
(82.7) 
(78.1) 
(69.0) 
(11.1) 
(32.2) 
(33.4) 
(34.4) 
(36.5) 
(35.2) 
(19.7) 
(34.3) 
(35.0) 
(18.0) 
(57.1) 
(12.2) 
(33.8) 
(38.3) 
(16.2) 
(32.7) 
(18.5) 
(15.0) 
(20.8) 
(33.3) 
(35.1) 
(53.3) 
(25.9) 
(27.0) 
(38.4) 
(30.0) 
(17.3) 
(23.2) 
(25.6) 
(22.1) 
(40.4) 
(37.5) 
(13.0) 
(58.7) 
(32.8) 
(47.5) 
(27.6) 
(40.7) 
8 
130 
1,439 
823 
689 
431 
58 
2,793 
742 
25 
4 
14 
780 
1,931 
718 
40 
11 
8 
26 
10 
53 
1 
727 
489 
1,703 
403 
42 
1,475 
86 
960 
288 
11 
102 
247 
20 
347 
2,192 
1,386 
6 
50 
799 
588 
539 
351 
44 
1,832 
527 
16 
0 
2 
527 
1,188 
555 
27 
4 
7 
12 
3 
54 
0 
673 
83 
1,268 
308 
33 
596 
29 
373 
148 
4 
359 
645 
17 
173 
1,132 
1,245 
4 
249 
2,325 
1,437 
1,279 
768 
35 
4,460 
1,582 
20 
10 
25 
991 
4,171 
459 
31 
12 
5 
15 
53 
104 
256 
369 
235 
5,322 
163 
23 
1,330 
49 
1,217 
640 
17 
133 
1,282 
21 
1,385 
2,557 
3,540 
(57.1) 
(72.2) 
(64.3) 
(58.3) 
(56.1) 
(55.1) 
(56.9) 
(60.4) 
(58.5) 
(61.0) 
(100.0) 
(87.5) 
(59.7) 
(61.9) 
(56.4) 
(59.7) 
(73.3) 
(53.3) 
(68.4) 
(76.9) 
(49.5) 
(100.0) 
(51.9) 
(85.5) 
(57.3) 
(56.7) 
(56.0) 
(71.2) 
(74.8) 
(72.0) 
(66.1) 
(73.3) 
(22.1) 
(27.7) 
(54.1) 
(66.7) 
(65.9) 
(52.7) 
(22.2) 
(58.0) 
(51.0) 
(50.5) 
(51.0) 
(49.5) 
(25.5) 
(49.1) 
(55.5) 
(32.8) 
(71.4) 
(61.0) 
(43.1) 
(57.2) 
(26.5) 
(31.6) 
(44.4) 
(25.0) 
(28.3) 
(80.3) 
(49.3) 
(99.6) 
(20.9) 
(29.1) 
(64.2) 
(18.6) 
(23.5) 
(39.1) 
(29.9) 
(47.7) 
(59.5) 
(53.1) 
(22.4) 
(59.0) 
(36.2) 
(72.7) 
(43.5) 
(57.4) 
total 5,852 2,066 4,134 (73.9) (34.3) 3,578 2,377 6,097 (60.1) (50.6) 
Notes:  See Technical Notes for definition of newly identified confirmed HIV-positive testing event.
Indicator percentages exclude ‘Missing/invalid’ from denominators. ‘Missing/invalid’ percentages include all data in denominators. 
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table 29: Partner and HIV prevention services referrals, among newly identified confirmed HIV-positive individuals tested 
in non-health care testing sites, 54 health department jurisdictions submitting test-level data in the United States and 
Puerto Rico, 2011 
referred to partner services referred to HIV prevention services 
Characteristic 
Referred Not referred Missing/invalid (Indicator %) (Missing/invalid %) Referred Not referred Missing/invalid (Indicator %) 
(Missing/
invalid %) 
<13 3 2 1 (60.0) (16.7) 3 2 1 (60.0) (16.7) 
13-19 116 22 34 (84.1) (19.8) 75 27 70 (73.5) (40.7) 
20-29 1,425 292 391 (83.0) (18.5) 950 420 738 (69.3) (35.0) 
30-39 959 210 222 (82.0) (16.0) 670 265 456 (71.7) (32.8) 
40-49 691 204 233 (77.2) (20.7) 487 227 414 (68.2) (36.7) 
50+ 477 124 178 (79.4) (22.8) 317 143 319 (68.9) (40.9) 
Male 3,101 696 847 (81.7) (18.2) 2,126 937 1,581 (69.4) (34.0) 
Female 531 155 189 (77.4) (21.6) 336 149 390 (69.3) (44.6) 
Transgender 59 17 23 (77.6) (23.2) 53 17 29 (75.7) (29.3) 
White 967 218 211 (81.6) (15.1) 666 319 411 (67.6) (29.4) 
Black or African American 1,566 326 591 (82.8) (23.8) 1,000 380 1,103 (72.5) (44.4) 
Hispanic or Latino 970 277 178 (77.8) (12.5) 703 358 364 (66.3) (25.5) 
Asian 75 15 13 (83.3) (12.6) 68 15 20 (81.9) (19.4) 
American Indian or Alaska Native 8 7 4 (53.3) (21.1) 9 4 6 (69.2) (31.6) 
Native Hawaiian or Pacific Islander 10 2 3 (83.3) (20.0) 9 2 4 (81.8) (26.7) 
Multi-race 42 7 17 (85.7) (25.8) 34 9 23 (79.1) (34.8) 
Declined 17 5 39 (77.3) (63.9) 6 4 51 (60.0) (83.6) 
Don’t know 38 11 5 (77.6) (9.3) 25 12 17 (67.6) (31.5) 
Northeast 549 351 238 (61.0) (20.9) 527 374 237 (58.5) (20.8) 
Midwest 256 59 136 (81.3) (30.2) 261 79 111 (76.8) (24.6) 
South 1,917 295 512 (86.7) (18.8) 924 371 1,429 (71.4) (52.5) 
Male-to-male sexual contact and injection drug 84 16 17 (84.0) (14.5) 67 24 26 (73.6) (22.2) 
use 
Male-to-male sexual contact 2,203 314 503 (87.5) (16.7) 1,502 553 965 (73.1) (32.0) 
Injection drug use 99 35 32 (73.9) (19.3) 107 26 33 (80.5) (19.9) 
High-risk heterosexual contact 744 174 198 (81.0) (17.7) 479 172 465 (73.6) (41.7) 
Low-risk heterosexual contact 152 59 161 (72.0) (43.3) 62 66 244 (48.4) (65.6) 
Other 6 4 4 (60.0) (28.6) 8 1 5 (88.9) (35.7) 
No acknowledged risk 60 157 36 (27.6) (14.2) 55 155 43 (26.2) (17.0) 
Not asked about risk 71 40 15 (64.0) (11.9) 62 41 23 (60.2) (18.3) 
Declined to discuss risk 10 7 1 (58.8) (5.6) 8 5 5 (61.5) (27.8) 
Yes 3,007 731 789 (80.4) (17.4) 2,138 922 1,467 (69.9) (32.4) 
No 693 137 273 (83.5) (24.8) 382 181 540 (67.9) (49.0) 
total 3,700 868 1,062 (81.0) (18.9) 2,520 1,103 2,007 (69.6) (35.6) 
Age at test (years) 
Missing/invalid 29 14 3 (67.4) (6.5) 18 19 9 (48.6) (19.6) 
gender 
Missing/invalid 9 0 3 (100.0) (25.0) 5 0 7 (100.0) (58.3) 
race/Ethnicity 
Missing/invalid 7 0 1 (100.0) (12.5) 0 0 8 (0) (100.0) 
u.S. geographic region (Puerto rico excluded) 
West 884 137 175 (86.6) (14.6) 700 267 229 (72.4) (19.1) 
risk category 
Missing/invalid 271 62 95 (81.4) (22.2) 170 60 198 (73.9) (46.3) 
rapid test used in testing event 
Notes:  54 health department jurisdictions are included because Alabama did not submit any testing events conducted in non-health care settings. 
See Technical Notes for definition of newly identified confirmed HIV-positive testing event.
Indicator percentages exclude ‘Missing/invalid’ from denominators. ‘Missing/invalid’ percentages include all data in denominators. 
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table 30: Partner and HIV prevention services referrals, among newly identified confirmed HIV-positive men who have sex 
with men, 55 health department jurisdictions submitting test-level data in the United States and Puerto Rico, 2011 
Characteristic 
Referred 
referred to partner services 
Not referred Missing/invalid (Indicator %)  (Missing/invalid %) Referred 
referred to HIV prevention services 
Not referred Missing/invalid (Indicator %)  (Missing/invalid %) 
Age at test (years) 
<13 4 0 1 (100.0) (20.0) 3 1 1 (75.0) (20.0) 
13-19 202 28 54 (87.8) (19.0) 123 38 123 (76.4) (43.3) 
20-29 2,543 367 721 (87.4) (19.9) 1,647 593 1,391 (73.5) (38.3) 
30-39 1,179 189 271 (86.2) (16.5) 810 329 500 (71.1) (30.5) 
40-49 653 120 208 (84.5) (21.2) 436 187 358 (70.0) (36.5) 
50+ 274 58 81 (82.5) (19.6) 197 88 128 (69.1) (31.0) 
Missing/invalid 4 1 7 (80.0) (58.3) 1 1 10 (50.0) (83.3) 
race/Ethnicity 
White 1,394 223 375 (86.2) (18.8) 950 420 622 (69.3) (31.2) 
Black or African American 1,989 309 719 (86.6) (23.8) 1,338 401 1,278 (76.9) (42.4) 
Hispanic or Latino 1,164 196 176 (85.6) (11.5) 765 365 406 (67.7) (26.4) 
Asian 86 15 15 (85.1) (12.9) 71 21 24 (77.2) (20.7) 
American Indian or Alaska Native 16 2 3 (88.9) (14.3) 9 4 8 (69.2) (38.1) 
Native Hawaiian or Pacific Islander 15 2 4 (88.2) (19.0) 11 4 6 (73.3) (28.6) 
Multi-race 53 9 13 (85.5) (17.3) 42 13 20 (76.4) (26.7) 
Declined 17 2 27 (89.5) (58.7) 5 2 39 (71.4) (84.8) 
Don’t know 39 5 11 (88.6) (20.0) 26 7 22 (78.8) (40.0) 
Missing/invalid 86 0 0 (100.0) (0) 0 0 86 (0) (100.0) 
u.S. geographic region (Puerto rico excluded) 
Northeast 581 351 231 (62.3) (19.9) 544 431 188 (55.8) (16.2) 
Midwest 416 75 213 (84.7) (30.3) 408 95 201 (81.1) (28.6) 
South 2,669 188 710 (93.4) (19.9) 1,385 271 1,911 (83.6) (53.6) 
West 1,068 135 189 (88.8) (13.6) 754 427 211 (63.8) (15.2) 
testing site type 
Health care and correctional facilities 2,279 415 805 (84.6) (23.0) 1,517 629 1,353 (70.7) (38.7) 
Non-health care facilities 2,287 330 520 (87.4) (16.6) 1,569 577 991 (73.1) (31.6) 
Other facilities 265 10 16 (96.4) (5.5) 117 21 153 (84.8) (52.6) 
Missing/invalid 28 8 2 (77.8) (5.3) 14 10 14 (58.3) (36.8) 
rapid test used in testing event 
Yes 3,534 583 779 (85.8) (15.9) 2,516 914 1,466 (73.4) (29.9) 
No 1,325 180 564 (88.0) (27.3) 701 323 1,045 (68.5) (50.5) 
total 4,859 763 1,343 (86.4) (19.3) 3,217 1,237 2,511 (72.2) (36.1) 
Notes:  See Technical Notes for definition of newly identified confirmed HIV-positive testing event.
Indicator percentages exclude ‘Missing/invalid’ from denominators. ‘Missing/invalid’ percentages include all data in denominators. 
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table 31: Partner and HIV prevention services referrals, among newly identified confirmed HIV-positive  high-risk
heterosexual males, 55 health department jurisdiction submitting test-level data in the United States and Puerto Rico, 2011 
referred to partner services referred to HIV prevention services 
Characteristic  (Missing/  (Missing/Referred Not referred Missing/invalid (Indicator %) Referred Not referred Missing/invalid (Indicator %) invalid %) invalid ) 
Age at test (years) 
<13 1 1 1 (50.0) (33.3) 2 0 1 (100.0) (33.3) 
13-19 34 2 12 (94.4) (25.0) 19 1 28 (95.0) (58.3) 
20-29 324 64 144 (83.5) (27.1) 203 66 263 (75.5) (49.4) 
30-39 313 64 90 (83.0) (19.3) 191 65 211 (74.6) (45.2) 
40-49 315 91 94 (77.6) (18.8) 217 83 200 (72.3) (40.0) 
50+ 259 56 62 (82.2) (16.4) 155 69 153 (69.2) (40.6) 
Missing/invalid 23 3 4 (88.5) (13.3) 6 18 6 (25.0) (20.0) 
race/Ethnicity 
White 113 27 66 (80.7) (32.0) 83 27 96 (75.5) (46.6) 
Black or African American 859 165 278 (83.9) (21.4) 479 184 639 (72.2) (49.1) 
Hispanic or Latino 253 78 44 (76.4) (11.7) 200 83 92 (70.7) (24.5) 
Asian 7 5 2 (58.3) (14.3) 9 2 3 (81.8) (21.4) 
American Indian or Alaska Native 4 1 0 (80.0) (0) 3 1 1 (75.0) (20.0) 
Native Hawaiian or Pacific Islander 4 0 1 (100.0) (20.0) 3 1 1 (75.0) (20.0) 
Multi-race 7 2 4 (77.8) (30.8) 8 1 4 (88.9) (30.8) 
Declined 7 1 7 (87.5) (46.7) 3 1 11 (75.0) (73.3) 
Don’t know 6 2 5 (75.0) (38.5) 5 2 6 (71.4) (46.2) 
Missing/invalid 9 0 0 (100.0) (0) 0 0 9 (0) (100.0) 
u.S. geographic region (Puerto rico excluded) 
Northeast 243 129 123 (65.3) (24.8) 244 139 112 (63.7) (22.6) 
Midwest 70 12 46 (85.4) (35.9) 65 13 50 (83.3) (39.1) 
South 817 93 214 (89.8) (19.0) 353 91 680 (79.5) (60.5) 
West 79 20 24 (79.8) (19.5) 61 42 20 (59.2) (16.3) 
testing site type 
Health care and correctional facilities 834 175 297 (82.7) (22.7) 510 204 592 (71.4) (45.3) 
Non-health care facilities 388 97 95 (80.0) (16.4) 262 94 224 (73.6) (38.6) 
Other facilities 41 4 9 (91.1) (16.7) 15 3 36 (83.3) (66.7) 
Missing/invalid 6 5 6 (54.5) (35.3) 6 1 10 (85.7) (58.8) 
rapid test used in testing event 
Yes 816 186 202 (81.4) (16.8) 537 200 467 (72.9) (38.8) 
No 453 95 205 (82.7) (27.2) 256 102 395 (71.5) (52.5) 
total 1,269 281 407 (81.9) (20.8) 793 302 862 (72.4) (44.0) 
Notes:  See Technical Notes for definition of newly identified confirmed HIV-positive testing event.
Indicator percentages exclude ‘Missing/invalid’ from denominators. ‘Missing/invalid’ percentages include all data in denominators. 
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table 32: Partner and HIV prevention services referrals, among newly identified confirmed HIV-positive  high-risk
heterosexual females, 55 health department jurisdictions submitting test-level data in the United States and Puerto Rico, 
2011 
Characteristic 
Referred 
referred to partner services 
Not referred Missing/invalid (Indicator %)  (Missing/invalid %) Referred 
referred to HIV prevention services 
Not referred Missing/invalid (Indicator %)  (Missing/invalid %) 
Age at test (years) 
<13 4 1 0 (80.0) (0) 1 1 3 (50.0) (60.0) 
13-19 59 9 9 (86.8) (11.7) 27 5 45 (84.4) (58.4) 
20-29 362 66 138 (84.6) (24.4) 190 59 317 (76.3) (56.0) 
30-39 322 58 94 (84.7) (19.8) 169 69 236 (71.0) (49.8) 
40-49 283 57 91 (83.2) (21.1) 176 66 189 (72.7) (43.9) 
50+ 181 45 47 (80.1) (17.2) 117 51 105 (69.6) (38.5) 
Missing/invalid 4 0 3 (100.0) (42.9) 1 0 6 (100.0) (85.7) 
race/Ethnicity 
White 199 24 58 (89.2) (20.6) 99 30 152 (76.7) (54.1) 
Black or African American 783 154 274 (83.6) (22.6) 410 166 635 (71.2) (52.4) 
Hispanic or Latino 194 52 34 (78.9) (12.1) 155 51 74 (75.2) (26.4) 
Asian 4 2 2 (66.7) (25.0) 6 0 2 (100.0) (25.0) 
American Indian or Alaska Native 1 0 1 (100.0) (50.0) 0 0 2 (0) (100.0) 
Native Hawaiian or Pacific Islander 2 1 0 (66.7) (0) 2 1 0 (66.7) (0) 
Multi-race 5 2 3 (71.4) (30.0) 4 1 5 (80.0) (50.0) 
Declined 7 0 8 (100.0) (53.3) 3 0 12 (100.0) (80.0) 
Don’t know 7 1 2 (87.5) (20.0) 1 2 7 (33.3) (70.0) 
Missing/invalid 13 0 0 (100.0) (0) 1 0 12 (100.0) (92.3) 
u.S. geographic region (Puerto rico excluded) 
Northeast 173 120 103 (59.0) (26.0) 171 134 91 (56.1) (23.0) 
Midwest 59 11 37 (84.3) (34.6) 51 15 41 (77.3) (38.3) 
South 869 74 228 (92.2) (19.5) 346 69 756 (83.4) (64.6) 
West 49 12 14 (80.3) (18.7) 41 21 13 (66.1) (17.3) 
testing site type 
Health care and correctional facilities 823 154 267 (84.2) (21.5) 450 169 625 (72.7) (50.2) 
Non-health care facilities 356 77 103 (82.2) (19.2) 217 78 241 (73.6) (45.0) 
Other facilities 32 2 8 (94.1) (19.0) 11 1 30 (91.7) (71.4) 
Missing/invalid 4 3 4 (57.1) (36.4) 3 3 5 (50.0) (45.5) 
rapid test used in testing event 
Yes 687 159 196 (81.2) (18.8) 421 174 447 (70.8) (42.9) 
No 528 77 186 (87.3) (23.5) 260 77 454 (77.2) (57.4) 
total 1,215 236 382 (83.7) (20.8) 681 251 901 (73.1) (49.2) 
Notes:  See Technical Notes for definition of newly identified confirmed HIV-positive testing event.
Indicator percentages exclude ‘Missing/invalid’ from denominators. ‘Missing/invalid’ percentages include all data in denominators. 
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table Section 4
Risk groups among newly identified confirmed 

HIV-positive individuals 
table 33: Number and percentage of newly identified confirmed HIV-
positive individuals by risk category, 55 health departments submitting 
test-level data in the United States and Puerto Rico, 2011 
Newly identified  
confirmed HIV-positive (Column %) 
individuals 
risk category Male-to-male sexual contact and injection drug use 218 (1.2) 
Male-to-male male sexual contact 6,747 (36.6) 
Injection drug use 340 (1.8) 
High-risk heterosexual contact 3,790 (20.5) 
Low-risk heterosexual contact 1,586 (8.6) 
Other 53 (0.3) 
No acknowledged risk 867 (4.7) 
Not asked about risk 2,354 (12.8) 
Declined to discuss risk 77 (0.4) 
Missing/invalid 2,414 (13.1) 
total 18,446 (100.0) 
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Notes: 
See Technical Notes for definition of newly identified confirmed HIV-positive testing event and risk groups 
table 34: Number and percentage of newly identified confirmed HIV-positive individuals by risk category 
by male and female gender, 55 health department jurisdictions submitting test-level data in the United 
States and Puerto Rico, 2011 
risk category Newly identified  
confirmed HIV-positive 
males 
Males 
(Column %) 
Females 
 Newly identified
confirmed HIV-positive 
females 
(Column %) 
Male-to-male sexual contact and injection drug use 
Male-to-male sexual contact 
Injection drug use 
High-risk heterosexual contact 
Low-risk heterosexual contact 
Other 
No acknowledged risk 
Not asked about risk 
Declined to discuss risk 
Missing/invalid 
218 
6,747 
195 
1,957 
969 
0 
681 
1,821 
54 
1,702 
(1.5) 
(47.0) 
(1.4) 
(13.6) 
(6.8) 
(0) 
(4.7) 
(12.7) 
(0.4) 
(11.9) 
... 
... 
127 
1,833 
617 
53 
179 
524 
23 
513 
... 
... 
(3.3) 
(47.4) 
(15.9) 
(1.4) 
(4.6) 
(13.5) 
(0.6) 
(13.3) 
total 14,344 (100.0) 3,869 (100.0) 
Annual HIV Testing Report | 2011 | Tables | page 63 
Notes:  Ellipses (...) indicate not applicable.  
See Technical Notes for definition of newly identified confirmed HIV-positive testing event and risk groups. 
